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 Abstract 
  
 Synthetic peptides derived from the active core of a natural antimicrobial peptide were used as 
a template for the design of novel bolaamphiphilic peptides and hybrid molecules. The amphiphilic 
character of the original compounds was modified by using non-natural amino acids (AAs) – such 
as ω-AA – and varying the hydrophobic content. The outcomes of these modifications were studied 
focusing on structural and biological properties. 
 Because of the bolaamphiphilic character, the alternation of polar and non-polar AAs and the 
use of hydrophobic AAs such as tyrosine and leucine, these novel molecules were designed to 
undergo self-assembly in response to certain stimuli (e.g. a pH increase). This significant property 
was investigated by means of different tools, such as fluorescence measurements, electron 
microscopy (EM), Fourier transform infrared spectroscopy (FT-IR) and circular dichroism (CD). 
By using fluorescence it was possible to determine the critical aggregation concentration (CAC) of 
the new compounds. Differences in amino acid composition, which were reflected into diverse 
secondary structures and hydrophobicity (H), resulted in different CAC values and aggregation 
profiles. The data were consistent with the literature and showed that (i) the aggregation of these 
basic compounds was triggered by a pH increase, (ii) the use of hydrophobic AA highly augmented 
the self-assembly tendency while (iii) the presence of proline strongly reduced it. EM revealed the 
morphology of the peptide assemblies: microtubes and microvesicles were identified and 
characterised by dimensions of 500 nm to 2 µm. The presence of 3-way junctions and vesicles 
budding out of the microtubes demonstrated that the self-assembly is a dynamic process. The 
aggregation was confirmed by FT-IR spectroscopy, by studying the dried peptide assemblies and 
the significant spectral signs the process left, especially in the amide II envelope. 
 The relationship between hydrophobicity and self-assembly was expanded by experimentally 
and theoretically determining the hydrophobic content of the novel bolaamphiphiles. Data from 
liquid chromatography and computational calculations (two common ways used to determine the 
hydrophobicity of a given molecule) correlated well with the tendency to self-assemble, as 
expressed by CAC values. Importantly, some structural parameters (such as the presence of β-turn 
induced by proline) also showed significant influence on the aggregation, highly limiting the role 
of the peptides’ hydrophobicity. 
 These novel peptide bolaamphiphiles displayed a very low haemolytic action and retained 
some antimicrobial activity at high concentrations against both Gram-positive and -negative 
bacteria. Unfortunately, the activity was greatly reduced at low concentrations, as clearly 
demonstrated by the use of two antimicrobial tests. The inability to provoke cell lysis was also 
evident when using liposomes mimicking a negative bacterial membrane. 
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 The loss of activity is possibly related to the modifications of the three-dimensional structure 
caused by the use of ω-AA and proline, which strongly alter the secondary structure. 
 The results of this study were valuable in terms of understanding the relationships between 
self-assembly and structural parameters, such as AA compositions, hydrophobicity and secondary 
structure. Possible applications of the synthesised compounds were however limited as a result of 
the loss of the biological activity at low concentrations. 
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Opsomming 
 
 Sintetiese peptiede verkry vanaf die aktiewe kern van ŉ natuurlike antimikrobiese peptied is 
as ŉ templaat gebruik vir die ontwerp van nuwe bola-amfifiliese peptiede en hibriedmolekule. Die 
amfifiliese karakter van die oorspronklike verbindings is verander met behulp van nie-natuurlike 
aminosure (ASe), soos byvoorbeeld ω-AS, en deur die hidrofobiese inhoud te verander. Die 
gevolge van hierdie veranderinge is bestudeer, met die fokus op strukturele en biologiese 
eienskappe. 
 As gevolg van die bola-amfifiliese karakter, die afwisseling van polêre en nie-polêre ASe en 
die gebruik van hidrofobiese ASe, soos tirosien en leusien, is hierdie unieke molekules ontwerp om 
selfmontering te ondergaan in reaksie op sekere stimuli (bv. ŉ verhoging in pH). Hierdie belangrike 
eienskap is met verskeie tegnieke ondersoek, soos byvoorbeeld fluoressensie-metings, 
elektronmikroskopie (EM), Fourier-transform infrarooispektrometrie (FT-IR), en sirkulêre 
dichroisme (CD). Fluoressensie is gebruik om die kritieke aggregasie konsentrasie van die nuwe 
verbindings te bepaal. Verskille in aminosuursamestelling, wat gereflekteer is in ŉ verskeidenheid 
sekondêre strukture en hidrofobisiteite (H), het aanleiding gegee tot verskillende kritieke 
aggregasie konsentrasiewaardes en aggregasieprofiele. Die data was in pas met die literatuur en het 
gewys dat (i) die aggregasie van hierdie basiese verbindings veroorsaak is deur ŉ verhoging in die 
pH, (ii) die gebruik van hidrofobiese ASe die selfmonteringstendens baie versterk het, terwyl (iii) 
die teenwoordigheid van prolien dit sterk laat afneem het. EM het die morfologie van die 
peptiedsamestellings uitgewys: mikrobuisies en mikroblasies is geïdentifiseer en gekarakteriseer 
met afmetings van 500 nm tot 2 µm.  Die teenwoordigheid van 3-rigtingverbindings, en blasies wat 
uit die mikrobuisies groei, toon aan dat die selfmontering ŉ dinamiese proses is.  Die aggregasie is 
bevestig met FT-IR, deur bestudering van die gedroogde peptiedmonterings en die opmerklike 
spektrale tekens wat die proses nagelaat het, veral in die amied-II-omhulsel. 
 Die verwantskap tussen hidrofobisiteit en selfmontering is verder ondersoek deur die 
eksperimentele en teoretiese bepaling van die hidrofobiese inhoud van die nuwe bolo-amfifiele. 
Resultate vanuit vloeistofchromatografie en rekenaarmatige berekeninge (twee metodes wat 
algemeen gebruik word om hidrofobisiteit van ŉ spesifieke molekule te bepaal), het goed 
ooreengestem met die tendens tot selfmontering, soos uitgedruk in die kritieke aggregasie 
konsentrasie-waardes.  Dit is belangrik om ook daarop te let dat sekere strukturele parameters (soos 
die teenwoordigheid van ‘n β-draai, geïnduseer deur prolien) ook ŉ sterk invloed op aggregasie 
getoon het, met gevolglike beperking van die rol van die hidrofobisiteit van die peptied. 
 Hierdie unieke peptied-bola-amfifile het ŉ baie lae hemolitiese aksie getoon, en behou 
gedeeltelike antimikrobiese aktiwiteit by hoë konsentrasies teen beide Gram-positiewe en -
negatiewe bakterieë. Die aktiwiteit is egter baie laer teen lae konsentrasies, soos duidelik blyk uit 
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twee antimikrobiese toetse.  Die onvermoë om sel-liesse te veroorsaak is ook uitgewys met die 
gebruik van liposome wat ŉ negatiewe bakterie-membraan nageboots het. 
 Die verlies aan aktiwiteit is moontlik verwant aan veranderings aan die drie-dimensionele 
struktuur veroorsaak deur die gebruik van ω-AS en prolien, wat die sekondêre struktuur aansienlik 
verander het. 
 Die resultate van hierdie studie is waardevol in terme van die verstaan van die verwantskappe 
tussen selfmontering en strukturele parameters, soos AS-samestellings, hidrofobisiteit en sekondêre 
struktuur.  Moontlike aanwending van die gesintetiseerde verbindings was egter beperk, weens die 
verlies van biologiese aktiwiteit by lae konsentrasies. 
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Marco Polo descrive un ponte, pietra per pietra. 
- Ma qual è la pietra che sostiene il ponte? - chiede Kublai Kan. 
- Il ponte non è sostenuto da questa o da quella pietra, - risponde Marco, - ma dalla 
linea dell'arco che esse formano. 
Kublai Kan rimase silenzioso, riflettendo. Poi soggiunse: - Perché mi parli delle pietre? 
è solo dell'arco che mi importa. 
Polo risponde: - Senza pietre non c'é arco. 
 
 
Italo Calvino 
“Le città invisibili”, 1972 
 
 
 
 
 
Marco Polo describes a bridge, stone by stone. 
- But which is the stone that sustains the bridge? Asks Kublai Kan. 
- The bridge is not sustained by this or that stone, - replies Marco, - but by the line  
of the arch they form. 
Kublai Kan kept silent, thinking. Then he added: - Why do you speak about the 
stones? 
I only care about the arch. 
Polo answers: - Without stones there is no arch. 
 
 
Italo Calvino 
“Le città invisibili”, 1972 
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Preface 
 
The work presented in this dissertation was planned and performed by the author at the 
Institute for Polymer Science (IPS) UNESCO-Associated Centre for Macromolecules and 
Materials, Department of Chemistry and Polymer Science (Stellenbosch University, South Africa). 
This project developed from a previous study carried out at the Department of Biochemistry of the 
same university by VB Naidoo and M Rautenbach in a collaboration with IPS. When the project 
was entirely moved to IPS, this institution was mainly involved in research dealing with 
membranes for water purification, new polymeric materials, their synthesis and characterisation, 
new polymerisation techniques, development of polymeric and magnetic nanoparticles for coatings 
and packaging, polymeric nanomaterials, (co)polymerisation of activated amino acids, polymers 
for paper production. Hence, with this project, the IPS entered for the very first time into the field 
of the synthesis and characterisation of peptides. Peptides can be considered as polymers (or rather, 
biopolymers), but synthesis and purification, materials, conditions of work and analytical 
techniques are very different from those ones commonly used in a polymer chemistry laboratory. 
A laboratory was dedicated to solid-phase peptide synthesis and bioorganic chemistry in 
general. Since then, J Juodaityte and the author dedicated many efforts upgrading the lab and 
setting up of a suitable work space with adequate facilities for peptide synthesis, purification, 
analysis and characterisation, for part of the biological work and for the self-assembly studies. 
Solvents and chemicals generally used in polymer chemistry that could affect the synthesis were 
removed, distillation apparatuses for high quality solvents were set up, an existing HPLC system 
was fixed, upgraded and dedicated to peptide analysis and purification, a vacuum system for 
solvent removal and a freeze-drier were acquired. Because of the need to perform biological tests 
and use instrumentation unavailable at IPS, collaborations with other institutions were created by 
the author, within the University of Stellenbosch (Biochemistry, Microbiology) and with the 
University of Cape Town (Microbiology, Molecular and Cellular Biology, Clinical Pharmacology). 
Thanks to all these efforts a bio-organic laboratory is now established and operational at the 
Institute for Polymer Science, providing facilities for peptide chemistry and peptide-related 
research. 
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Chapter 1 
 
Introduction 
 
 
 
1.1 Background 
 
The recent interest in cationic antimicrobial peptides (CAMPs) is mainly due to the lack of 
efficacy of traditional synthetic antibiotics and to the increase of bacterial resistance to standard 
drugs (WHO, 2002a; WHO, 2002b). Over the past decades the development of new antibiotics has 
been accompanied by a parallel growth of bacterial resistance and now for nearly every drug a 
certain degree of resistance is reported. Hence, the scientific community and pharmaceutical 
industries are investing resources into and making efforts towards the discovery of new products to 
be used as antimicrobial agents, for humans, animals and plants. 
Unfortunately, many cationic peptides cannot be used as drugs because of their indiscriminate 
action against prokaryotic and eukaryotic cells. Therefore, research now focuses on the 
modification of active compounds in order to increase the killing action towards pathogens. In this 
way it is also possible to obtain a selective action against bacteria/fungi/viruses, avoiding any 
dangerous interactions with mammalian cells. 
Over the past twenty years structure-activity relationship (SAR) studies have discovered many 
active sequences commonly found in natural antimicrobial peptides (Hancock et al., 2006; 
Zelezetsky and Tossi, 2006). These patterns are frequently used in the development of new 
molecules. An interesting approach to the design of novel peptide-based antimicrobial drugs 
involves the creation of hybrid molecules that combine active sequences of CAMPs with non-
natural features. Examples include the conjugation to fatty acids (Mak et al., 2003; Oh et al., 2004; 
Thennarasu et al., 2005) and biopolymers (Guiotto et al., 2003), with the aim to change peptides’ 
pharmacokinetic and pharmacodynamic profiles. Other techniques involve the replacement of the 
amide bond with other unusual bonds (Lee and Oh, 2000) and the use of non-standard amino acids 
(AA) – such as D-amino acids or chemically modified AA – instead of the natural ones (Hong et 
al., 1999; Kawai et al., 2003).  
The research work that is detailed in this dissertation developed from previous investigations 
made at the University of Stellenbosch (Department of Biochemistry, in collaboration with the 
Institute for Polymer Science). Here new molecules were designed focusing on the use of non-
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natural amino acids, such as ω-amino acids, and bifunctional organic molecules, such as 
α-ω-dicarboxylic acids (Naidoo, 2004). Such molecules were created starting from a common 
antimicrobial motif made of different combinations of lysine and leucine and derived from the 
active core of an insect defensin, named sapecin B (Hirakura et al., 1996; Naidoo, 2004). 
Peptides derived from sapecin B (Alvarez-Bravo et al., 1994; Nakajima et al., 1997) are 
natural bolaamphiphiles. A bolaamphiphile is a molecule made of two hydrophilic groups 
connected by a hydrophobic frame. In this case the hydrophilic group was a lysyl-leucyl-lysine 
(KLK) tripeptide and the hydrophobic region comprised a poly-leucine chain with 3 to 5 residues. 
The substitution of this hydrophobic region by α-ω-dicarboxyl acids and ω-amino acids led to the 
creation of peptide hybrids (Naidoo, 2004). The design of these initial compounds also considered 
the work carried out by Shimizu’s group during the past decade, which was focused on 
oligopeptide bolaamphiphiles (Shimizu et al., 1996; Kogiso et al., 1998; Kogiso et al., 2000; 
Kogiso et al., 2004). Those peptide bolaamphiphiles showed strong self-assembly properties and, 
under certain conditions, gave supramolecular architectures such as micro/nanotubes, vesicles and 
nano/microfibres (Shimizu et al., 1996). 
Peptide fibres and peptide aggregates are often studied as scaffolds for tissue regeneration, 
cell growth and other nanobiotechnological applications (Hartgerink et al., 2001; Niece et al., 2003; 
Gao and Matsui, 2005). Macromolecular structures formed by peptides and proteins in solutions 
offer a three-dimensional network for cells to grow. Additionally, if bioactive sequences are used, 
they can act at a molecular level boosting cell adhesion, differentiation and growth (Silva et al., 
2004). In other cases, starting from antimicrobial self-assembling compounds, the creation of 
supramolecular architectures gives networks of antibiotic fibres/aggregates with many possible 
applications as scaffolds for cell growth and wound healing patches (Fernandez-Lopez et al., 2001). 
 
 
1.2 Objectives 
 
 This research project focused on the design and synthesis of hybrid peptides based on sapecin-
derived synthetic peptides. Two main aspects were considered: the study of the aggregation/self-
assembly behaviour of peptides and peptide hybrids and the investigation of their biological 
properties. Within these two areas multiple objectives were pursued and these included: 
 
I. to understand the self-organisation behaviour of the synthesised bolaamphiphiles by using 
different tools and determine the propensity towards aggregation according to experimental 
conditions, amino acid composition and three-dimensional structure, 
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II. to evaluate the morphology of the bolaamphiphile supramolecular assemblies by using 
diverse microscopy techniques, 
 
III. to evaluate the hydrophobic content of the peptide bolaamphiphiles both theoretically and 
experimentally and correlate it to the self-assembly process, 
 
IV. to determine the influence of non-natural amino acids on the biological activity of 
bolaamphiphilic peptides and peptide hybrids. 
 
 
 1.3 Layout of the dissertation 
 
 A general introduction to antimicrobial peptides (sources, actions and applications) and the 
properties of peptide bolaamphiphiles are presented in Chapter 2.  
 The entire set of bolaamphiphilic peptides and peptide hybrids is presented in Chapter 3. 
Solid-phase peptide synthesis (SPPS) using the Fluorenylmethoxycarbonyl (Fmoc) polyamide 
protocol, purification by semi-preparative reversed-phase high performance liquid chromatography 
(RP-HPLC) and characterisation by electrospray ionisation mass spectrometry (ESI-MS) are here 
discussed. The path followed for the design of a new library of compounds, which formed the basis 
of this study, is also considered. 
 The aggregation behaviour of the synthesised bolaamphiphiles was investigated by 
fluorescence measurements, different microscopic tools, such as optical microscopy (OM), 
scanning electron microscopy (SEM) and cryo-fracture SEM, Fourier transform infrared 
spectroscopy (FT-IR) and circular dichroism spectroscopy (CD). These techniques are described in 
Chapter 4. 
 The structural characterisation of the synthesised peptide bolaamphiphiles was expanded with 
particular attention to the hydrophobicity of the synthesised molecules. Theoretical methods and 
HPLC retention times were both used. This further characterisation of the molecules allowed for a 
consistent correlation between self-assembly and hydrophobicity to be drawn (Chapter 5). 
 The new peptides and peptide hybrids were biologically tested using different protocols, 
focusing on interaction with bacteria, human erythrocytes and model membranes (Chapter 6). 
 Finally, general conclusions, limitations and some recommendations for future work are given 
(Chapter 7). 
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 The outcomes of this research were publicised and presented to the scientific community in 
the following formats: 
 
I. Martari M, Juodaityte J and Sanderson RD, Supramolecular structures and biological 
properties of novel peptide bolaamphiphiles. Poster presented at the 9th UNESCO-IUPAC 
Conference “Polymers for advanced applications”, 21-23 November 2006, Stellenbosch, 
South Africa. 
 
II. Martari M and Sanderson RD, Amphiphilic peptides and peptide hybrids: A fluorescence 
study of the aggregation behaviour in water. Poster presented at the 9th Frank Warren 
Conference 2006 on Organic Chemistry, 22-25 January 2006, Cape Town, South Africa. 
 
III. Martari M, Bioactive self-assembling peptides. Talk presented at the 3rd IUPAC-Workshop 
on Advanced Materials (WAM III), 5-8 September 2005, Stellenbosch, South Africa. 
 
  
 Additionally, the following original papers have been recently submitted for publication or are 
under preparation: 
 
I. Martari M and Sanderson RD, Steady-state fluorescence measurements to study peptide 
aggregation in water. SUBMITTED to Analytical Biochemistry. 
 
II. Martari M and Sanderson RD, Hydrophobic content of bolaamphiphilic peptides and 
correlation to their aggregation behaviour. IN PREPARATION / TO BE SUBMITTED to 
Biochemical and Biophysical Research Communications. 
 
III. Martari M and Sanderson RD, Supramolecular structures and biological properties of novel 
peptide bolaamphiphiles. IN PREPARATION / TO BE SUBMITTED to Macromolecular 
Symposia. 
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Chapter 2 
 
Theoretical framework 
 
 
 
2.1 Cationic antimicrobial peptides 
 
2.1.1 Sources and characteristics 
All organisms protect themselves against pathogens thanks to their innate immune system. 
The latter comprises inducible effectors (non-specific immune response), quickly and easily 
induced, often within hours or minutes, and adaptive humoral and cellular immune responses, 
which need several days before being activated (Steiner et al., 1981). 
An important part of the non-specific immune response available to organisms is formed by 
cationic antimicrobial peptides, which represent an ancient mechanism of host defence (Lehrer and 
Ganz, 1999). This class of molecules includes hundreds of different substances♣ and they are 
commonly present in bacteria, insects, plants and mammals, human beings included  (Brogden et 
al., 2003; Marshall and Arenas, 2003). They are especially produced in epithelial or mucosal cells 
(including gastrointestinal, genitourinary and pulmonary epithelia) and phagocytes cells: those cells 
that first come into contact with bacteria, viruses and pathogens in general (Hancock and Chapple, 
1999; Raj and Dentino, 2002). 
In many cases CAMPs correspond to the first weapon used by the body when a possible 
dangerous microorganism is detected. They show minimal inhibitory concentrations (MICs) in the 
range 0.25–16 µg/ml against many pathogens (Robinson et al., 2005). CAMPs have been found 
active against Gram-positive and -negative bacteria, fungi, parasites, yeasts (Brown and Hancock, 
2006), enveloped viruses (Daher et al., 1986) and tumour cells (Winder et al., 1998). They are 
easily synthesised in large amounts at low metabolic cost, quickly available and help to protect the 
organism, killing a wide range of microbes while the immune system prepares an adequate reaction 
through the adaptive immune response (Shai and Oren, 2001). Moreover, their action is not limited 
to the elimination of microorganisms, they also have a role in the inflammation process and display 
chemotactic properties, particularly chemoattracting neutrophils, monocytes, mast cells and T cells, 
while some of them are believed to promote angiogenesis (Fig. 2.1) (Hancock and Diamond, 2000; 
                                                          
♣ See Appendix A for an overview of the most important antimicrobial peptides (structures, sources and PDB 
ID) and also visit the antimicrobial peptide databases at www.bbcm.univ.trieste.it/~tossi/pag1.htm or at 
http://aps.unmc.edu/AP/main.php for more complete and updated lists (last accessed on 11/10/06). 
 - 8 -
Hancock, 2001; Raj and Dentino, 2002; Sugiarto and Yu, 2004; Izadpanah and Gallo, 2005, 
Bowdish et al., 2005). 
 
 
 
Fig. 2.1 Actions naturally performed by cationic antimicrobial peptides  
(adapted from Sugiarto and Yu, 2004). 
 
 
Antimicrobial peptides have been extensively studied in the last two decades and their general 
characteristics, judged important for the biological activity, can be described as follows (Hancock, 
1997a; Rautenbach and Hastings, 1999; Powers and Hancock, 2003; Hancock et al., 2006): 
I. an amino acid sequence with a number of residues between 5 and 50, mostly including 
L-amino acids 
II. a net positive charge (due to the presence of lysine and arginine residues, less commonly 
histidine) which gives them the name of ‘cationic antimicrobial peptides’ 
III. a three-dimensional amphiphilic structure with a 30-50% content of hydrophobic amino 
acids and generally an α-helical or β-sheet structure (even if many small CAMPs have little 
or no structure in solution). 
 
2.1.2 Structures and classification 
With almost one thousand compounds recorded as antimicrobial peptides, general 
considerations about their secondary structure are commonly used to classify them (Epand and 
Vogel, 1999). Cationic antimicrobial peptides can be divided into four families: β-sheet, α-helical, 
looped and extended coil peptides (Fig. 2.2) (Hancock, 1997b). 
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Fig. 2.2: Molecular models of the different structural classes of antimicrobial peptides: a) β-sheet structure of 
human β-defensin-2, b) α-helical structure of magainin 2, c) looped structure of bovine bactenecin and d) 
extended structure of bovine indolicidin. Models are taken from the NMR structural database and based on 
two-dimensional NMR spectroscopy of the peptides in water (a) or in a membrane 
mimetic condition (b, c and d) (adapted from Hancock, 2001). 
 
Peptides belonging to the first group (i.e. human β-defensin-2, tachyplesins, protegrins, 
lactoferricin) generally exist in the β-sheet conformation and kill bacteria perturbing the membrane 
or forming channels. On the other hand, α-helical peptides (i.e. magainin, cecropin A, temporins) 
often only form α-helices upon interaction with the bacterial membrane thanks to their amphipathic 
character and they can absorb on the membrane or/and insert into the hydrophobic compartment. 
Peptides with looped structure (i.e. nisin, bovine bactenecin) are usually rich in proline/arginine 
and therefore cannot form amphipathic structures. Peptides with an extended structure (i.e. histatin, 
tritrpticin, indolicidin) commonly exhibit the repetition of one or more amino acids (such as His, 
Trp, Arg/Pro and Pro/Phe) and these patterns are studied as SAR models (Hancock, 2001). 
 
2.1.3 Mechanisms of antibacterial activity 
The interest in CAMPs is closely related to their mechanism of action. It is commonly 
recognised that they interact with the outer membrane of bacterial cells, disorganising the lipid 
bilayer. This phenomenon leads to the lysis of the cells, depolarization of the membrane and 
consequently to the death of the microorganism. The interaction is based on electrostatic and 
hydrophobic interactions (thus partially explaining the selectivity of CAMPs towards prokaryotic 
cells, which have a negatively charged membrane). However, new studies underlined the presence 
of various modes of action, like binding to intracellular targets or stimulating host defence systems 
(Yaeman and Yount, 2003). If the theoretic mechanism of action is widely accepted by the 
 - 10 -
scientific community, how things happen in the real world is still a source of discussion and 
hypothesis. Since there are antimicrobial peptides with various secondary structures it can be said 
that different CAMPs use different mechanisms to express their antimicrobial activity and often, 
for the same molecule, different mechanisms coexist. To date, four models have been proposed. 
 
A. ‘barrel-stave’ model  
The ‘barrel-stave’ model describes the formation of transmembrane pores or channels as a 
result of the self-association of peptides into larger structures (Fig. 2.3) (Ehrenstein and Lecar, 
1977; Oren and Shai, 1998). This self-association process occurs on the external surface of the 
bacterial cell wall and is followed by the insertion of the assembly into the membrane. Cell death is 
a consequence of leakage of cellular components through the pores. Peptides with a strong 
amphipathic structure (such as an amphipathic α-helix or β-sheet) are more likely to interact with 
membranes with this mechanism (Shai, 2002). 
 
B. the ‘carpet’ model 
According to the ‘carpet’ model, peptides first bind to the negatively charged lipids of the 
bacterial membrane and, after a threshold concentration has been reached, they cause membrane 
permeation and lysis with a detergent-like mechanism (Fig. 2.4) (Pouny et al., 1992; Shai, 1999). 
Peptides with a high net positive charge and without a particular structure are more likely to behave 
in a way similar to this model (Shai, 2002).  
 
C. ‘toroidal pore’ model 
This model was developed to explain how certain peptides could kill bacteria without causing 
membrane depolarization. According to the ‘toroidal pore’ model, peptides insert into the 
membrane creating a positive curvature of the membrane itself and associate into unstructured 
aggregates and short-lived transmembrane clusters (Fig. 2.5) (Matsuzaki et al., 1996; Matsuzaki, 
1998; Matsuzaki, 1999). Peptides can thus cross the membrane with a flip-flop mechanism without 
provoking depolarization and then act on intracellular targets or facilitate the efflux of intracellular 
components (Oren and Shai, 1998). 
 
D. alternative mechanisms: intracellular targets 
Antimicrobial peptides that do not strongly interact with membrane lipids might target 
intracellular biomolecules such as DNA, RNA and enzymes, thus inhibiting protein synthesis, 
interfering with energy transport and metabolism and/or increasing membrane permeability (Reddy 
et al., 2004; Otvos, 2005). Moreover, CAMPs are also believed to stimulate host defence 
mechanisms, activate peroxidases and chemoattract neutrophils (Hancock and Rozek, 2002; 
Yaeman and Yount, 2003; Sugiarto and Yu, 2004). 
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Fig. 2.3: Barrel-stave model for membrane permeation. Peptides reach the membrane either as monomers or 
oligomers and first assemble on the surface of the membrane (A), then insert into the lipid core of the 
membrane following recruitment of additional monomers (B). Colour designation: black, hydrophobic 
surface; grey, hydrophilic surface (adapted from Shai, 2002). 
 
 
 
 
Fig. 2.4: Carpet model. The peptides reach the membrane either as monomers or oligomers and then bind to 
the surface of the membrane with their hydrophobic surfaces facing the membrane and their hydrophilic 
surfaces facing the solvent (A). When a threshold concentration of peptide monomers is reached, the 
membrane is permeated and transient pores can be formed (B), a process that can lead also to membrane 
disintegration (C). Colour designation: black, hydrophobic surface; grey, hydrophilic surface (adapted from 
Shai, 2002). 
 
 
 
 
Fig. 2.5: Toroidal pore model. Peptides interact with the membranes with their hydrophilic regions (a) and 
positively modify the membrane curvature (b). With a flip-flop mechanism they translocate and act on 
intracellular targets (c) (adapted from Matsuzaki, 1999). 
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2.1.3 Antimicrobial peptides as next generation therapeutics 
Over the past two decades the interest in CAMPs has been driven by the desperate search for 
new therapeutic treatments, especially against the spread of bacterial resistance (Dancer, 2004; 
Alanis, 2005). In particular, antimicrobial peptides’ peculiar mechanism of action, based on a 
physical interaction with membrane lipids, seemed to be a very useful starting point for the 
development of a new class of antibiotics (Hancock and Lehrer, 1998). The physical disruption of 
the membrane was thought to make it difficult for bacteria to develop resistance and they are seen 
as natural antimicrobial agents with minimal or no side effects, high selectivity, low 
immunogenicity and a significant immunomodulatory action (Hancock et al., 2006). 
Antimicrobial peptides have many possible applications, covering a wide potential market: 
food packaging and food preservation (Ryan et al., 2002), wound dressing and wound healing 
(Andreu and Rivas, 1998), detergents and gels for topical treatments of skin/mucosa infections (Raj 
and Dentino, 2002) and contraception (Aranha et al., 2004; Zairi et al., 2005). Some molecules are 
already on the market such as nisin, pediocin PA-1 (for dairy and canned products) and 
daptomycin♣ (derived from vancomycin and used to treat skin Gram-positive infections). A few 
more compounds are successfully passing clinical trials in phase II and III, such as pexiganan 
(magainin variant peptide MSI-78), iseganan (a protegrin-derived peptide) and rBPI21 (a modified 
recombinant fragment of bactericidal/permeability-increasing protein) (Tab. 2.1) (Breithaupt, 1999; 
Toney, 2002; McPhee and Hancock, 2005). 
Systemic administration of CAMPs has been considered as a possible solution for the 
treatment of systemic resistant infections. The major problems associated with systemic 
administration are generally correlated to the low half-life of peptides in the blood stream, high 
clearance, low or impossible absorption through the intestinal tract and potential immunogenicity 
and/or interferences with metabolic processes (through interactions with receptors). Therefore, their 
applications have been often limited to topical and external uses. 
Other restrictions to the many applications of antimicrobial peptides include their high 
production costs, especially as inexpensive antibiotics are still produced and used worldwide. 
Solid-phase synthesis techniques are preferred for R&D studies but these techniques do not seem to 
be a feasible way for the mass production of antibiotic peptides, because of both high running costs 
and the environmental impact of the synthesis. Anyway, DNA recombinant technology, enzymatic 
synthesis and solution phase strategies might yield larger amounts of active peptides from much 
less expensive processes and more environment-friendly methods (Gill et al., 1996; Hancock and 
Lehrer, 1998). 
                                                          
♣ Nisin (Nisaplin®) and pediocin PA-1 (ALTA™) are currently commercialized by Aplin&Barret (UK) and 
Quest Intl. (FL, USA) respectively. Daptomycin (Cubicin®) is produced by Cubist Pharmaceuticals (MA, 
USA). 
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Tab. 2.1: List of CAMP drugs, companies responsible for commercialization, testing status, and the disease 
they are designed to treat (adapted from Breithaupt, 1999; McPhee and Hancock, 2005) 
 
 
 
 
The question of possible resistance is still under discussion. Even if the physical interactions 
between CAMPs and bacterial membranes do not suggest resistance development, resistance has 
been nonetheless reported, already several years ago (Guo et al., 1998; Ernst et al., 1999). Bacterial 
defence mechanisms against antimicrobial peptides might include DNA-expressed superficial 
peptidases (for the degradation of the peptides before interacting with the membranes) and other 
mechanisms already active in resistance against traditional antibiotics, such as efflux pumps and 
modifications of membrane properties (fluidity, charge and lipid composition, membrane potential, 
reduction of disulfide bonds) (Hancock, 1997a; Andreu and Rivas, 1998; Peschel and Collins, 
2001; Nikaido,2001; Peschel, 2002). 
 
 
2.2 Antimicrobial peptides from Sarcophaga peregrina 
 
Sarcotoxin is a family of antimicrobial peptides discovered during the 1980s in the 
haemolymph of Sarcophaga peregrina larvae (an insect best known as the flesh fly) and produced 
in response to external injuries (Okada and Natori, 1983; Okada and Natori, 1985). Other proteins 
were then detected and purified from the culture medium of the embryonic cell line of Sarcophaga, 
some belonged to the sarcotoxin group, another (later sapecin A) to a new family (Matsuyama and 
Natori, 1988a; Matsuyama and Natori, 1988b). Along with the antibacterial activity, further studies 
established the role of sapecin in the development and cell proliferation during the embryonic life, 
Target diseaseTesting statusCompanyCompound 
Sepsis   
    
PreclinicalInimex 
Pharmaceuticals
IMXC001 
Infection at site of in-
dwelling catheter 
insertion 
Phase III completedMigenix & Cadence 
Pharmaceuticals Omiganan (MX-226)
Acne Phase IIa completedMigenix MBI 594AN 
Severe bacterial 
meningitis Phase III completedXoma & Baxter Intl.rBPI21 (NEUPREX
®)
Oral mucositis 
resulting from cancer 
treatment 
Phase III halted 
prematurely IntraBiotics Corp.Iseganan 
Infection of diabetic 
foot ulcers Phase III completedMagainin Pharm. & SmithKline BeechamPexiganan (MSI-78)
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thus suggesting a dual role of this small protein, in the defence and in the development of 
Sarcophaga larvae (Komano et al., 1991). Other researchers determined different homologues of 
sapecin A (named sapecin B and sapecin C) (Yamada and Natori, 1993), which led to the total 
synthesis and characterisation of sapecin A (PDB ID: 1L4V) and sapecin B (Fig. 2.6) (Hanzawa et 
al., 1990; Kim JI et al., 1994). 
 
 Sapecin B   L T C  -  -  -  -  -  -  E I  D R S L C L L  H C R L K G YL R A Y C  S Q Q  K V C R C V Q 
 
 Sapecin A   A T C D L L S G T G I N H S A C A A H C L L R G N R G G Y C N G K A V C V C R N 
 
 Sapecin C   A T C D L L S G  I G V Q H S A C A L H C V F R G N R G G Y C T G K  G I CV C R  N 
 
Fig. 2.6: Comparison of primary structures of sapecin A and its homologues. Identical amino acids are 
highlighted (modified from Yamada and Natori, 1993). 
 
Studies focused on sapecin B which consists of 34 amino acids and has three disulfide bonds 
that give stability to the secondary structure. It comprises an α-helix from Arg7 to Lys17 and β-
sheet structures from Gly18 to Lys28 and from Val29 to Gln34 (Fig. 2.7). 
 
 
Fig. 2.7: Primary structure of sapecin B. Disulfide bridges are indicated  
(modified from Yamada and Natori, 1993). 
 
 A Japanese research group studied the amino acid composition of sapecin B, looking for its 
active core, so as to simplify and minimise the structural requirements for the antimicrobial activity 
(Yamada and Natori, 1994; Alvarez-Bravo et al., 1994; Hirakura et al., 1996). These studies 
revealed that the minimal structure corresponds to the α-helix region and its simplification led to 
the determination of a general antimicrobial structure, KLKLnKLK-NH2 (n = 3, 4, 5) (Fig. 2.8) 
(Nakajima et al., 1997). 
 This model structure is composed of two hydrophilic and charged sequences (lysyl-leucyl-
lysine or arginyl-leucyl-lysine) divided by several hydrophobic amino acids, thus generating 
peptide bolaamphiphiles. 
 
 
          L T C E I D R S L C L L H C R L K G Y L R A Y C S Q Q K V C R C V Q  
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Fig. 2.8: Synthetic peptides derived from sapecin B. From sapecin B, the first generation peptides are in the 
first line (I), the second generation compounds in the second line (II) and the third generation peptides in the 
last 6 cells (III). The rational path between sapecin B and the leader antimicrobial sequence is shown by the 
grey boxes. 
 
Since then, many researchers have tried to further modify the antimicrobial pattern and to test 
these molecules against a broad spectrum of bacteria and other microorganisms so as to determine 
better structure-function relationships (Nakajima-Shimada et al., 1998). It should be noted here that 
antimicrobial properties of lysine/leucine-rich peptides were not new at that time. Basic peptides 
have been studied since the 1980s for their antibiotic properties and they have been used for many 
years as model compounds for structure-activity relationships of CAMPs (Lee et al., 1986; Suenaga 
et al., 1989; Anzai et al., 1991; Castano et al., 2000). 
  
 Recently, SAR studies were undertaken at this university (Biochemistry) and focused on the 
bolaamphiphilic structure of these synthetic sapecin-derived compounds (Naidoo, 2004). Both the 
biological activity and aggregation properties of these new peptide hybrids were pointed out. 
Nonetheless, further studies were necessary to corroborate the preliminary results and to have a 
deeper insight into the influence of the use non-natural amino acid on biological activity and 
aggregation behaviour. 
 
 
 
 
I 
 
 
II 
 
 
 
 
 
III 
SAPECIN B  
H-LTCEID-NH2 H-RSLCLLHCRLK-NH2 H-GYLRAYCSQQK-NH2 H-VCRCVQ-NH2 
H-RSLCLLHCRLK-OH H-RSLLLLHLRLK-NH2 H-RLKCLLLCRLK-NH2 H-RLKCLLLCRLK-OH 
H-RLKLLLLLRLK-NH2 
H-RLKLLLLRLK-NH2 
H-RLKLLLRLK-NH2 
H-KLKLLLLLKLK-NH2 
H-HLHLLLLLHLH-NH2 
H-RLRLLLLLLRL-NH2 
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2.3 Peptide bolaamphiphiles 
 
2.3.1 Bolaamphiphiles 
The term ‘bolaamphiphile’ refers to a class of molecules which are formed by two hydrophilic 
groups linked together by a hydrophobic skeleton (Fuhrhop and Mathieu, 1984). The name comes 
from a South American hunting weapon made of two balls connected by a string, which is 
commonly called “bolas”∗. Bolaamphiphiles are naturally found in the membranes of 
archeabacteria and are responsible for the unusual characteristics of these microorganisms, such as 
resistance at tremendous temperatures, extreme pH, UV light, radiations (Driessen et al., 1996; 
Rusterholtz and Pohlschröder, 1999; Gliozzi et al., 2002) (Fig. 2.9). 
 
O
H O
OH
O
O
R
H
CH3 CH3
CH3 CH3
CH3CH3
CH3CH3
CH3
CH3
O
R1 = H
R2 =
OH
H
OH
HOH
H
H
OH
OH
H
 
 
Fig. 2.9: Chemical structure of the hydrophobic backbones that can be obtained by hydrolysis of archaeal 
tetraether lipids (after Gliozzi et al., 2002). 
 
 
 Synthetic bolaamphiphiles try to mimic these natural compounds, avoiding their structural 
complexity and including diverse hydrophilic groups. Existing bolaamphiphiles comprise sugars 
(Masuda and Shimizu, 2004), alcohols (Sirieix et al., 2000), acids, amino acids (Kogiso et al., 
1998a; Kogiso et al., 1998b; Kogiso et al., 2000; Matsui and Gologan, 2000; Matsui and Douberly, 
2001) and bioactive di/tripeptides (Claussen et al., 2003). They are made of different building 
blocks but they share similar physicochemical properties and, once in solution, they tend to 
spontaneously aggregate and form supramolecular architectures such as nanotubes and nanofibres, 
fibrils and vesicles: a process known as self-assembly or self-organisation (Shimizu et al., 1996). 
Figure 2.10 shows some of the peptide-based bolaamphiphiles synthesised by Shimizu’s group. 
 
                                                          
∗ Definition from www.en.wikipedia.org/wiki/Bolas (last accessed 09/05/06). 
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Fig. 2.10: Molecular structure of oligopeptides bolaamphiphiles synthesised by Shimizu’s group in the late 
1990s (modified from Kogiso et al., 1998). 
 
 
2.3.2 Self-assembly properties 
 ‘Molecular self-assembly is the spontaneous association of molecules under thermodynamic 
equilibrium conditions into structurally well-defined arrangements due to non-covalent 
interactions, such as hydrogen and ionic bonds, hydrophobic and van der Waals interactions’ 
(Zhang and Altman, 1999). In nature, self-assembly is a quite diffuse mechanism of molecular 
organization: DNA, RNA, proteins and lipids spontaneously form supramolecular functional 
nanostructures (Rajagopal and Schneider, 2004). The packed structure of DNA and RNA inside a 
nucleus, a folded protein with a specific function and a lipid membrane are natural examples of 
functional structures in the range of nanometres (1 nm = 10-9 m) which depend on a spontaneous 
process. 
 Many molecules – such as surfactants and lipids, proteins and peptides, amphiphilic and 
bolaamphiphilic organic compounds (including peptide bolaamphiphiles) – are studied for their 
self-assembly properties. In many cases the interest is in how to regulate the process itself and in 
the understanding of the key elements that move it. Knowing how to trigger the aggregation of a 
certain kind of molecules – i.e. using pH modifications (Aggeli et al., 2003; Claussen et al., 2003; 
Niece et al., 2003), ionic strength, metals (Matsui and Douberly, 2001), light (Collier et al., 2001), 
temperature (Pochan et al., 2003) – permits one to create smart materials which can only form in 
response to precise conditions or stimuli.  
In the last decade, due to the development of nanotechnology, self-assembling peptides and 
proteins have been extensively studied because of their many possible applications in material 
science, engineering and manufacture of nanostructured biological materials (Zhang, 2003; Zhang 
 - 18 -
et al., 2002; Gao and Matsui, 2005). Peptide amphiphiles and bolaamphiphiles were synthesised 
and studied because of the combination of self-assembly properties and biological activity. 
Peptides can therefore offer a function and/or a smartness in the scaffold and, being chiral, they can 
also provide a particular handedness which can amplify the level of recognition (Fairman and 
Åkerfeldt, 2005). The self-assembly of these amphiphilic molecules is exploited for the creation of 
nanosized-functional structures, useful as biological scaffolds for tissue regeneration (Silva et al., 
2004), mineralization of hydroxyapatite crystals in a particular orientation (Hartgerink et al., 2001), 
for biocompatible implants and molecular wires (Matsui et al., 2000; Santoso et al., 2002). 
Peptide self-assembly can also result in the formation of hydrogels. To date, many 
amphiphiles and bolaamphiphiles based on peptides have been designed for diverse applications 
and beautifully combine biological and structural properties leading to the development of next 
generation biomaterials for regenerative medicine (Holmes et al., 2000; Kisiday et al., 2002; 
Hartgerink et al., 2002; Kretsinger et al., 2005).   
 On the other hand, the study of the self-assembly process is also important for the 
investigation of undesired aggregations. Peptide and protein aggregation in pharmaceutics is one of 
the major problems for the production and manufacture of peptide-based drugs (Wang, 2005). It is 
often regarded as the most frequent type of instability for this class of drugs and it frequently 
affects their biological activity. For antimicrobial peptides as well, the aggregation has in some 
cases been correlated to a lower or absent antibiotic activity (Hider et al., 1983; Alvarez-Bravo et 
al., 1994; Rautenbach et al., 2006). The effects of the spontaneous assembly of peptides inside the 
human body are even more dramatic: β-amyloid fibril formation in vivo has been correlated 
without doubts to the development of the Alzheimer’s disease (Hardy and Selkoe, 2000). Hence, 
the control over peptide aggregation both in vitro and in vivo under specific conditions is the focus 
of the medical research in this field (Pastor et al., 2005).  
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Chapter 3 
 
Synthesis of novel bolaamphiphilic peptides and peptide hybrids 
 
 
 
3.1 Introduction 
 
3.1.1 Amino acids, peptides and proteins 
Amino acids are known as the building blocks of life and they represent the starting units for 
the assembly of peptides and proteins. They are characterised by two main functional groups, an 
amino group and a carboxyl group, both linked to a carbon atom which is named the α-carbon or 
Cα. They exist as zwitterionic molecules at neutral pH (Fig. 3.1). As Cα is also substituted with a 
hydrogen atom and a side-chain group (R) it forms a chiral centre (except in the case of glycine). 
Side-chain groups are different for each amino acid, they are essential for the determination of the 
chemical properties of peptides and proteins and they play an important role in the structure and 
function of these biomacromolecules (refer to p. XXIV for a complete list of naturally occurring 
side-chain groups). 
O
NH3
+
O
-
RH
 
Fig. 3.1: Zwitterionic structure of a general amino acid at pH 7. 
 
In nature there are 21 amino acids encoded by DNA and they are connected to each other to 
form peptides and proteins by an amide bond (or peptide bond) which links the carboxyl group of 
one AA to the amino group of the following AA (Fig. 3.2). 
 
OH
NH2
R
O
NH2
OH
R1
O
NH2
NH
OH
R
O R1
O
- H2O
 
 
Fig. 3.2: The peptide bond forms the backbone of peptides and proteins. 
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The atoms involved in the peptide bond (showed in a rectangle in Fig. 3.3, left) form the so 
called “peptide group”: it comprises the carbonyl carbon and the α-carbon of the first amino acid 
(C1 and α1 respectively) together with the carbonyl oxygen, the amide nitrogen and the α-carbon of 
the second amino acid (N2 and α2) together with the amide hydrogen. These six atoms create a 
planar structure because of the partial double bond character of the C-N amide bond. Consequently, 
the peptide bond exists as two rotamers: the trans configured (Fig. 3.3 left) – occurring in most of 
the natural peptides and proteins because of the lower steric hindrance –  and the cis configured 
(Fig. 3.3 right).  
 
 
Fig. 3.3: The peptide bond (adapted from: www.codefun.com/Genetic_tRNA.htm, last accessed 25/11/05). 
 
 
From a structural point of view, peptides and proteins can be described at four different levels 
of complexity (Fig. 3.4). The linear sequence of amino acids that forms a polypeptide chain gives 
the primary structure of the macromolecule. According to the different composition of amino 
acids, different three-dimensional structures of the peptide backbone can be obtained (called α-
helix and β-sheet) and they create the secondary structure of the polypeptide. The secondary 
structure is mainly based on hydrogen bonds between the amide hydrogen and the carboxyl 
oxygen. The global organization of an entire protein or peptide is expressed by its tertiary structure 
which is based on the interactions between different amino acids belonging to the same chain. 
Covalent bonds (i.e. disulfide bridges) and noncovalent interactions (i.e. ionic bonds) are 
responsible for the tertiary structure. Finally, the term quaternary structure refers to the special 
arrangements of different polypeptide chains associated by noncovalent interaction to form 
supramolecular assemblies (Sewald and Jakubke, 2002).  
 
 
Trans configured Cis configured
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Fig. 3.4: Protein and peptide structures: primary, secondary, tertiary and quaternary 
(adapted from: www.geneticsolutions.com, last accessed 24/10/05). 
 
 
 3.1.2 Principles and development of solid-phase peptide synthesis 
For centuries the work of chemists and biochemists has been based on semi-synthetic products 
mainly obtained from natural sources (animals, plants and minerals). During the 1960s, because of 
an increasing interest in peptide and protein research, these sources were not enough and new 
synthetic routes for the preparations of such compounds were necessary. Hence, synthetic 
techniques for the synthesis of polypeptides were developed; they were basically divided into 
solution and solid-phase approaches. The solid-phase approach, proposed by Merrifield, marked 
the future of peptide and protein synthesis, and brought the Nobel prize to its developer (Merrifield, 
1963; Merrifield, 1964; Merrifield, 1969; Merrifield, 1997). 
Solid-phase peptide synthesis soon proved its advantages over solution phase methods: 
purification steps were performed simply by washing the polymeric support, the amide bond 
formation was forced by increasing the concentration of reagents and the loss of product was 
reduced by being attached to the resin beads via a linker. However, SPPS does have some negative 
aspects. Purity and high yields are possible only if each reaction is quantitative. Supposing only 
95% yield is achieved in every coupling and Fmoc deprotection step in the synthesis of a 124-
amino acid protein (such as the ribonuclease synthesised by Merrifield), the final yield will then be 
in the range of 0.0002% (Bayer, 1991). But, on the other hand, in the solution phase methodology it 
was necessary to isolate and purify the intermediates after each coupling and deprotection, thus 
requiring more time for reaction work-up, wasting more product and more solvent/chemicals for 
purification and isolation of the growing peptide chain. 
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An amide bond is formed by the reaction between a carboxyl group and an amino group 
belonging to different AAs. Hence, to avoid side reactions, an orthogonal protection scheme is 
necessary when the building blocks have many functionalities, as do most of the amino acids (α-
amino and carboxyl groups, side-chains with amino and carboxyl groups, alcohols, thiols, etc.). 
During the synthesis, certain groups (i.e. α-amino groups) have to be momentarily protected and 
others (i.e. those ones on the side-chains) have to be kept permanently protected until the end of the 
synthesis. Moreover, the temporary protecting group must be easy to remove under conditions that 
will not affect the permanent protecting groups. Usually the removal of these permanent protecting 
groups occurs together with the release of the peptide from the solid support (Jones, 2002). A 
schematic representation of SPPS is shown in Figure 3.5. 
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O
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Coupling
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NH2
NH
OH
R1
O
O
R2
Repeated until 
completion of the 
sequence
Activated and protected amino acid
amino function
 
 
Fig. 3.5: Principle of SPPS.  
P and P’: permanent protecting group; T: temporary protecting group; X: activating group. 
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Several protocols have been developed from Merrifield’s original idea which was based on 
the use of a tert-butoxycarbonyl (Boc) α-amino protecting group. The polyamide protocol is one of 
the most widely employed and it is based on the use of the N9-fluorenylmethyloxycarbonyl group 
for the protection of the α-amino function (Carpino and Han, 1970). This protocol, developed by 
Atherton, Sheppard and Dryland, presents many advantages over the Boc protocol (Atherton et al., 
1979; Atherton and Sheppard, 1989; Wellings and Atherton, 1997). First of all it requires only mild 
chemistry: the Fmoc group is easily and quickly removed in weak basic conditions – 20% v/v 
piperidine in dimethylformamide (DMF) (Carpino and Han, 1972) – in which the permanent 
protecting groups are stable. In Merrifield’s solid-phase approach the Boc group was removed by 
treating the resin with trifluoroacetic acid (TFA). Acid-stable permanent protecting groups were 
used for the side-chains (Fig. 3.6). Cleavage and complete deprotection were performed at the end 
of the synthesis by HF treatment. This could lead to loss of the growing peptide from the resin and 
many costly safety measures required when using liquid HF (Pennington, 1997a). A second 
advantage is that the free Fmoc group reacts with the excess of piperidine and the concentration of 
this adduct is measurable by ultraviolet (UV) spectrophotometry, thus enabling one to follow the 
completion of each elongation step and monitor the entire synthesis (see Section 3.3.2.7 for details) 
(Sheppard, 2003). 
i) TFA/DCM
ii) DIEA/DCM
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ii) HF/anisole
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Fig. 3.6: Boc SPPS or Merrifield’s SPPS (Merrifield, 1963).  
P and P’ are permanent protecting groups removed by HF while the Boc group is removed by TFA. 
Activation strategy shown: preformed symmetrical anhydrides. 
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Finally, the use of an acid labile peptide-resin linkage in the Fmoc protocol allows one to 
cleave the peptide from the resin with a strong acid (i.e. TFA) with the concurrent removal of side-
chain protecting groups (Guy and Fields, 1997; Dick, 1997). Therefore, with the Fmoc-polyamide 
strategy it is possible to avoid some typical problems of the progressive acidolysis of the 
Merrifield’s strategy (Boc removal by TFA and final cleavage with HF). The two different 
protocols for SPPS are shown in Figures 3.6 and 3.7. 
O
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Fig. 3.7: Fmoc SPPS. P and P’ are permanent protecting groups removed by the final TFA cleavage while the 
Fmoc group is removed by piperidine. Activation strategy shown: active esters. 
 
In this study Fmoc-based SPPS was chosen for the synthesis of the designed bolaamphiphilic 
peptides. It is now quite a common technique for the production of small peptides and proteins, and 
applying the same principle, different activation strategies and polymeric supports can be utilized 
(Bayer, 1991; Chan and White, 2000b). 
 
3.1.2.1 Side-chain protecting groups 
As about half of the natural amino acids have reactive groups on their side-chains the use of 
protecting groups during SPPS is essential in order to avoid (or highly reduce) the production of 
wrong sequences. For the classical Fmoc protocol two important aspects must be considered when 
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choosing an orthogonal protecting group: (i) it must be stable during the normal 
coupling/deprotection steps (both carried out in a basic environment) and (ii) it must be easy to 
remove, preferably during the TFA cleavage (thus achieving simultaneous deprotection and release 
from the solid support). On the other hand if a selective deprotection of certain amino acids is 
necessary during the synthesis (i.e. for the synthesis of cyclic peptides, biotinylated peptides or 
chemically modified peptides) a wide range of protecting groups is available (Pennington, 1997b). 
The most common side-chain protecting groups are listed in Table 3.1. 
 
Tab. 3.1: Common protecting groups for routine synthesis of peptides 
(adapted from Chan and White, 2000a) 
 
SIDE-CHAIN 
FUNCTIONALITY 
PROTECTING 
GROUP 
ABBREVIATION
CLEAVAGE 
CONDITIONS 
Arg 
OCH3
S
CH3
CH3
NH
R
CH3
O O  
Mtr 
 
90-95% TFA v/v,  
4-6 h or 
TFA-anisole (9:1),  
1 h 
Asp/Glu 
R O
CH3
CH3
CH3
O
 
OtBu 90% TFA v/v, 30 min 
Asn/Gln 
NH
R
 
Trt 90% TFA v/v, 1 h 
Cys S
R
 
Trt 90% TFA v/v, 30 min 
His 
N
 
Trt 50% TFA in DCM, 30 min 
Lys/Orn 
NH O
CH3
CH3
CH3
O
R
 
Boc 90% TFA v/v, 30min 
Ser/Thr/Tyr O
CH3
CH3
CH3
R
 
tBu 90% TFA v/v, 30 min 
Trp 
N
OO
CH3
CH3
CH3
 
Boc 
(i) 90% TFA, 1 h and (ii) 
1% aq.TFA, 1-2 h 
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3.1.2.2 Fmoc deprotection 
The removal of the Fmoc protecting group is performed by treating the resin with 20% (v/v) 
piperidine in DMF. As shown in Fig. 3.8, the initial step is the deprotonation of the fluorene ring to 
generate an aromatic intermediate that rearranges, giving the dibenzofulvene (a). The latter reacts 
with the piperidine (in excess) leading to the formation of the fulvene adduct (b) (Fields, 1997; 
Chan and White, 2000a). 
The product of the deprotection reaction (b) absorbs UV strongly (λmax at 301 nm) and this 
characteristic is used to follow both the deprotection and the elongation steps (the millimoles of 
fulvene-adduct are directly correlated to the millimoles of amino acid coupled during the coupling 
reaction) (See Section 3.3.2.7 for details). 
NH R
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H
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N
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+
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N
H2
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O
-
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O
- H2N R
CH2N
H
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a
b
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Fig. 3.8: Reactions involved in the Fmoc deprotection. 
 
3.1.2.3 Activation strategies 
Considering the main step of the peptide synthesis, the coupling reaction, many approaches 
and reagents can be employed in Fmoc SPPS (Bailey, 1990; Albericio and Carpino, 1997; Chan 
and White, 2000a; Chan and White, 2000b). In order to facilitate the formation of the amide bond 
between the amino group of the growing peptide and the carboxyl group of the incoming Fmoc- 
protected amino acid (Fmoc-AA), different activation reagents are used (Marder and Albericio, 
2003; Montalbetti and Falque, 2005). 
Some of the most widely used activation methods for peptide coupling are discussed below. 
A. Preformed symmetrical anhydrides 
DCC† and DIC are used in dichloromethane (DCM) for the preparation of symmetrical 
anhydrides of the Fmoc-AA (Sheehan and Hess, 1955). They have been widely used in the past 
                                                          
† Refer to the list of abbreviations (p. XII) for a complete explanation of the acronyms. 
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because of their reactivity but their use produces a huge loss of reagents as only one out of two 
equivalents of protected amino acid reacts. Moreover certain symmetrical anhydrides have a low 
solubility in DCM. 
B. Active esters (HOBt esters and pentafluorophenyl esters) 
- HOBt† esters are easily prepared in situ using different kinds of carbodiimides (DCC, DIC) 
or phosphonium/amminium salts (BOP, PyBOP, TBTU, HBTU, HATU)† and react quickly with 
the amino group of the growing peptide (Albericio et al., 1998). Side reactions include the 
formation of diketopiperazines by intramolecular aminolysis (Fields, 1997). 
- Fmoc-protected amino acids can be bought as pentafluorophenyl esters and used directly. 
They quickly react with no side reactions (Kisfaludy and Schön, 1980; Atherton et al., 1988). 
C. Acid fluoride 
Acid fluorides of the corresponding amino acid can be generated by using TFFH† (Chan and 
White, 2000b) or cyanuric fluoride (Carpino et al., 1990), they are less reactive than acid chlorides 
and more stable in the presence of tertiary amines and in the common conditions of SPPS.   
A comparison of the coupling methods used in SPPS is given in Table 3.2. 
 
Tab. 3.2: Coupling methods used in Fmoc SPPS: methods using active esters are shown in bold 
(adapted from Chan and White, 2000a) 
 
COUPLING 
REAGENT 
 
ADDITIVE ACTIVE SPECIES 
 
CONDITIONS 
 
COMMENTS 
DCC (or DIC) / 
Symmetrical 
anhydrides 
Fmoc-AA/DIC (2:1) 
in DCM 
1 eq. Fmoc-AA 
wasted 
DCC (or DIC) HOBt Benzotriazolyl ester 
Fmoc-AA/DIC/HOBt 
(1:1:1) in DMF 
Slow activation in 
DMF 
PyBOP (or TBTU, 
HBTU) 
HOBt Benzotriazolyl ester 
Fmoc-AA/ 
PyBOP/HOBt/DIEA 
(1:1:1:2) in DMF 
Common activation 
method/fast 
activation 
HATU / 
9-Azabenzotriazolyl 
ester 
Fmoc-AA/ 
HATU/DIEA (1:1:2) 
in DMF 
Excellent for difficult 
couplings 
Fmoc-AA 
pentafluorophenyl 
ester 
HOBt Benzotriazolyl ester 
Fmoc-AA 
pentafluorophenyl 
ester/HOBt (1:1) in 
DMF 
No side-reactions 
TFFH / Acid fluoride 
Fmoc-AA/ 
TFFH/DIEA (1:1:2) 
in DMF 
Useful for N-alkyl and 
α-substituted 
residues 
 
                                                          
† Refer to the list of abbreviations (p. XII) for a complete explanation of the acronyms. 
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3.1.2.4 Racemisation 
Most of the natural amino acids, excluding glycine, have a chiral centre of L-configuration on 
their α-carbon atoms. The presence of such chiral centres is often important for the correct 
biological functions of peptide and proteins. Possible modifications of the Cα chirality can occur 
during the activation step of the carboxyl group. Due to the activated carboxyl group the hydrogen 
atom (natural substituent at the asymmetric α-carbon) presents enhanced acidity and can be easily 
removed by a base. The reattachment of such a proton represents the first mechanism of 
racemisation (direct enolization). The second more common one, involves deprotonation and ring 
opening of an oxazolone intermediate, that is generated by attack on the activated carboxy group of 
the adjacent amide bond (Fig. 3.9) (Chan and White, 2000a). 
Oxazolone formation takes place quite easily when using carboxy-activated amino acids 
especially if the activation strategy includes strong activators (such as DCC). It has been 
experimentally proved that when utilizing HOBt as catalyst during the coupling step the 
racemisation reaction is drastically reduced (Gamet et al., 1984; Benoiton et al., 1992). For this 
reason the chosen activation method for the synthesis of the designed bolaamphiphilic peptides 
involved the use of HOBt esters generated in situ with amminium/phosphonium salts. PyBOP® has 
been used for the loading of the first amino acid on the resin and HBTU for the elongation of the 
peptide chain (Fields, 1991; Angell et al., 2002). 
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Fig. 3.9: Racemisation via oxazolone formation. 
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3.2 Design of novel peptide bolaamphiphiles 
 
3.2.1 Guidelines 
Peptides derived from the general active motif suggested by Alvarez Bravo et al. (Alvarez-
Bravo et al., 1994) were used as parent compounds (L3, L4 and L5): 
 
H-KLKLnKLK-NH2          with n = 3, 4, 5; 
 
The design of novel peptides and peptide hybrids took into account: 
1. the importance of the KLK moiety and the hydrophobic poly-leucine chain for the 
antimicrobial activity (Nakajima-Shimada et al., 1998) 
2. a library of compounds previously designed at the University of Stellenbosch 
(Biochemistry) and derived from the abovementioned peptides (Naidoo, 2004) 
3. the well-established use of model antimicrobial peptides containing lysine and leucine 
(Lee et al., 1986; Suenaga et al., 1989; Anzai et al., 1991; Park et al., 2003; Béven et al., 
2003).  
Moreover, the project also focused on the self-assembly properties of these natural peptide 
bolaamphiphiles. Special consideration was therefore paid to previous work regarding self-
assembling peptides and peptide hybrids (Shimizu et al., 1996; Santoso and Zhang, 2004). 
Various modifications were introduced so as to investigate and evaluate the connections 
between the amino acid composition, the secondary structure and the biological activity. 
Additionally, for the development of new functional nanomaterials with antibiotic properties, it was 
important to modify the amino acid composition so as to increase the tendency to self-assemble. 
Modifications and changes were applied in different positions along the primary structure of  
the original model peptides. They are discussed below:  
A) Many synthetic and natural antimicrobial peptides (such as temporin A, magainin II amide, 
melittin, cecropin, nisin) have an amide functional group at the C terminus, hence, the 
entire set of peptides was synthesised as peptide amide. Only two compounds (KL1 and 
KL2♦) were designed as peptide acids, thus possibly providing a better understanding of 
SAR in this position. 
B) The charged amino acid lysine was replaced by the non-proteinogenic amino acid 
ornithine. The introduction of a non-natural amino acid is often intended to reduce the 
degradation of the peptide by bacterial hydrolytic enzymes (Hong et al., 1999). 
C) The hydrophobic amino acid leucine was substituted by the amino acid tyrosine. The 
phenolic functionality of the latter could increase the interactions with bacterial membranes 
                                                          
♦ Refer to Fig. 3.10 for the primary structure of KL1 and KL2.  
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because of its ability to disorganise phospholipid bilayers (hence its use as disinfectant 
since 1867 when Lister first introduced it in the clinical practice). Moreover, it could 
enhance the self-assembly properties (Zhang, 2003; Santoso and Zhang, 2004).  
D) The poly-leucine chain was changed into a linear spacer using ω-amino acids, more 
precisely using 6-aminohexanoic acid (with an aliphatic chain made of 5 carbons) and 9-
aminononanoic acid (with an aliphatic chain made of 8 carbons) (Naidoo, 2004). 
E) A glycyl-prolyl-glycine (GPG) tripeptide was also used instead of 9-aminononanoic acid, 
providing the same length (in terms of number of atoms) between the two hydrophilic 
heads. The use of proline involves the creation of a β-turn in the secondary structure, 
which influences the interaction with membranes and the self-assembly properties (Rex, 
2000). 
F) In order to create a large diversity inside the designed library of peptides and to evaluate 
the importance of the hydrophobicity in SAR, the charged amino acid (ornithine and 
lysine) and the hydrophobic amino acids (tyrosine and leucine) were switched.  
The outlined changes were not introduced simultaneously in the entire set of molecules. They 
were applied at different levels in various compounds, creating a series of molecules with some 
common features (length between 7 and 9 amino acids, net positive charge, general 
bolaamphiphilic structure) and some differences (amino acid composition, hydrophobicity, three-
dimensional structure). 
 
3.2.2 Library of peptides 
The library of synthesised compounds can be divided into four smaller families (Fig. 3.10). The 
first one comprises the parent compounds L3, L4 and L5 representing the original antimicrobial 
motif. In the second one 6-aminohexanoic acid and 9-aminononanoic acid are used instead of the 
poly-leucine chain. In the third group, molecules maintain the same overall positive charge (+5) but 
both ω-amino acid and GPG tripeptide are used. The last group includes peptide hybrids with a 
higher content in the hydrophobic AA leucine and a lower net positive charge (+3/+1)§. 
The entire library was planned and created focusing on the KL4 peptide hybrid which includes 
9-aminononanoic acid (Fig. 3.10). In preliminary studies this compound showed a biological 
activity higher than other peptide hybrids derived from the same motif and which included 6-
aminohexanoic acid and 12-aminododecanoic acid as linear aliphatic skeleton (Naidoo, 2004). 
Furthermore, the 9-aminononanoic acid provides a distance (in terms of number of atoms) between 
the two KLK charged motives comparable to the poly-leucine chain of the sapecin's first derivative  
(L3), the most active peptides derived from sapecin B (Hirakura et al., 1996). 
 
                                                          
§ Physicochemical properties of the designed peptides are extensively reviewed later in this chapter. 
  - 38 -  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.10: Library of synthesised compounds: the original amino acid pattern is shown at the top of the 
diagram. For simplicity, C8 and C5 represent 9-aminononanoic acid and 6-aminohexanoic acid respectively. 
 
Therefore, peptides’ physicochemical properties changed:  
I. the use of ornithine instead of lysine (OL1 and OL2), besides introducing a non natural AA, 
means increasing the charge density on the molecule, thus influencing the interaction with 
negatively charged membranes (such as bacterial cell wall).  
II. the substitution of leucine with tyrosine (OY1 and OY2) implies the possibility of stabilizing 
intramolecular hydrophobic interactions which can change the three-dimensional structure 
of the tyrosine-containing peptides.  
III. the diverse hydrophobic content between the various families entails different interactions 
with membranes and alters the self-organisation behaviour as the use of more hydrophobic 
amino acids (Tyr, Phe, Trp) increases the self-assembly ability (Santoso and Zhang, 2004).  
IV. not much is known about the effect on the biological activity of non-natural amino acids 
such as the ω-amino acids used in KL1, KL2, KL3, KL4, OL1, OY1, LO1 and LY1. Their 
hydrocarbon chain interferes with the classical α-helical structure of the parent peptides but 
provides a hydrophobic core comparable to that created by the poly-leucine chain. 
V. in OL2 and OY2, the use of a glycyl-prolyl-glycine tripeptide instead of the linear aliphatic 
ω-amino acid also involves modifications of three-dimensional structural properties, 
destroying the α-helical conformation.  
The modifications experimented in the library of peptides and peptide hybrids allowed us to 
investigate the effects on biological activity and aggregation properties of the following changes in 
the 3D-structure: {α-helices (parent peptides) → distorted α-helices (peptides including C5 and C8 
) → β-turn (GPG)}. They were later taken into account during the structural and biological 
characterisation of the novel compounds and correlated to their properties. 
H-KLK-C8-KLK-OH   KL2
H-KLK-C8-KLK-NH2   KL4
H-OLO-C8-OLO-NH2   OL1 H-OYO-C8-OYO-NH2   OY1 
H-OLOGPGOLO-NH2   OL2 H-OYOGPGOYO-NH2   OY2 
H-LOL-C8-LOL-NH2   LO1 H-LYL-C8-LYL-NH2   LY1
H-KLK-C5-KLK-OH   KL1 
H-KLK-C5-KLK-NH2   KL3 
H-KLK-Ln-KLK-NH2 n = 3, 4, 5;   L3, L4, L5
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3.3 Materials and instrumentation 
 
3.3.1 Chemicals 
3.3.1.1 Solvents and general reagents 
N,N’-dimethylformamide (99%) and toluene (99%) were supplied by Saarchem (Wadeville, 
South Africa). 
Pyridine (99%) and t-amyl alcohol (2-methylbutan-2-ol, 99%) were supplied by Acros 
Organics (Geel, Belgium). 
Glacial acetic acid (AcOH, 99%) was supplied by BDH (Poole, UK).  
Trifluoroacetic acid (99.5%) and acetic anhydride (99%) were supplied by Merck 
(Hohenbrunn, Germany). 
Acetonitrile (ACN, HPLC grade) was supplied by Riedel-de Haën (Seelze, Germany). 
Methanol (MeOH, 99.9%), N,N’-diisopropylethylamine (DIEA, 99.5%) and piperidine (99%) 
were supplied by Aldrich (Steinheim, Germany). 
Technical grade dichloromethane and diethyl ether were used after distillation. 
Analytical grade water (Milli-Q® water) was obtained by filtering glass-distilled water with a 
Millipore Milli-Q® (Bedford, MA, USA) 0.22-µm filtering system. 
Potassium cyanide was purchased from Merck (Darmstadt, Germany). Ninhydrin (99%) was 
from Aldrich (Steinheim, Germany). Phenol (99%) was from Labchem (Edenvale, South Africa). 
Chloranil (99%) and triisopropylsilane (TIS, 99%) were from Fluka (Buchs, Switzerland). 
Drying agents, salts, silica gel, 3 Å and 4 Å molecular sieves (ms) were supplied by Saarchem 
(Wadeville, South Africa), Fluka (Buchs, Switzerland) and Merck (Darmstadt, Germany). 
 
3.3.1.2 Protected amino acids, resins and coupling reagents 
Fmoc-Gly-OH♣, Fmoc-Leu-OH, Fmoc-Lys(Boc)-OH, Fmoc-Orn(Boc)-OH, Fmoc-Pro-OH, 
Fmoc-Tyr(tBu)-OH were supplied by Novabiochem (Laufelfingen, Switzerland). 
Fmoc-9-Anc-OH and Fmoc-6-Ahx-OH were supplied by Advanced ChemTech (Louisville, 
KY, USA). 
Novasyn TGA-Fmoc-Lys(Boc)-OH resin (loading capacity 0.21 mmol/g), Novasyn TGA 
resin (loading capacity 0.25 mmol/g), Novasyn TGR resin (loading capacity 0.23 mmol/g) were 
from Novabiochem (Laufelfingen, Switzerland). 
Benzotriazol-1-yloxytris(pyrrolidino)phosphonium hexafluorophosphate (PyBOP®) and 
1-hydroxybenzotriazole (HOBt) were from Novabiochem (Laufelfingen, Switzerland). 
2-(1H-benzotriazo1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) was supplied by 
both Advanced ChemTech (Louisville, KY, USA) and Novabiochem (Laufelfingen, Switzerland). 
                                                          
♣ Amino acid codes denote (S)-amino acids with an L-configuration unless stated otherwise. 
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Some crude L3, L4 and L5 peptides were kindly provided by Dr M Rautenbach (Department 
of Biochemistry, Stellenbosch University). 
 
3.3.2 Instrumentation 
3.3.2.1 Bench solid-phase peptide synthesis  
Solid-phase peptide synthesis was performed using a glass peptide reaction vessel coupled to 
a vacuum pump for solvents removal. 
A Stuart flask shaker SF1 (Bibby Sterilin, UK) was used during the elongation and 
deprotection reactions to vigorously mix the resin. 
The absorbance of the fulvene-piperidine adduct was determined using a Lambda 20 UV-Vis 
spectrophotometer (Perkin Elmer, UK). 
Lyophilization of the final pure products was performed using an Alpha 2-4 LD2 freeze-drier 
(Christ, Germany). 
 
3.3.2.2 Reversed-phase high performance liquid chromatography 
Reversed-phase high performance liquid chromatography was carried out using two different 
systems: 
 
1. a Waters Alliance 2690 Separations Module (Waters Corp., MA, USA) including an 
Alliance pump and autosampler connected to an Agilent 1100 Series UV detector (Agilent 
Technologies, CA, USA) and a PL-ELS 1000 evaporative light-scattering detector 
(EL-SD) (Polymer Laboratories, UK). The column was eluted at 30 °C. The UV detector 
was set at 220 nm. The parameters for the EL-SD detector were set as follows: nebuliser 80 
°C, evaporator 90 °C, gas flow (N2) 1.5 l/min. The system was controlled by GPC-7 
software (Polymer Laboratories, UK). 
 
2. a Kontron 500 HPLC System (Kontron Instruments, Italy) comprising a Kontron Bio-Tek 
522 dual solvent pump, a Kontron HPLC 560 autosampler, a Kontron degasser 3493, a 
Kontron HPLC 535 dual wavelength UV detector and a PL-ELS 2100 EL-SD (Polymer 
Laboratories, UK). The column was eluted at 30 °C. The UV detector was set at 220 and 
254 nm. The parameters for the EL-SD detector were set as follows: nebuliser 70 °C, 
evaporator 40 °C, gas flow (N2) 1 l/min. The system was controlled by Geminyx software 
(Goebel-Instrumentelle Analytik, Germany). 
 
Analytical RP-HPLC was performed on a C12 Proteo Jupiter column (250 x 4.6 mm, 4 µm 
particle size, 90 Å pore size) (Phenomenex, CA, USA). The purification of the synthesised 
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products was carried out using a semi-preparative C12 Proteo Jupiter column (250 x 10 mm, 10 µm 
particle size, 90 Å pore size) (Phenomenex, CA, USA). 
 
3.3.2.3 Electrospray ionisation mass spectrometry 
Electrospray ionisation mass spectrometry was performed on the crude peptides and on the 
pure peptides so as to confirm the mass and the purity of the synthesised compounds. The 
spectrometer used was a Waters Micromass Q-TOF Ultima API (Waters Corp., MA, USA) fitted 
with an electrospray source. Peptides were analysed in the positive mode. The parameters for the 
analysis were set as follows: capillary voltage 3.5 kV, cone voltage 35 kV, source 100 ºC, 
desolvation temperature 350 ºC, desolvation gas 400 l/h, cone gas 50 l/h. 
 
 
3.4 Experimental methods 
 
3.4.1 Preparation of solvents 
Solvents employed in solid-phase peptide synthesis were distilled before use and stored in 
different ways according to the guidelines given in Table 3.3. Solvents not listed in this table were 
bought of the highest quality commercially available and used without further purification. 
 
Tab. 3.3: Distillation and storage of solvents used for SPPS 
ms = molecular sieves 
 
 
3.4.2 Peptide synthesis  
Peptides were synthesised at room temperature (RT) by manual solid-phase peptide synthesis, 
applying the Fmoc protocol to the shake-flask method (Fig. 3.11) (Chan and White, 2000b). 
 
                                                          
∞ Pyridine was kept on KOH (20 g/l) for a few days before the distillation. 
SOLVENT AGENT BOILING POINT (°C) CONDITIONS STORAGE 
DMF Ninhydrin (100 mg/l) 153 Vacuum 4 Å ms, dark bottle 
Pyridine KOH (20 g/l) ∞ 115 N2 or Ar 3 Å ms, dark bottle 
Piperidine KOH (20 g/l) 106 N2 or Ar Dark bottle 
DCM CaCl2 40 N2 / 
Acetic anhydride / 139-140 N2 Used immediately 
Diethyl ether P2O5 34.5 N2 / 
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Fig. 3.11: Shake-flask method used for manual solid-phase peptide synthesis. 
 
3.4.2.1 Attachment of the first amino acid 
435 mg (0.1 mmol) of Novasyn TGR resin (for the synthesis of peptide amides) or 300 mg 
(0.075 mmol) Novasyn TGA resin (for the synthesis of peptide acids) was swollen in DMF (20 
ml/g) for 30 minutes. The first amino acid (5 eq.)# was loaded on the resin using PyBOP® (5 eq.), 
HOBt (5 eq.) and DIEA (10 eq.). The reaction was left to proceed for 4-6 h.  
358 mg (0.075 mmol) of Novasyn TGA-Fmoc-Lys(Boc)-OH (pre-loaded resin for the 
synthesis of peptide acids) were used. The resin was swollen in DMF and then deprotected with 
piperidine (see Section 3.3.2.4) before proceeding to the elongation step. 
 
3.4.2.2 Capping 
After the attachment of the first amino acid, possible free hydroxyl groups on the resin were 
treated with acetic anhydride (20% v/v in DMF) so as to prevent the growth of incorrect peptide 
chains. The resin was treated for 20 minutes with the abovementioned mixture and then washed 
with DMF (15 times, 10 ml/g of resin). 
 
3.4.2.3 Elongation of the peptide chain 
Fmoc-amino acids were loaded on the resin using a three times molar excess. HBTU (3 eq.) 
was used as coupling reagent as a cost-effective alternative to PyBOP® (Rautenbach, 1999). HOBt 
(3 eq.) and DIEA (6 eq.) were also used.  
                                                          
# Equivalents were calculated considering the resin loading capacity. 
COUPLING 
Fmoc-AA+HBTU 
+HOBt+DIEA in DMF 
60 min 
DEPROTECTION 
20% Piperidine 
in DMF 30 min 
sample for 
ninhydrin 
test 
sample for 
ninhydrin 
test 
repeat
= mixing
= DMF  
washing 
  - 43 -  
All the reagents were mixed together using a small amount of DMF (< 1.5 ml) to activate the 
carboxyl group of the incoming Fmoc-AA and then added to the unprotected growing peptide. The 
reaction usually lasted for 60 minutes. The completion of the reaction was monitored by 
performing a ninhydrin test (see Section 3.4.2.6). 
Reagents were removed by washing the resin with DMF (15 times, 10 ml/g of resin). 
 
3.4.2.4 Deprotection of the attached Fmoc-amino acid 
For the selective removal of Fmoc groups from the attached amino acids a 20% (v/v) 
piperidine solution in DMF was used. The reaction was left to proceed for 30-45 minutes. The resin 
was then washed with DMF (24 times, 10 ml/g of resin) so as to remove the excess of piperidine. 
 
3.4.2.5 Cleavage of the peptide from the resin 
After the last coupling/deprotection cycle the resin was washed with DMF and prepared for 
the final cleavage of the peptide. Traces of DMF can interfere with the acid cleavage (Chan and 
White, 2000b; Novabiochem, 2004), therefore, the resin was washed with different solvents: 
distilled DCM (20 ml/g of resin), t-amyl alcohol (10 ml/g of resin), glacial acetic acid (10 ml/g of 
resin), t-amyl alcohol (10 ml/g of resin) and finally with distilled diethyl ether (20 ml/g of resin). It 
was then dried under vacuum for 4-6 hours, using potassium hydroxide and phosphorous pentoxide 
as drying agents (Novabiochem, 2004). 
The peptide was cleaved from the resin using a solution of 95% TFA (v/v), 2.5% Milli-Q® 
water (v/v) and 2.5% TIS (v/v) for 3 to 4 hours (Paerson et al., 1989). For those peptides containing 
tyrosine a solution of 92.5% TFA (v/v), 2.5% Milli-Q® water (v/v), 2.5% TIS (v/v) and 2.5% 
phenol (w/v) was used and the cleavage time was extended to 5-6 hours (King et al., 1990). 
The cleavage solution containing the peptide was collected and the resin was washed with 
TFA (20 ml/g of resin). The solvents of the combined filtrates were evaporated under reduced 
pressure. The crude peptide was dissolved in analytical grade water and lyophilised. 
 
3.4.2.6 Ninhydrin test 
The ninhydrin test (also called Kaiser test) (Kaiser et al., 1970) was used to evaluate the 
completion of the acylation reaction during the coupling of an amino acid and also to monitor the 
deprotection step after the removal of the Fmoc group. 
Three solutions are required to perform the test: 
A. 1 g of ninhydrin in 20 ml 95% ethanol 
B. 80 g of phenol in 20 ml 95% ethanol 
C. 0.5 ml of 1 mM KCN diluted to 25 ml with distilled pyridine. 
A few resin beads were taken after the coupling reaction or after the piperidine deprotection, 
washed with distilled diethyl ether and air dried. Four drops of each solution were added to the 
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resin and the mixture was heated for 5 minutes in an 85 °C water bath. In the absence of free amino 
groups no change in colour was noticed (the solution was slightly yellow and the resin beads were 
colourless). If free primary amino groups were present (i.e. after the removal of the Fmoc group) 
the resin beads and the solution turned blue. Resin samples were taken twice in every coupling 
cycle: after the coupling of the amino acid and after the deprotection. The test had to be negative in 
the first case and positive in the second one. If not, the coupling reaction or the deprotection 
(respectively) was repeated.  
This reaction is very sensitive for free primary amino groups (about 1 µmol/g resin – 99.5% 
coupling for resins having a loading capacity of 0.2-0.5 mmol/g) (Albericio and Carpino, 1997). 
The Kaiser test was also used for quality control on protected amino acids: few milligrams of 
amino acid derivative were mixed with the three solutions and heated for 5 minutes in an 85 °C 
water bath. The reagent was used for peptide synthesis if no colour changes were noticed. 
 
3.4.2.7 Chloranil test 
This test was used for the detection of free secondary amino groups (i.e. proline) as chloranil 
(2,3,5,6-tetrachloro-1,4-benzoquinone) reacts with secondary and primary amines – in presence of 
acetone or acetaldehyde respectively - to give a green-blue colour on the resin beads (Christensen, 
1979; Albericio and Kates, 2000). A few resin beads were taken after the coupling reaction and 
after the piperidine deprotection, placed in a test tube, washed with distilled diethyl ether and dried. 
Then, 200 µl of acetone and 50 µl of a saturated solution of chloranil in toluene were added. The 
beads were shaken manually and turned green-blue if free amino groups were present.  
The sensitivity for secondary amines is in the range of 2-5 µmol/g resin (97-99% coupling for 
resins having a loading capacity of 0.2-0.5 mmol/g) (Albericio and Carpino, 1997). 
 
3.4.2.8 Determination of coupling efficiency 
As it has already been described in Section 3.1.2.4, the removal of the Fmoc protecting group 
leads to the production of a benzofulvene derivative characterised by a high UV absorbance.  
The piperidine/DMF mixture used for the deprotection step was collected in a clean flask and 
the absorbance at 301 nm measured. A solution of 20% piperidine in DMF was used as blank. The 
millimoles of free Fmoc-derivative, hence the millimoles of free amino groups on the resin, were 
calculated using the following equationƒ: 
 
mmol/g = [(A301 / ε301) x (V / g)] x 1000 
 
                                                          
ƒ Modified from the webpage of the Peptide Synthesis Lab of the University of Trieste (Italy), visit: 
www.bbcm.units.it/~tossi/PepSynt.htm (last accessed 22/05/04). 
 
(1) 
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Where A301 is the absorbance of the sample at 301 nm, ε301 is the extinction coefficient of the 
fulvene-piperidine adduct (7800 M-1cm-1), V the volume of the sample (ml) and g is the total 
weight of the resin (g). 
 
3.4.3 Peptide purification 
The purification of the synthesised peptides was performed by semi-preparative RP-HPLC using a 
binary solvent system (A = 95% H2O, 5% ACN, 0.1%TFA and B = 95% ACN, 5% H2O, 0.1% 
TFA) with a flow rate of 2.5 ml/min. Semi-preparative column and HPLC systems (No. 2) are 
described in Section 3.3.2.2. Different solvent gradients were developed so as to achieve an optimal 
separation for the various peptides as described in Tables 3.4, 3.5 and 3.6.  
 
 Tab. 3.4: Gradient A     Tab. 3.5: Gradient B     Tab. 3.6: Gradient C 
Time 
(min) 
A (%) B (%) 
0 100 0 
5 100 0 
30 50 50 
35 0 100 
40 100 100 
 
 
 
Time 
(min) 
A (%) B (%) 
0 100 0 
7 100 0 
35 60 50 
37 30 70 
40 30 70 
45 100 0 
 
 
Time 
(min) 
A (%) B (%) 
0 100 0 
7 100 0 
35 60 40 
37 50 50 
40 50 50 
45 100 0 
3.4.4 Analysis of purified peptides 
Analytical RP-HPLC was used to asses the purity of the synthesised peptides and to confirm their 
retention times. A binary solvent system was used (A = 95% H2O, 5% ACN, 0.1% TFA and 
B = 95% ACN, 5% H2O, 0.1% TFA) with a flow rate of 1 ml/min. Analytical column and HPLC 
systems (No. 1 and 2) are described in Section 3.2.2.2. The gradients used for this type of analysis 
are listed below (Tabs. 3.7 and 3.8). 
 
Tab. 3.7: Gradient C1        Tab. 3.8: Gradient H1 
Time 
(min) 
A (%) B (%) 
0 100 0 
7 100 0 
35 60 40 
37 50 50 
40 50 50 
45 100 0 
Time 
(min) 
A (%) B (%) 
0 100 0 
1 100 0 
36 0 100 
39 0 100 
44 100 0 
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ESI-MS was also used to characterise the purified peptides and peptide hybrids, confirming 
the mass and giving indications on the achieved purity (refer to Section 3.3.2.3 for details regarding 
the ESI-MS). 
 
 
3.5 Results and discussion 
 
3.5.1 Peptide synthesis 
SPPS proved to be an excellent technique for the synthesis of the entire set of peptides, made 
of small amphiphilic molecules. The chosen activation strategy, using PyBOP® (or HBTU) and 
HOBt/DIEA in DMF, gave fast reactions and high yields. Furthermore, as suggested by literature, 
the use of benzotriazolyl esters as active species during the coupling reaction implied that the chiral 
centres maintained their natural configurations (no additional studies were performed in this 
regard) (Gamet et al., 1984). The coupling/deprotection cycles were followed by the ninhydrin test 
(or by the chloranil test if proline was present): negative results were obtained after the coupling 
step and positive ones after the Fmoc deprotection, thus confirming the good elongation of the 
peptide chain. The measurement of the coupling efficiency - according to formula (1) - was 
successfully performed, determining the released fulvene-adduct by UV spectroscopy. In general it 
was in the range of 80-95% per coupling step. 
The use of the correct protection scheme permitted cleavage of the resin and removal of the 
side-chain protecting groups from the protected peptide with the same TFA treatment. During the 
final TFA cleavage different scavengers were employed: H2O/TIS was employed for most of the 
peptides, while H2O/TIS/phenol for tyrosine-containing peptides. They both gave good results and 
low amounts of impurities were detected in the analysis performed after the synthesis. 
Different quantities were used for the synthesis; these ranged from 0.075 mmol to 0.1 mmol, 
with an average theoretical yield of between about 65 and 90 mg of pure product. Real yields 
(calculated after purification) were in the range of 70-95%. 
 
The synthesised peptides and peptides hybrids are listed in the following pages: each one is 
described by its sequence (three-letter code) and reference name, molecular formula, molecular 
weight, yield (mg, µmol and percentage), RP-HPLC retention time and method, purity and mass 
determination by ESI-MS (expected m/z-values were calculated from the monoisotopic mass of the 
AA residues present in peptides and peptide hybrids). 
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H-Lys-Leu-Lys-Leu-Leu-Leu-Lys-Leu-Lys-NH2    (L3) 
C54H106N14O9 (1095.81 g/mol) 
Yield: * 
HPLC analytical (Method H1): tR = 28.26 min 
Purity HPLC (%): 98 
ESI-MS monoisotopicm/z:  Calculated: 1095.83 [M+H]+ 
      Found: 1095.80 [M+H]+ 
 
H-Lys-Leu-Lys-Leu-Leu-Leu-Leu-Lys-Leu-Lys-NH2   (L4) 
C60H117N15O10 (1208.67 g/mol) 
Yield: * 
HPLC analytical (Method H1): tR = 28.20 min 
Purity HPLC (%): 99 
ESI-MS monoisotopicm/z:  Calculated: 1208.92 [M+H]+ 
      Found: 1208.90 [M+H]+ 
 
H-Lys-Leu-Lys-Leu-Leu-Leu-Leu-Leu-Lys-Leu-Lys-NH2  (L5) 
C66H128N16O11 (1321.82 g/mol) 
Yield: * 
HPLC analytical (Method H1): tR = 27.98 min 
Purity HPLC (%): 99 
ESI-MS monoisotopicm/z:  Calculated: 1322.00 [M+H]+ 
      Found: 1322.00 [M+H]+ 
 
H-Lys-Leu-Lys-6-Ahx-Lys-Leu-Lys-OH     (KL1) 
C42H83N11O8 (870.18 g/mol) 
Yield: 50 mg, 57 µmol (72%) 
HPLC analytical (Method C1): tR = 24.67 min 
Purity HPLC (%): 99 
ESI-MS monoisotopicm/z:  Calculated: 870.65 [M+H]+ 
      Found: 870.51[M+H]+ 
 
H-Lys-Leu-Lys-9-Anc-Lys-Leu-Lys-OH     (KL2) 
C45H89N11O8 (912.26 g/mol) 
Yield: 45 mg, 49 µmol (75%) 
                                                          
* Received from Dr M Rautenbach as crude peptides.  
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HPLC analytical (Method C1): tR = 21.29 min 
Purity HPLC (%): 99 
ESI-MS monoisotopicm/z:  Calculated: 912.70 [M+H]+ 
      Found: 912.63 [M+H]+ 
 
H-Lys-Leu-Lys-6-Ahx-Lys-Leu-Lys-NH2     (KL3) 
C42H84N12O7 (869.19 g/mol) 
Yield: 82 mg, 94 µmol (95%) 
HPLC analytical (Method C1): tR = 23.30 min 
Purity HPLC (%): 98 
ESI-MS monoisotopicm/z:  Calculated: 869.67 [M+H]+ 
      Found: 869.64 [M+H]+ 
 
H-Lys-Leu-Lys-9-Anc-Lys-Leu-Lys-NH2     (KL4) 
C45H90N12O7 (911.27 g/mol) 
Yield: 51 mg, 56 µmol (67%) 
HPLC analytical (Method C1): tR = 26.00 min 
Purity HPLC (%): 97 
ESI-MS monoisotopicm/z:  Calculated: 911.71 [M+H]+ 
      Found: 911.32 [M+H]+ 
 
H-Orn-Leu-Orn-9-Anc-Orn-Leu-Orn-NH2     (OL1) 
C41H82N12O7 (855.17 g/mol) 
Yield: 59 mg, 69 µmol (75%) 
HPLC analytical (Method C1): tR = 23.88 min 
Purity HPLC (%): 98 
ESI-MS monoisotopicm/z:  Calculated: 855.65 [M+H]+ 
      Found: 855.56 [M+H]+ 
 
H-Orn-Leu-Orn-Gly-Pro-Gly-Orn-Leu-Orn-NH2   (OL2) 
C41H78N14O9 (911.15 g/mol) 
Yield: 62 mg, 68 µmol (94%) 
HPLC analytical (Method C1): tR = 20.31 min 
Purity HPLC (%): 96 
ESI-MS monoisotopicm/z:  Calculated: 911.62 [M+H]+ 
Found: 911.52 [M+H]+ 
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H-Orn-Tyr-Orn-9-Anc-Orn-Tyr-Orn-NH2     (OY1) 
C47H78N12O9 (955.20 g/mol) 
Yield: 77 mg, 81 µmol (89%) 
HPLC analytical (Method C1): tR = 21.43 min 
Purity HPLC (%): 99 
ESI-MS monoisotopicm/z:  Calculated: 955.61 [M+H]+ 
Found: 955.61 [M+H]+ 
 
H-Orn-Tyr-Orn-Gly-Pro-Gly-Orn-Tyr-Orn-NH2   (OY2) 
C47H74N14O11 (1011.18 g/mol) 
Yield: 62 mg, 61 µmol (77%) 
HPLC analytical (Method C1): tR = 17.33 min 
Purity HPLC (%): 99 
ESI-MS monoisotopicm/z:  Calculated: 1011.57 [M+H]+ 
Found: 1011.52 [M+H]+ 
 
H-Leu-Orn-Leu-9-Anc-Leu-Orn-Leu-NH2     (LO1) 
C43H84N10O7 (853.19 g/mol) 
Yield: 60 mg, 70 µmol (83%) 
HPLC analytical (Method H1): tR = 17.70 min 
Purity HPLC (%): 100 
ESI-MS monoisotopicm/z:  Calculated: 853.66 [M+H]+ 
Found: 853.64 [M+H]+ 
 
H-Leu-Tyr-Leu-9-Anc-Leu-Tyr-Leu-NH2      (LY1) 
C51H82N8O9 (951.24 g/mol) 
Yield: 77 mg, 81 µmol (91%) 
HPLC analytical (Method H1): tR = 22.11 min 
Purity HPLC (%): 99 
ESI-MS monoisotopicm/z:  Calculated: 951.63 [M+H]+ 
Found: 951.60 [M+H]+ 
 
3.5.2 Peptide purification and analysis 
The standard purification procedure which includes the diethyl ether precipitation was shown 
to be inappropriate for the purification of these short amphiphilic peptides (personal 
communication from Dr Rautenbach). RP-HPLC was hence the method of choice both for analysis 
and purification of the peptides (Mant et al., 1997). Two different RP-HPLC systems were used for 
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the analysis of crude and purified peptides (see Section 3.2.2.2 for details). Consistency and 
reproducibility were showed throughout the various analyses and the use of a C12 column - both for 
analytical and semi-preparative RP-HPLC - appeared to be a good choice for the separation of 
these short amphiphilic compounds.  
Crude peptides were analysed on different gradients so as to evaluate the best elution 
conditions for an optimal separation. Gradient C (see Section 3.3.3 for details) was widely used 
because of the very slow increase in the acetonitrile concentration (from 0 to 40% over 28 minutes) 
leading to a fast elution of water soluble impurities, better interaction of the peptides with the 
column and therefore a better separation.  
The good protocol followed for the SPPS, the purity of the solvents and the good quality of 
the chemicals were important elements for synthesizing pure molecules. Pure peptides were 
synthesised as confirmed by analytical RP-HPLC on crude samples. The use of an EL-SD coupled 
to the chromatography system was revealed to be an excellent tool for the quantitative detection of 
impurities regardless of their UV absorbance (Fig. 3.12, A and B). 
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Fig. 3.12: A) RP-HPLC chromatogram of crude OY2 on system 1 (C12 column) eluted with gradient C. Note 
the difference between the signal of the UV detector and the one from the EL-SD (refer to Section 3.2.2.2 for 
details about UV/EL-SD settings). B) RP-HPLC chromatogram of pure OY2 (same conditions). 
 
Semi-preparative RP-HPLC was successfully carried out for the purification of the 
bolaamphiphilic peptides and hybrids thereof (Fig. 3.13). Good separation of the desired peptides 
was achieved. Two different gradients were employed for the peptides’ purifications, taking into 
account the diverse amino acid composition and the difference in lipophilicity among the 
synthesised molecules. Gradient C was used for more hydrophilic peptides (KL1, KL2, KL3, KL4, 
OL1, OL2, OY1, OY2) while gradient B was employed for the purification of more lipophilic 
peptides (L3, L4, L5, LO1, LY1). The two gradients present different increases in the concentration 
of the organic modifier, reaching a higher value in gradient B (70%) and a lower value in gradient 
A B 
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C (50%). Purified peptides were further analysed by analytical RP-HPLC for assessing the 
achieved purity, which was determined to be greater than 96%. 
0 10 20 30 40
0,00
0,01
0,02
0,03
0,04
0,05
0,06
0,07
23.88
D
et
ec
to
r s
ig
na
l
Time (min)
 UV
 EL-SD
 
0 10 20 30 40
0,00
0,01
0,02
0,03
0,04
0,05
0,06
0,07
23.88
D
et
ec
to
r s
ig
na
l
Time (min)
 UV
 EL-SD
Fig. 3.13: RP-HPLC chromatogram of crude OL1 on system 1 (C12 column) eluted with gradient C. B) RP-
HPLC chromatogram of pure OL1 (same conditions). 
 
ESI-MS was used directly after the synthesis to confirm the presence of the desired peptide in 
the crude mixture and to give a first indication on the quality of the synthesis (Burdick and Stults, 
1997) (Fig. 3.14). 
 
Fig. 3.14: ESI-MS spectrum of crude KL3. Isotope variations are marked by i1, i2 and i3 corresponding to 
m/z-values with 1, 2 or 3 amu higher than the mass calculated from the monoisotopic residue mass (unknown 
fragments are indicated by *). 
 
 Mass analysis on crude peptides revealed the presence of contaminants, mostly including 
deaminated peptides, dimers (Figs. 3.15 and 3.16) (Smith and Light-Wahl, 1993; Loo, 2000) and 
sodium salts (Fig. 3.17). Mass spectra of the remaining crude compounds are reported in Appendix 
B. In no cases was the presence of the Fmoc/Boc-protected peptides revealed, thus confirming the 
successful deprotection of the amino group on the last amino acid and the removal of side-chains 
protecting groups by TFA cleavage. 
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Fig. 3.15: ESI-MS spectrum of crude LO1. Isotope variations are marked by i1, i2 and i3 corresponding to 
m/z-values with 1, 2 or 3 amu higher than the mass calculated from the monoisotopic residue mass  
(unknown fragments are indicated by *). 
 
 
Fig. 3.16: ESI-MS spectrum of crude LY1. Isotope variations are marked by i1, i2 and i3 corresponding to 
m/z-values with 1, 2 or 3 amu higher than the mass calculated from the monoisotopic residue mass  
(unknown fragments are indicated by *). 
 
 
Fig. 3.17: ESI-MS spectrum of crude KL2. Isotope variations are marked by i1, i2 and i3 corresponding to 
m/z-values with 1, 2 or 3 amu higher than the mass calculated from the monoisotopic residue mass 
(unknown fragments are indicated by *). 
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ESI-MS determination was then repeated after semi-preparative RP-HPLC purification to 
confirm the mass of the purified peptide and assess its purity (Fig. 3.18). 
 
 
Fig. 3.18: ESI-MS spectrum of pure KL1. Isotope variations are marked by i1, i2 and i3 corresponding to m/z-
values with 1, 2 or 3 amu higher than the mass calculated from the monoisotopic residue mass. 
 
 
3.6 Conclusions 
 
The designed library of peptides and peptide hybrids was successfully synthesised using a 
solid-phase approach based on the Fmoc protocol and performed manually with a shake flask 
procedure. The total yields after purification were generally between 70 and 95%. 
SPPS produced quite pure molecules but the entire set of compounds was nonetheless purified 
by RP-HPLC to achieve a purity greater than 96% (as subsequently determined by RP-HPLC 
coupled to an EL-SD). This choice was made considering the sensitivity of biological studies 
(antimicrobial properties, haemolytic activity, interactions with liposomes) and structural 
characterisation (fluorescence, infrared, circular dichroism) later performed on the same set of 
peptides. 
For each pure peptide, ESI-MS analysis confirmed the presence of the expected mass and also 
proved the purity of the final products. 
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Chapter 4 
 
Self-assembly behaviour and structural characterisation of 
novel bolaamphiphiles 
 
 
 
 4.1 Introduction 
 
 Nanotechnology is a very recent research field and it is growing in importance year after year. 
Among the different aspects of nanotechnology, the concept of self-assembly or self-organisation 
of molecules is extremely important. It is especially significant in the “bottom-up” approach, where 
functional structures are built at the atomic or molecular level to create functional structures 
(Zhang, 2003). The reason for this interest lies in the possibility to create nanostructured materials, 
planned to have certain characteristics, physical properties and shapes that are formed by the 
autonomous association of small molecules under certain conditions (Zhang and Altman, 1999). 
Nature provides scientists with many examples of self-organisation processes, from protein folding 
and unfolding to DNA and RNA expression, from lipid vesicles to membranes formation 
(Rajagopal and Schneider, 2004). Many efforts have been made in the last decade to mimic these 
processes and create macroscopic structures starting from single atoms. 
 The creation of new self-assembling molecules with the ability to give novel and useful 
supramolecular architectures is the focus of many studies in biomaterials engineering (Zhang, 
2003). Moreover, a parallel interest is developing around the molecular mechanisms which regulate 
and trigger the process. To date, different stimuli have been used to activate the self-assembly, 
including modifications of pH (Aggeli et al., 2003; Claussen et al., 2003; Niece et al., 2003), ionic 
strength and metal ions (Matsui and Douberly, 2001), light (Collier et al., 2001) and temperature 
(Pochan et al., 2003). 
 In this study the investigation into the self-organisational behaviour of the designed library 
was carried out by using a multifaceted approach. Different techniques were used to look at the 
self-assembly process from different points of view. Some of them – such as steady-state 
fluorescence measurements and Fourier-transform infrared spectroscopy – gave a strong 
physicochemical perspective to the study of peptide assemblies. Others – such as electron 
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microscopy (EM), Congo red (CR) staining – were used to investigate the peptide assemblies from 
a morphological perspective. 
 
 
4.2 Materials  
 
Peptides were synthesised on solid phase using the Fmoc-polyamide protocol and purified by 
RP-HPLC as previously described (see Chapter 3). 
Pyrene (99%) was supplied by Fluka (Buchs, Switzerland). Congo red (99%) was purchased 
from Saarchem (Wadeville, South Africa). 
Triethylamine (TEA, 99%) and trifluoroethanol (TFE, 99%) were supplied by Aldrich 
(Steinheim, Germany). 
Salts for buffers were provided by Saarchem (Wadeville, South Africa), Fluka (Buchs, 
Switzerland) and Merck (Darmstadt, Germany). 
Analytical grade water was obtained by filtering glass-distilled water with a Millipore Milli 
Q® (Bedford, MA, USA) 0.22-µm filtering system. 
 
 
4.3 Experimental methods 
 
4.3.1 Steady-state fluorescence measurements 
Peptides were dissolved in pyrene/Milli-Q® water or pyrene/Milli-Q® water/0.1% TEA at a 
starting concentration of about 45 mM. Samples were diluted with the same solvent directly inside 
the cuvette reaching a final concentration of about 1 x 10-3 mM. Sufficient time was allowed 
between dilutions to permit the samples to reach an equilibrium state. Pyrene emission spectra were 
recorded in a 10 mm path length ultra-micro quartz cuvette (Hellma, Germany) with a LS50B 
luminescence spectrometer (Perkin Elmer, UK) fitted with a xenon discharge lamp and controlled 
by FL WinLab software (Perkin Elmer, UK). The excitation wavelength was set at 334 nm and the 
emission wavelengths recorded at 373 and 384 nm (I1 and I3 respectively). Excitation and emission 
slits were set at 2.5 nm (Ganesh et al., 2003; Bakshi and Kaur, 2005; Yin et al., 2005). Experiments 
were carried out in triplicate at 25 ºC. The ratio I1/I3 was automatically calculated by the software 
and plotted against the concentration of peptides in solutions. Non-linear regression was performed 
on the concentration-response data and a sigmoidal fit with variable slope was fitted to every data 
set. Critical aggregation concentration (CAC) values were extrapolated from the experimental data 
by calculating the derivative of the sigmoidal fit. The minimum of the derivative was taken as the 
CAC. 
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4.3.2 Self-assembly experiments 
Self-assembly experiments were carried out under different conditions to evaluate the 
possibility to enforce or inhibit aggregation. Peptides were dissolved in 0.1% TEA (pH 10) 
(Naidoo, 2004) at a concentration above their CAC and left undisturbed for up to 15 days. 
Experiments were performed in glass vials at RT. The process was followed by various techniques 
(electron microscopy, Congo red staining and optical microscopy). 
 
4.3.3 Congo red staining and optical microscopy 
A Congo red staining solution was used to detect the presence of β-sheet structure after an 
aging period up to 15 days. The solution was prepared by dissolving a saturating amount of CR in 
80% absolute ethanol saturated with NaCl. The excess dye was filtered off through a 0.45 µm filter. 
The staining was performed by letting 10 µl of peptide solution air-dry on a microscope slide and 
then adding 20 µl of CR staining solution for a few seconds (Nilsson, 2004). The stained samples 
were air-dried and observed with an Axiolab optical microscope (Zeiss, Germany) equipped with 
50x, 100x, 200x magnification lenses and a polarised light source. The microscope was connected 
to a Sony CCD IRIS colour video camera coupled to a PTR Plus image capturing system. A 
microscope slide with 10 µl of stained solvent was used as reference. 
 
4.3.4 Scanning electron microscopy (SEM) 
SEM was performed on a Leo S440 scanning electron microscope (Department of Physics, 
University of Cape Town) with an accelerating voltage of 10 kV. Samples of peptide solutions in 
0.1% TEA (concentration above CAC) were freeze-dried to preserve the 3D structure and then 
fixed on a round (1 cm diameter) metal support using a double-sided carbon tape. The preparations 
were then sputter-coated with a thin gold/palladium layer. 
 
 4.3.5 Cryo-fracture scanning electron microscopy (cryo-SEM) 
 Cryo-SEM was used to observe frozen aqueous samples. Analyses were performed using a 
Leo S440 scanning electron microscope (Department of Physics, University of Cape Town) with an 
accelerating voltage of 5 kV. Samples of peptide solutions in 0.1% TEA (concentration above 
CAC) were placed in a capillary, frozen in liquid N2, and then the capillary was broken to create a 
fracture. 
 
4.3.6 Fourier-transform photoacoustic infrared spectroscopy 
FT-IR analyses were carried out on a Paragon 1000 spectrometer (Perkin Elmer, UK) fitted 
with a MTEC 300 photoacoustic detector and controlled by Spectrum 1.00 software (Perkin Elmer, 
UK). Peptides were dissolved in 0.1% TEA (above their CAC), left undisturbed for sufficient time 
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to reach an equilibrium state and freeze-dried directly into an aluminium sample holder. Emission 
spectra were recorded between 4500 and 500 cm-1. For each spectrum 128 interferograms were co-
added. Spectra in the amide I region were deconvolved by Spectrum 1.00 software (Perkin Elmer, 
UK). 
 
4.3.7 Circular dichroism spectroscopy 
Circular dichroism was performed on a Jasco J-810 spectrophotometer (Molecular and 
Cellular Biology, University of Cape Town). CD spectra were recorded in a 2 mm path length 
quartz cell at 25 ºC. Each sample was scanned five times at a scan speed of 100 nm/min, with a 
band width of 2 nm and a response time of 1 s over the wavelength range 180-260 nm. Peptides 
were analysed at different concentrations, above and below their CAC. Peptides were dissolved in: 
(1) 10 mM phosphate buffer pH 6.8, (2) 50% TFE/50% 20 mM phosphate buffer pH 6.8 and (3) 
0.1% TEA (pH 10) (Naidoo, 2004). Buffers were filtered through a 0.45 µm filter  
Scans were repeated after twelve days to monitor the effect of aging on the aggregation 
process. Samples were left at RT during this period. 
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4.4 Results and discussion 
 
4.4.1 Steady-state fluorescence measurements 
Fluorescence spectroscopy combined with a fluorescent probe is a technique commonly 
applied to the determination of the critical micelle concentration (CMC) of surfactants and can also 
be used to resolve the critical aggregation concentration of aggregating molecules, such as peptide 
bolaamphiphiles (Ganesh et al., 2003). Many different fluorescent probes can be used but the most 
diffuse is pyrene, which is very hydrophobic and has a solubility in water of 3.9 x 10-7 mol/l at 25 
ºC (Ninomiya et al., 2003). The relative intensity of each peak composing its fluorescence spectrum 
depends strongly on the polarity of the microenvironment. In the presence of micelles and other 
macromolecular assemblies, the pyrene molecule is preferentially solubilised in the interior 
hydrophobic regions of these aggregates. This characteristic can be used to monitor modifications 
in the aggregation status of a certain molecule. As shown below (Fig. 4.1), the relative intensity of 
the third band (I3, at 384 nm) increases with an increased polarity of the environment (i.e. 
aggregated molecules, curve B) while a diminished effect is seen on the relative intensity of the 
first band (I1, at 373 nm). The ratio I1/I3 is therefore used to follow the changes in environmental 
polarity of aggregating molecules in water, i.e. their status as aggregates or single molecules 
(Ganesh et al., 2003; Bakshi and Kaur, 2005; Yin et al., 2005). 
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Fig. 4.1: Pyrene fluorescence emission spectra in water, OY1 in 0.1% TEA ([OY1]<CAC) [A] and OY1 in 
0.1% TEA ([OY1]>CAC) [B]. Differences in I3 intensity are highlighted by the dotted ellipse. λexc = 334 nm, 
emission recorded between 350 and 450 nm on a LS50B Fluorescence Spectrometer (Perkin Elmer, UK), 
scan speed 500 nm/min.  
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The CAC values for the synthesised molecules were successfully determined with this 
technique. The changes of pyrene ratios I1/I3 with peptide concentration were followed both in 
water and 0.1% TEA (pH 10). Significant differences were found within the series of peptides and 
peptide hybrids and they were strongly related to the different amino acid compositions (Santoso 
and Zhang, 2004). Sigmoidal curves were successfully fitted to the concentration-response data sets 
and a correlation factor (R2) variable between 0.93 ± 0.01 and 0.99 ± 0.01 was found for each 
curve. The following graphs show the aggregation behaviour in 0.1% TEA for compounds KL1, 
KL2, KL3, KL4, OL1, OL2, OY1 and OY2 (Fig. 4.2). Because of the low water solubility of 
compounds LO1 and LY1, it was not possible to follow their aggregation behaviour under the same 
conditions. The experiments were carried out using a low starting concentration of peptide 
bolaamphiphile (about 5 mM) which corresponded to already high I1/I3 ratios (∼1.6), thus 
precluding the determination of the CAC. The same phenomenon occurred for the study of peptide 
aggregation in water (pH 7), where the probable CAC was much higher than a technically feasible 
starting concentration. Only for compounds OY1 and OY2 it was possible to accurately establish 
the CAC value under both conditions. 
 A summary of the critical aggregation concentration values for peptides and peptide hybrids 
in water and 0.1% TEA is reported in Table 4.1. 
 
Tab. 4.1: CAC values (in water and 0.1% TEA) for the synthesised compounds determined by fluorescence 
spectroscopy using pyrene as fluorescent probe (n.d. = not determined) 
 
REF CACa (mM) CACb (0.1% TEA) (mM) 
KL1 >45 6.50 
KL2 >45 8.16 
KL3 >45 5.84 
KL4 >45 7.45 
OL1 >45 3.30 
OL2 >45 7.60 
OY1 8.64 0.14 
OY2 30.02 2.10 
LO1 n.d. n.d. 
LY1 n.d. n.d. 
    a: pH 7; b: pH 10 
 
The use of two different environments (pH 7 and 10) permitted to study the aggregation 
behaviour of the compounds in an effort to understand the conditions that trigger the process. 
Hence, it was possible to determine how to enforce the aggregation, in this case by simply 
increasing the pH with an organic base (TEA), and how to inhibit it, by lowering the pH to neutral 
values (mQ water). 
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Fig. 4.2: Change of pyrene I1/I3 ratios with peptide concentration in 0.1% TEA.  
The arrows graphically indicate the CAC values. 
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 Looking at the CAC values it was possible to identify two main classes of parameters which 
influenced the self-assembly: external parameters (concentration, pH) and internal parameters 
(three-dimensional structure, amino acid composition).  
 The concentration of peptides/peptide hybrids in solution was the driving force of the 
aggregation. All the molecules exhibited higher I1/I3 values (i.e. they were present in the aggregated 
form) at high concentrations than in dilute solutions (Fung et al., 2003; Chen, 2005). 
Another important factor which determined the propensity towards aggregation was the pH. 
Because of the presence of primary amino groups on the side-chains of several AA (such as Orn 
and Lys), an acidic/neutral pH could be translated into a net positive charge on the molecule. This 
positive charge could ultimately lead to strong repulsive electrostatic forces, with a resultant high 
CAC. On the other hand, a basic environment gives a neutral charge on the molecules and 
facilitates the formation of hydrogen bonds, thus lowering the CAC (Caplan et al., 2000). This 
tendency is clearly marked by the comparison of the behaviour in water and 0.1% TEA of OY1 and 
OY2 (Figs. 4.3 and 4.4). For OY1, the shift to higher CAC values is very striking; the CAC in 
water is more than 60 times greater than in 0.1% TEA (8.64 mM and 0.14 mM respectively). For 
OY2 the difference is smaller, but there is still a decrease of 15 times in the CAC value going from 
water to 0.1% TEA (from 30.02 mM to 2.10 mM). 
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Fig. 4.3: Effect of pH on the aggregation process of OY1.  
The arrows graphically indicate the CAC values. 
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Fig. 4.4: Effect of pH on the aggregation process of OY2.  
The arrows graphically indicate the CAC values. 
 
 The effect of pH was also considered to be important in the aggregation behaviour of 
KL1/KL2 and KL3/KL4. These four compounds display a different C terminus functionality, 
which is acid in the first two and amide in the others. In a basic environment, KL1 and KL2 present 
negative charges that KL3 and KL4 do not have and they lose the possibility to create 
intermolecular H bonds at the C terminus. KL1 and KL2 were therefore expected to show higher 
CAC. Nonetheless, the comparison of the aggregation behaviour of KLx peptides (where x = 1, 2, 
3, 4) showed only small differences in the CAC (all comprised between 6 and 8 mM), probably 
also indicating that the functionality at the C terminus is not a critical factor for the aggregation 
(Fig. 4.5). 
 Additionally, the presence of hydrophobic AA (i.e. OY1 and OY2) and the structure of the 
compounds in solution (i.e. OL2 and OY2) gave other indications of the important parameters that 
governed the aggregation. Proline strongly influenced the aggregation of the peptides. OY2 and 
OL2’s sequences are similar to the corresponding hybrid peptides OY1 and OL1 except for the 
presence of the GPG linker between the two charged heads, which is replaced by 9-aminononanoic 
acid in OY1 and OL1. Nonetheless, they showed a higher CAC than OY1 and OL1 (15 times 
higher for OY2 and more than twice for OL2). Because of the introduction of a β-turning AA 
(Pro), the three-dimensional arrangements in solution were altered and molecules were forced into 
a structure which decreased the possibility of intermolecular interactions. Differences in CAC 
values and aggregation behaviour of OY1 and OY2, OL1 and OL2 are shown (Figs. 4.6 and 4.7). 
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Fig. 4.5: Despite differences in the primary structure KL1, KL2, KL3 and KL4  
show a similar behaviour in 0.1% TEA. 
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Fig. 4.6: Role of three-dimensional structure on the aggregation behaviour of OY1 and OY2 in 0.1% TEA. 
The arrows graphically indicate the CAC values.  
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Fig. 4.7: Role of three-dimensional structure on the aggregation behaviour of OL1 and OL2 in 0.1% TEA. 
The arrows graphically indicate the CAC values. 
 
 
 As was previously mentioned, the content of hydrophobic AA also affected the aggregation 
profiles (Zhang et al., 1993; Santoso and Zhang, 2004). Tyrosine-containing compounds 
aggregated at lower concentrations than the leucine-containing homologues (more than 23 times 
lower for OY1 and about 4 for OY2) (Figs. 4.8 and 4.9). 
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Fig. 4.8: Effect of Leu→Tyr substitution on the aggregation behaviour in 0.1% TEA of OL1 and OY1.  
The arrows graphically indicate the CAC values. 
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Fig. 4.9: Effect of Leu→Tyr substitution on the aggregation behaviour in 0.1% TEA of OL2 and OY2.  
The arrows graphically indicate the CAC values. 
 
The use of more hydrophobic AA tends to enhance the self-organisation process of 
aggregating molecules as hydrophobic interactions are considered one of the driving forces of the 
process (Wang et al., 2005). This trend was clearly noticed in some of the compounds. OY1 and 
OY2 are derived from OL1 and OL2 (Leu→Tyr substitution). The presence of a more hydrophobic 
AA caused a noteworthy decrease in the CAC values because of π-stacking interactions (Caplan et 
al., 2002; Gazit, 2002). 
 
4.4.2 Self-assembly through microscopy 
 After the occurrence of aggregation was confirmed by steady-state fluorescence 
measurements, it was important to study the morphology of such aggregates by using different 
microscopic tools.  
Peptide assemblies were treated with CR and observed with OM. Congo red binds to 
proteins/peptides assemblies that assume a β-sheet structure and under polarised light they exhibit 
green birefringence (Nilsson, 2004; Madhavaiah et al., 2005). Peptides assembled into ribbons after 
7 days in 0.1% TEA and were detected in the form of red/brown fibres/ribbons. The use of 
polarised light confirmed the existence of aggregates showing birefringence (Figs. 4.10 and 4.11). 
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Fig. 4.10: Assembly of OY1 in 0.1% TEA (after 7 days at 25 °C) upon treatment with CR (left) and 
birefringence under polarised light (right). The scale bar represents 100 µm. 
 
  
Fig. 4.11: Assembly of OY2 in 0.1% TEA (after 7 days at 25 °C) upon treatment with CR (left) and 
birefringence under polarised light (right). The scale bar represents 100 µm. 
 
 
 SEM micrographs revealed the presence of a very fine texture in the dried peptide assemblies. 
The lyophilisation of the samples helped to preserve their 3D structure. Significant SEM 
micrographs of peptide assemblies are presented in Figures 4.12, 4.13, 4.14 and 4.15. Peptides 
assembled into microfibres/microtubes with diameters in the range of 500 nm to 2 µm and lengths 
of tens of microns. On the other hand the EM work that was performed letting air-dry the samples 
gave low quality images, possibly because of residual moisture in the samples and/or 
disorganisation of the supramolecular aggregates due to slow evaporation (results not shown).  
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Fig 4.12: SEM images of dried assemblies from KL1. [A] Vesicles budding out of interwoven microtubes. 
   
Fig 4.13: SEM images of dried assemblies from KL4. 
   
Fig 4.14: SEM images of dried assemblies from OY2. [A] Vesicles budding out of microtubes. 
   
Fig 4.15: SEM images of 3-way junctions (arrows) from dried assemblies: OL2 [A] and OL1 [B]. 
A 
A 
A 
A B 
B 
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 Cryo-fracture SEM micrographs also revealed fibre-like structures after an incubation time of 
two weeks at RT in 0.1% TEA (Figs. 4.16, 4.17 and 4.18). Fibres were oriented in different 
directions: vertically (circles) and horizontally (arrows). The macromolecular assemblies of the 
peptides consisted mainly of microtubes/microfibres with lengths of several microns and uniform 
diameters of about 600 nm. 
 
   
Fig. 4.16: Microtubes from OY1 [A] and OY2 assemblies [B] after 15 days in 0.1% TEA. 
 
 
 
Fig. 4.17: Microtubes from KL4 assemblies after 15 days in 0.1% TEA. 
 
 
   
Fig. 4.18: Microtubes from OL1 [A] and OL2 assemblies [[B] after 15 days in 0.1% TEA. 
  
A B 
A B 
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 Peptides made of alternating hydrophilic and hydrophobic residues tend to form unusually 
stable β-sheet structures in water. Polar and non polar AAs are secluded on the two different sides 
of the β-sheet surface and, therefore, hydrophilic and hydrophobic interactions are much stronger. 
Moreover, they are added to conventional β-sheet hydrogen bonds along the backbones (Vauthey et 
al., 2002). Most of the peptide bolaamphiphiles designed for this study present an alternation of 
polar (Orn, Lys) and non polar (Leu, Tyr, 9-Anc, 6-Ahx) residues and have structural similarities 
with some compounds developed by Zhang and co-workers (von Maltzahn et al., 2003). Only LO1 
and LY1 present an excess of hydrophobic amino acids. The microscopy study that was carried out 
proved that they self-assemble in response to an increase in pH when the net charge of the peptide 
molecules is near zero (Caplan et al., 2000). The use of both cryo-fracture SEM and SEM (upon 
lyophilisation of the samples) permitted to looked at the 3D complexes formed in solution. SEM 
images revealed the presence of microtubes and microvesicles with diameters ranging from 500 nm 
to 2 µm. The peptide assemblies were characterised by a network of interwoven fibres. Moreover, 
3-way junctions (branches) connecting the microtubes were also observed and resulted in sponge-
like three-dimensional arrangements. Such branched supramolecular organisations are attracting 
significant interest especially because of their effects on rheological properties (Cates, 1987; 
Shikata and Imai, 2000). 
 In many cases the peptides created heterogeneous populations of microfibres, vesicles and 
entangled rod-like micelles. Furthermore, vesicles budding from the microtubes and developing in 
3-way junctions were also noticed. Their presence is often considered as a sign of the dynamic 
behaviour of the self-assembly process of this kind of molecules (Vauthey et al., 2002). 
 Cryo-fracture SEM also showed the existence of hollow tubes, at least for some of the peptide 
bolaamphiphiles. Such an observation is consistent with the presence of branches and vesicles. 
 
 4.4.3 Gels from peptide bolaamphiphiles 
 Except for the formation of microfibres observed by EM, in some cases the self-assembly had 
also visible consequences. Peptide hybrid OY1 at high concentration (∼7 mM or ∼9 mg/ml or 9% 
by weight) in 0.1% TEA (clear solution after solubilisation) gave a gel after standing for 7 days at 
room temperature in a closed glass vial. The gel phase self-supported upon inversion. 
 The peptide gel was observed with an optical microscope at different magnifications 
(described in Section 4.3.3) under cross-polarised light, and showed a complex optical texture 
(Fig. 4.19). OM revealed striations with a parallel development and strong birefringence properties 
(Fig. 4.19 C and D). Birefringence commonly indicates orientation of the material at the level of 
tens of microns (Hartgerink et al., 2002). This indication is consistent with the other microscopy 
observations carried out on the peptide assemblies derived from OY1. 
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Fig. 4.19: Light microscope images showing birefringence1 from OY1 gel, observed under cross-polarised 
light. The bar scale represents 100 µm. 
 
                                                 
1 “Birefringence is defined as the double refraction of light in a transparent molecularly ordered material, 
which is manifested by the existence of orientation-dependent differences in refractive index. […] Although 
birefringence is an inherent property of many anisotropic crystals […] it can also arise from other factors, 
such as structural ordering, physical stress, deformation, […]. Structural birefringence is a term that applies 
to a wide spectrum of anisotropic formations, including biological macromolecular assemblies such as 
chromosomes, muscle fibres, microtubules, liquid crystalline DNA and fibrous protein structures such as 
hair”. From http://micro.magnet.fsu.edu/primer/lightandcolor/birefringenceintro.html (accessed 25/05/06). 
A B 
C D 
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 4.4.4 Fourier-transform photoacoustic infrared spectroscopy 
 FT-IR PAS was used to study the dried peptide assemblies and especially to evaluate the 
nature of the hydrogen bonds present in the supramolecular structures. Spectra were dominated by 
the amide I envelope at 1670 cm-1 and amide II band at about 1554 cm-1. Characteristic bands are 
reported in Table 4.2. Two typical spectra are shown in Figures 4.20 and 4.21 as examples.  
 
Tab. 4.2: FT-IR bands for the dried peptide assemblies (cm-1) 
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Fig. 4.20: FT-IR spectrum of the dried OY1 assemblies in the region 500-4500 cm-1. 
 
assignment KL1 KL2 KL3 KL4 OL1 OL2 OY1 OY2 
Amide A 3270 3286 3270 3272 3289 3287 3286 3252 
NH2 3077 3082 3052 3069 3084 3069 3087 3066 
CH2 asymmetric stretching 2954 2932 2930 2936 2930 2940 2932 2924 
CH2 symmetric stretching 2872 2858 2860 2860 2865 2860 2860 2863 
CH2 scissoring 1428 1410 1422 1428 1428 1452 1452 1454 
Amide II 1554 1546 1554 1552 1554 1552 1556 1556 
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Fig. 4.21: FT-IR spectrum of the dried KL2 assemblies in the region 500-4500 cm-1. 
 
 Amide I bands and deconvolved amide I bands (1700-1600 cm-1) gave information on the 
conformation that peptides took. See Figure 4.22. Most of the peptides adopted a β-sheet 
conformation with intramolecular hydrogen bonds, as demonstrated by the presence of bands at 
around 1630-1635 cm-1 and 1670-1675 cm-1 (Byler and Susi, 1986; Yamada et al., 1998; Stuart, 
2004). Amide I bands also gave an indication that the molecules assumed an antiparallel β-sheet 
conformation as a band around 1690 cm-1 was present in almost all the spectra (Yamada et al., 
1998; Ganesh et al., 2003). Nonetheless, random/unordered structure and turns were also present, 
as suggested by a band at around 1640 cm-1 (random structures) and one at around 1680 cm-1 
(turns) (Byler and Susi, 1986). The frequency of amide A bands usually reveals the existence of 
non-covalent interactions in the molecule (Ganesh et al., 2003). In the peptide bolaamphiphiles’ 
spectra these bands absorb between 3270-3286 cm-1 and there is no absorption at around 3400 cm-1, 
thus indicating that all the peptide amide NHs are involved in intermolecular hydrogen bonding 
(Ganesh et al., 2003). 
 C-H stretching vibration bands were also studied as they can provide useful information about 
the aggregation of peptides (Ricci et al., 2000). Alteration of band stretching, in terms of both 
position and width, indicate conformational order changes after peptides associate to form 
aggregates (Ganesh et al., 2003). The C-H asymmetric and symmetric stretching bands of n-octane 
(n-C8H18, comparable to the structure of 9-aminononanoic acid of the peptide hydrophobic core) 
are located at 2925 and 2855 cm-1 respectively. Peptide bolaamphiphiles presented a significant 
change in frequency (having C-H asymmetric and symmetric bands at around 2930-2940 cm-1 and 
2860-2870 cm-1 respectively), which is consistent with peptide aggregation (Ganesh et al., 2003). 
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Fig. 4.22: Amide I bands (black) and deconvolved amide I bands (grey) of dried peptide assemblies  
(1700-1600 cm-1). 
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  4.4.5 Circular dichroism spectroscopy 
 Peptides and peptide hybrids were further analysed by CD in different environments and 
concentrations. At low concentrations (0.2 mg/ml in 10 mM PBS pH 6.8), all the synthesised 
molecules showed a random structure (minima at 196-197 nm). Only the parent compounds (L3, 
L4, L5) showed an α-helical secondary structure in PBS (maxima at 192 nm and minima at 205 
and 218 nm) (Naidoo, 2004). Spectra did not change after an aging period of several days (up to 
twelve) thus indicating that (under those conditions) no significant changes took place in the three-
dimensional arrangements of the molecules. At the same concentration, in 20 mM PBS pH 6.8/TFE 
(1:1), compounds containing ω-AA (KL1, KL2, KL3, KL4, OL1, OY1) presented a different 
profile, which was very likely induced by the solvent itself. Again, no effects were detected after 
aging (Figs. 4.23 and 4.24 show CD spectra). In the same environment, peptides OL2 and OY2 
(containing proline instead of ω-AA) did not show any difference. 
 To enforce the aggregation, CD studies were also performed at higher concentrations (∼5 
mg/ml) dissolving peptides in 0.1% TEA (pH 10). However, under these conditions it was not 
possible to record noteworthy spectral information because of (i) the high absorption in the far-UV 
of the solvent itself and (ii) the high peptide concentration which also affected the measurements 
(Johnson, 1990). 
 The use of ω-amino acids (6-aminohexanoic acid and 9-aminononanoic acid) in the 
substitution of the poly-leucine chain proved to heavily affect the helicity, typical of the parent 
compounds (KLKLnKLK-NH2, n = 3, 4, 5). The lack of hydrogen donors and acceptors for the 
formation of hydrogen bonds was probably fundamental for the modification of the secondary 
structures in the peptide hybrids (containing 9-Anc and 6-Ahx). Moreover, the use of proline also 
greatly contributed towards the formation of unordered secondary structures at low concentration. 
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Fig. 4.23: CD spectra of peptide bolaamphiphiles [A] in a watery system and [B] in a more hydrophobic 
environment. 
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Fig. 4.24: CD spectra of peptide bolaamphiphiles [A] in a watery system and [B] in a more hydrophobic 
environment. 
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 4.5 Conclusions 
 
 The aggregation process of novel bolaamphiphilic peptides was studied both from a 
physicochemical point of view and from a morphological perspective. The determination of CAC 
values gave useful guidelines regarding the status of the molecules in solution (as single molecules 
or aggregates) according to concentrations and other conditions. The comparison of the different 
behaviours resulted in the possibility to correlate the CAC to the composition in AAs and the 3D 
structure of the molecules. Factors that are believed to influence the self-assembly (such as the 
presence of hydrophobic residues) were found to have a primary role in governing the aggregation 
(Zhang et al., 1993; Santoso and Zhang, 2004). Peptide bolaamphiphiles containing tyrosine 
showed a lower CAC than leucine containing homologue molecules, especially because of stronger 
hydrophobic interactions of the side chains due to π-stacking (Gazit, 2002). In addition, the role of 
the 3D structure was also clarified and established to be fundamental. Proline-containing molecules 
showed higher CAC values than homologue peptides which had 9-aminononanoic acid, and 
confirmed the critical importance of single-molecule properties on the aggregation process (Jun et 
al., 2004).   
 The morphology studies performed on the assemblies revealed the complex supramolecular 
architectures formed by these compounds. The aggregation was enforced by pH modifications, 
while CR staining and OM observation gave evidence of fibre-like structures with birefringence 
properties under cross-polarised light. SEM and cryo-SEM micrographs also confirmed the 
formation of fibres with dimensions in the range of several microns (between 500 nm and 2 µm). 
The coexistence of microtubes, vesicles, 3-way junctions, branches and vesicles budding out of 
microtubes revealed that the self-assembly process of these surfactant-like molecules is a dynamic 
event (Vauthey et al., 2002). 
 A peptide gel was formed by one of the compounds (OY1, 9% by weight in 0.1% TEA) as a 
result of the self-assembly. The observation of birefringence by optical microscopy under cross-
polarised light revealed a molecular structural organisation at the level of tens of microns. Peptide 
gels are currently attracting a lot of interest in biomaterials engineering and regenerative medicine 
because of the structural support combined to the biological activity (Holmes et al., 2000; Kisiday 
et al., 2002). 
 The use of FT-IR gave supporting information regarding the aggregation of the molecules. 
Specific bands related to the presence of antiparallel β-sheet structures were found. Additionally, 
bands referring to turns and unordered 3D arrangements were also discovered (Byler and Susi, 
1986). FT-IR analyses were consistent with the microscopy observations where different kinds of 
supramolecular architectures were revealed, such as microfibres, microtubes, vesicles and 3-way 
junctions. 
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 The self-assembly process could be explained by two hypothetical mechanisms which 
ultimately coexist and possibly explain the diverse structures detected.  
 A. The presence of β-sheet structures (FT-IR), microfibres and microtubules (cryo-SEM) 
indicated the existence of structured supramolecular architectures created by ordered arrangements 
of single molecules. Strong intramolecular hydrogen bonds tend to create β-sheets, which turn on 
themselves to give microtubules (Kogiso et al., 2000; Matsui and Gologan, 2000; Matsui and 
Douberly, 2001) (Fig. 4.25). 
 
     
Fig. 4.25: Hypothetical self-assembly mechanism of tubule formation 
(modified from Matsui and Douberly, 2001). 
 
 B. The discovery of turns and unordered structures (FT-IR) and the evidence of the 
aggregation (CAC by fluorescence measurements) presented a disordered and more dynamic 
aggregation process. The surfactant-like structure of the molecules could explain the formation of 
vesicles (micelles) and 3-way junctions (SEM) (Santoso et al., 2002; Vauthey et al., 2002; Masuda 
and Shimizu, 2004) (Fig. 4.26). 
 
Fig. 4.26: Potential mechanism of tubule formation. Red: hydrophilic; blue: hydrophobic. [A] each peptide 
may interact with one another to form closed rings, which stack on top of one another to give a nanotube. [B] 
three nanotubes are connected by a three-way junction (modified from Vauthey et al., 2002). 
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Chapter 5 
 
Hydrophobic characterisation and correlation  
with self-assembly behaviour 
 
 
 
 5.1 Hydrophobicity in peptide chemistry 
 
 The hydrophobic content of drugs has been historically considered an important parameter for 
pharmacokinetics studies (Tute, 1996). The prediction of adsorption through membranes such as 
the skin, blood-brain barrier and gastrointestinal tract (Donnely et al., 1996; Meng et al., 2001), the 
interaction with lipid bilayers (Klein et al., 2001) or receptors are all based on a molecule’s 
hydrophobic profile. Therefore, the determination of the hydrophobicity of drugs or biologically 
active molecules is fundamental for (i) the understanding of their mechanism of action and (ii) the 
optimisation of SAR parameters (Fauchère, 1996). 
 A universal tool for the experimental measurement of the hydrophobicity of a given molecule 
or peptide is its partition coefficient (P) between a non-polar phase and water, where often the non-
polar phase is n-octanol, as suggested by Fujita et al. (Fujita et al., 1964). Generally the logarithmic 
form is used (Log P). However, the determination of the Log P by direct measurements, using the 
flask-shake equilibration method, faces problems such as poor reproducibility and the long 
experimental times, besides requiring a reasonable quantity of pure compound (Cimpan et al., 
2000). Moreover, the flask-shake technique can produce experimental problems (formation of 
micelles, accumulation of the compounds at the octanol-water interface) and it is not advisable to 
use it with amphiphilic compounds (such as surfactants) (Klein et al., 2001). These limitations are 
overcome by using reversed-phase high performance liquid chromatography, where the stationary 
phase (generally C18 or C8) mimics the non-polar solvent. The liquid chromatographic method has 
the advantages of fast determination and better reproducibility, while the purity of the sample is not 
a necessary condition (Cimpan et al., 2000). Moreover, the quantity used can often be in the range 
of milligrams or less. In the case of peptides and the determination of their lipophilicity, the 
advantages offered by RP-HPLC are extremely important and turn this technique into a useful 
device for their hydrophobic characterisation. 
 One of the basic parameters for hydrophobicity characterisation by isocratic RP-HPLC is the 
capacity factor (k’), which can be calculated by the following relationship: 
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k’ = (tR – t0) /t0  
 
where tR is the retention time of the analyte and t0 is the retention time of an unretained compound 
(commonly methanol or acetonitrile) (OECD, 1989; vd Waterbeemd, 1996). Frequently, the 
logarithmic form is used as lipophilicity index (Log k). The capacity factor is independent of the 
column length and mobile phase flow rate (Meng et al., 2001) but its validity is limited to 
homologous series of molecules and if the operative conditions are constant for all of them 
(Pignatello and Puglisi, 2000; Hallgas et al., 2004). 
  Among the synthesised compounds several differences were present: charge, ratio between 
hydrophobic and hydrophilic amino acids, three-dimensional structure, number of AA, etc. (Tab. 
5.1). Therefore, the use of isocratic HPLC to characterise this variety of structures was considered 
inappropriate. As suggested by some examples in the literature (Kim et al., 2005), retention times 
from gradient RP-HPLC can correlate well with the biological activity of antimicrobial peptides 
(activity intended as ability to lyse membranes) and lipophilicity can be estimated by gradient 
liquid chromatography (Kaliszan et al., 2002). It was consequently decided to use the tR obtained 
by gradient RP-HPLC and study the correlation with theoretically calculated values of lipophilicity 
and the self-assembly profile of each compound in 0.1% TEA. In order to determine reliable data, 
tR values for the synthesised compounds were collected by using different columns and gradients, 
and the various data sets were compared. 
 
Tab. 5.1: Peptides and peptide hybrids used in this study 
 
  
  
 
 
 
 
 
 
 
   
    
 
 Theoretical calculations of the hydrophobic content give Log P values (defined as CLOGP or 
calculated Log P) which can be compared to the experimental ones. Various mathematical models 
have been developed since the introduction of the flask-shake method for the Log P determination 
(2)
PEPTIDE PROLINE LINEAR LINKER MW (g/mol) 
NET 
CHARGE # 
L3   1095.81 +5 
L4   1208.67 +5 
L5   1321.82 +5 
KL1  X 870.18 +5 
KL2  X 912.26 +5 
KL3  X 869.19 +5 
KL4  X 911.27 +5 
OL1  X 855.17 +5 
OL2 X  911.15 +5 
OY1  X 955.20 +5 
OY2 X  1011.18 +5 
LO1  X 853.19 +3 
LY1  X 951.24 +1 
  # net charge at pH 7 
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(Leo, 1996; Richards, 1996). The two most widely used in peptide chemistry are (A) the residue 
addition method and (B) the fragment addition method. 
  
 A) Residue addition method 
 Because peptides and proteins are formed by amino acids one can easily think that their 
hydrophobicities depend on their amino acid compositions. Therefore it should be possible to 
theoretically calculatehydrophobicityby knowing the contribution of each single residue. Over the 
past decades, different hydrophobicity scales have been developed and amino acids categorised 
accordingly. Two main models were created: the first one only considers the amino acid side-
chains’ contribution to the overallhydrophobicity(Kyte and Doolittle, 1982; Fauchère and Pliska, 
1983), while the second one also takes into account the peptide bonds’ contribution (Wimley et al., 
1996; Wimley and White, 1996). Thinking about the interactions between a polypeptide and a 
membrane, it is important to consider that the entire molecule interacts with the phospholipid 
bilayer and crosses it, not only the side chains. Therefore, the peptide bonds’ contribution appears 
to be as important as the side chains’ in the determination of the overall hydrophobicity. 
 The present study is based on the scale developed by Tao et al. (Tao et al., 1999), which 
considers the peptide bonds’ contribution, includes some non natural AA, and whose values can be 
adjusted if the peptide is present in the amide or acid form (Fig. 5.1). 
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Fig. 5.1: Hydrophobicity contribution of single amino acids (Tao et al., 1999). 
 
 
 According to this model the hydrophobic content of a given peptide can be calculated by the 
following equation: 
 
CLOGPRESIDUE = Σ  anRnP + bBP + uUP 
 
where an is the incidence of the nth kind of AA, RnP is the Log P contribution of the nth type of 
AA, b and u are indicator variables to account for different forms of the peptides. For blocked 
n (3) 
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peptides b is set to 1 and u to 0 and vice versa for free peptides. BP and UP are the corrections for 
CLOGP values of blocked and unblocked peptides, respectively (Tao et al., 1999). The 
contributions to the Log P and the values BP and UP are listed in Table 5.2. 
 
 
Tab. 5.2: [a] Hydrophobicity contributions of common amino acids, [b] for N-acetyl-peptide amides,  
and [c] for free peptides (adapted from Tao et al., 1999) 
 
Amino acid Log P contribution [a] Amino acid Log P contribution [a] 
Ala -0.27 Met  0.51 
Arg -0.79 Phe  1.16 
Asn -0.98 Pro  0.15 
Asp -0.28 Ser -0.45 
Cys  0.83 Thr -0.26 
Gln -1.00 Trp  1.46 
Glu -0.34 Tyr  0.55 
Gly -0.22 Val  0.32 
His -0.31 Orn -0.29 
Ile  0.70   
Leu  0.80 Blocked [b] -1.19 
Lys  0.17 Unblocked [c] -3.25 
 
 
 B) Fragment addition method 
 According to the fragment addition method molecules can be divided into various elementary 
chemical fragments (-COOH, -CO-NH-, -CH2-, -NH2, -OH, etc.) which have different contribution 
to the overall hydrophobic content (Rekker, 1977). The CLOGP value of a certain compound can 
therefore be determined by summing the contribution of each fragment (Tao et al., 1999), in a 
process which is commonly computerised. 
 
 
 5.2 Materials 
 
 Peptides and peptide hybrids were synthesised on solid phase with the Fmoc-polyamide 
protocol and purified by RP-HPLC as previously described (see Chapter 3). 
Trifluoroacetic acid (99.5%) was supplied by Merck (Hohenbrunn, Germany). Acetonitrile 
(HPLC grade) was supplied by Riedel-de Haën (Seelze, Germany). Analytical grade water was 
obtained by filtering glass-distilled water with a Millipore Milli-Q® (Bedford, MA, USA) 0.22-µm 
filtering system. 
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 5.3 Methods 
 
 5.3.1 Theoretical determination of the hydrophobic content 
 The determination of the hydrophobic content of the synthesised peptides was performed by 
both the residue addition method and the fragment addition method. 
 A. For the analysis of the hydrophobic content using the residue addition method the 
abovementioned formula (3) was used. Values were corrected for peptides present as amides or 
acids according to the author’s instructions (Tao et al., 1999). 
  B. The CLOGP values corresponding to the fragment addition method were obtained with a 
computer-based analysis. Bio-Loom software was used (BioByte Corp., CA, USA) [demo version 
available for download at www.BioByte.com/bb/prod/bioloom.html (last accessed on 15/10/06]. 
Structures were first generated with ACD/ChemSketch software (Advanced Chemistry 
Development Inc., Canada) version 5.12 [www.acdlabs.com last accessed on 15/10/06], 
transformed into SMILES (Simplified Molecular Input Line Entry System) and then submitted to 
the software for the calculation (see Appendix C for details about Bio-Loom analysis). 
 
 5.3.2 Experimental determination of the hydrophobic content by RP-HPLC 
 Reversed-phase high performance liquid chromatography was performed on a Kontron 500 
HPLC System (Kontron Instruments, Italy), composed by a Kontron Bio-Tek 522 dual solvent 
pump, a Kontron HPLC 560 autosampler, a Kontron degasser 3493, a Kontron HPLC 535 dual 
wavelength UV detector and a PL-ELS 2100 EL-SD (Polymer Laboratories, UK). The column was 
eluted at 30 °C. The UV detector was set at 220 nm and 254 nm. The parameters for the EL-SD 
detector were set as follow: nebuliser 70 °C, evaporator 40 °C, gas flow (N2) 1 l/min. The system 
was controlled by Geminyx software (Goebel-Instrumentelle Analytik, Germany). 
 Peptides were eluted using gradient C1 and H1 (Tabs. 5.3 and 5.4) with a flow rate of 1 
ml/min. Analyses were performed using a C12 Proteo Jupiter column (250 x 4.6 mm, 4 µm particle 
size, 90 Å pore size) (Phenomenex, Torrance, CA, USA) and a C18 Nucleosil column (250 x 4.6 
mm, 5 µm particle size, 100 Å pore size) (Supelco, Bellafonte, PA, USA). 
 
 
 
 
 
 
 
 
      Tab. 5.3: Gradient C1 
Time 
(min) 
A 
(%) 
B 
(%) 
0 100 0 
7 100 0 
35 60 40 
37 50 50 
40 50 50 
45 100 0 
Tab. 5.4: Gradient H1 
Time 
(min) 
A  
(%) 
B  
(%) 
0 100 0 
1 100 0 
36 0 100 
39 0 100 
44 100 0 
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 Samples were prepared by dissolving peptides in 50% ACN (~0.5 mg/ml) and filtering the 
solution through a 0.22 µm filter. A 20 µl aliquot of this solution was injected. Average retention 
times of two runs were taken. 
 
 5.3.2 Critical aggregation concentration 
 CAC values were determined by steady-state fluorescence measurements using pyrene as 
fluorescent probe, as described in Chapter 4. 
 
 
 5.4 Results and discussion 
 
 5.4.1 Theoretical determination of the hydrophobic content 
 The hydrophobic content of peptide bolaamphiphiles was determined by means of theoretical 
and experimental methods. Theoretical determination of the peptides’hydrophobicity(CLOGP) was 
based on two different methods the results of which were compared: the residue addition method 
(CLOGPRESIDUE) and the fragment addition method (CLOGPFRAGMENT) (Tab. 5.5).  
 
Tab. 5.5: CLOGP values (residue and fragment addition methods) for the synthesised compounds and the 
parent peptides L3, L4 and L5 (n.d.= not determined) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CLOGPRESIDUE values were calculated with formula (3) by simply adding the partial 
contribution of each amino acid to give the total H. Unfortunately, the recorded values only 
included natural amino acids, thus making impossible to determine the CLOGPRESIDUE values for 
PEPTIDE CLOGPRESIDUE CLOGPFRAGMENT 
L3 4.06 4.86 
L4 3.26 3.66 
L5 2.46 2.46 
KL1 n.d. -1.32 
KL2 n.d. -1.00 
KL3 n.d. -2.59 
KL4 n.d. 0.27 
OL1 n.d. -1.85 
OL2 -2.07 -5.33 
OY1 n.d. -3.26 
OY2 -2.57 -6.75 
LO1 n.d. 2.72 
LY1 n.d. 5.88 
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those peptides containing non-natural amino acids (such as 6-Ahx and 9-Anc) (refer to Tab. 5.1). 
The CLOGPFRAGMENTS values were successfully calculated using Bio-Loom software. As the 
fragments addition method is based on structural characteristics and not on single amino acid 
contributions, CLOGPFRAGMENTS values were determined for the entire set of molecules, regardless 
of the amino acid composition. 
 The consistency between the two sets of CLOGPs was tested by plotting the values of the one 
against the other. Figure 5.2 shows the resulting graph, which has a linear correlation between the 
two sets of data with a correlation coefficient of 0.999 ± 0.001, thus underlining a good consistency 
between the data obtained from the two methods. 
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Fig. 5.2: Linear correlation between the two sets of CLOGP values (calculated with the residue addition 
method and the fragment addition method) for peptides L3, L4, L5, OL2 and OY2. 
 
 
 The two different methods were therefore considered both reliable in terms of determining the 
hydrophobic content. Because the fragment addition method basically allows the use of any 
possible amino acid/organic molecules, CLOGPFRAGMENTS were chosen and compared to 
experimental values (expressed as retention times) obtained by RP-HPLC. 
 
 5.4.2 Experimental determination of the hydrophobic content by RP-HPLC 
 HPLC was chosen for the experimental determination of peptides’ lipophilicity, through 
measurements of the retention times (Kim et al., 2005), especially because of rapidity, sensitivity, 
the requirement for low amounts of sample and good reproducibility of the determinations. 
Octadecyl columns (C18) are widely used for this purpose. The results are generally accepted as 
good estimates of the hydrophobic content of the analyte. In this study the use of a dodecyl column 
(C12) was investigated and the results obtained compared to those obtained with a C18 column with 
Peptide Fragment addition 
Residue 
addition 
L3 2.46 2.46 
L4 3.66 3.26 
L5 4.86 4.06 
OL2 -5.33 -2.07 
OY2 -6.75 -2.57 
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the same dimensions. Retention times for the synthesised compounds are reported below (Tab. 
5.6). 
 
Tab. 5.6: CLOGPFRAGMENTS values and RP-HPLC retention times 
 
PEPTIDE CLOGPFRAGMENT 
tR (C1) 
(min) 
tR (H1) 
(min) 
tR (C1) 
(min) 
tR (H1)  
(min) 
  C12 C12 C18 C18 
L3 4.86 36.90 28.26 36.3 20.55 
L4 3.66 37.40 28.20 36.27 20.05 
L5 2.46 37.30 27.98 36.39 19.8 
KL1 -1.32 24.67 11.47 23.26 13.42 
KL2 -1.00 21.29 11.00 27.04 14.64 
KL3 -2.59 23.30 9.46 22.82 12.57 
KL4 0.27 26.00 12.56 29.63 15.35 
OL1 -1.85 23.88 11.26 26.17 14.41 
OL2 -5.33 20.31 9.39 22.07 12.15 
OY1 -3.26 21.43 9.81 23.85 13.18 
OY2 -6.75 17.33 8.38 20.12 11.06 
LO1 2.72 34.00 17.70 32.59 17.92 
LY1 5.88 41.09 22.11 42.52 23.45 
 
 
 
 Experimental and theoretical analyses of the hydrophobic content were compared by using the 
RP-HPLC retention times in the two chromatographic columns and the CLOGPFRAGMENTS. The 
correlation coefficient varied between 0.86 ± 0.01 (gradient H1) and 0.96 ± 0.01 (gradient C1) in the 
dodecyl column (Figs. 5.3 and 5.4) while it was 0.95 ± 0.01 and 0.94 ± 0.01 (respectively) in 
octadecyl column (Figs. 5.5 and 5.6). Both columns appeared to be suitable for the determination 
of the hydrophobic content of the synthesised peptides and peptide hybrids. Nonetheless, small 
differences were noted. The C12 column gave a better correlation when using gradient C1, which 
corresponded to a slower increase of the organic modifier (up to 50% B over 33 minutes). On the 
other hand the correlation was poorer when using gradient H1, which corresponded to a faster 
increase of the organic phase (up to 100% B over 35 minutes). Differences in the elution conditions 
can be translated into diverse interactions between the analyte and the column’s hydrophobic 
phase, which can eventually result in dissimilar values relating to the hydrophobic content of a 
given molecule. The differences due to the gradients used did not appear to be so important when 
using a C18 column as the two correlation coefficients were very similar. Hence, this type of 
column seemed to be less affected by external experimental conditions than the C12 column. 
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Fig. 5.3: Linear correlation between RP-HPLC retention times of bolaamphiphilic peptides and hybrids in a 
C12 column and CLOGP values (fragment addition method). The two circles indicate L3, L4 and L5 peptides. 
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Fig. 5.4: Graphical correlation between RP-HPLC retention times of bolaamphiphilic peptides and hybrids in 
a C12 column (gradient C1 and H1) and CLOGP values (fragment addition method). 
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Fig. 5.5: Linear correlation between RP-HPLC retention times of bolaamphiphilic peptides and hybrids in a 
C18 column and CLOGP values (fragment addition method). The two circles indicate L3, L4 and L5 peptides. 
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Fig. 5.6: Graphical correlation between RP-HPLC retention times of bolaamphiphilic peptides and hybrids in 
a C18 column and CLOGP values (fragment addition method). 
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 The chromatographic behaviour of the parent peptides (L3, L4 and L5) was very similar in 
both columns and gradients. They presented almost the same retention times even if the theoretical 
hydrophobic content is consistently different (Figs. 5.3 and 5.5, circles). This effect can probably 
be ascribed to the comparable three-dimensional arrangements of these compounds, as they present 
an α-helical structure with both hydrophobic and hydrophilic residues (Naidoo, 2004). Possibly the 
presence of one or two leucine residues more in the poly-leucine chain, which forms the 
hydrophobic core of these natural bolaamphiphiles, do not change much of the exterior surface that 
ultimately interacts with the column’s hydrophobic phase (Fig. 5.7). 
 
 
Fig. 5.7: Helical wheel representation of L3, L4 and L5 peptides. Colour designation: black = Lys; white = 
Leu. Computer-generated helical wheels were obtained by using Peptide Companion software (CSPS, 
Tucson, AZ, USA). 
 
 
 5.4.3 Correlation between hydrophobicity and aggregation behaviour  
 Aggregation depends on many factors, among them van der Waals interactions, hydrogen 
bonds, ionic bonds and hydrophobic interactions (Zhang and Altman, 1999). Some of these forces 
can prevail over others but the way in which they interfere with each other is not straightforward. 
Definitely, hydrophobicity plays an important role in the determination of the self-assembly 
behaviour of organic molecules in solution (Zhang et al., 1993; Gazit, 2002; Santoso and Zhang, 
2004). Therefore, peptides rich in hydrophobic amino acids (such as tyrosine, leucine, isoleucine, 
tryptophan, phenylalanine) are considered to be more likely to self-assemble and aggregate. In this 
study, peptides rich in tyrosine showed low CAC values, as determined by steady-state 
fluorescence measurements (see Chapter 4 for details), but the process was influenced by other 
elements as well. The three-dimensional structure and the possibility to create hydrogen bonds, for 
example, played a key role in the aggregation/self-assembly process, as testified by different CACs 
and aggregation profiles of OY1 and OY2 or OL1 and OL2. Therefore, it was important to evaluate 
the correlation betweenhydrophobicity(expressed as CLOGPFRAGMENTS or tR) and CAC values (in 
0.1% TEA) so as to assess the real influence ofhydrophobicityon the self-assembly. The following 
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graphs show CAC values compared to retention times in HPLC (Fig. 5.8) and CLOGPFRAGMENTS 
(Fig. 5.9). 
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Fig.5.8: Aggregation behaviour (expressed by CAC values) compared to hydrophobic content  
(expressed by retention times in RP-HPLC). 
 
 The good correlation between the four sets of tR (obtained using different columns and 
gradients) was once again underlined by the similar pattern of the lines connecting each data point 
(Fig. 5.8). Nonetheless, it was not possible to establish a direct correlation between the sets of 
values from HPLC analysis and CAC data. Importantly, increased CACs did not correspond to a 
proportional increase of HPLC retention times, underlying the limitations of this kind of 
experimental determination of H.  
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Fig. 5.9: Aggregation behaviour (expressed by CAC values) compared to hydrophobic content  
(expressed by CLOGPFRAGMENTS values). 
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 The use of CLOGPFRAGMENTS values as a hydrophobicity index instead of the HPLC retention 
times also did not provide a straightforward correlation. In Figure 5.9 some peptide 
bolaamphiphiles are listed in order of increasing CAC. Bars referring to CLOPG values do not 
follow a precise order, and especially OL2 and OY2 seem to show no relationship with the 
aggregation process. 
 The removal of data related to proline-containing peptides (OL2 and OY2) results in a more 
meaningful diagram (Fig. 5.10). Peptide bolaamphiphiles containing 9-aminononanoic acid as 
hydrophobic skeleton between the two charged heads showed a better correlation between the 
aggregation process and hydrophobicity, the latter as expressed by the CLOGPFRAGMENTS. 
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Fig. 5.10: Aggregation behaviour (expressed by CAC values) compared to hydrophobic content  
(expressed by CLOGPFRAGMENTS values) for peptide bolaamphiphiles including 9-Anc. 
 
 The tendency shown by ω-AA-containing molecules is consistent with the literature (Santoso 
and Zhang, 2004): the greater the hydrophobic content, the stronger is the self-assembly, the latter 
expressed by critical aggregation concentrations. Moreover, aromatic residues played a key role 
through the π-stacking of their side chains (Gazit, 2002), as was already underlined in Chapter 4. 
The anomaly which distinguishes the dissimilar behaviours of OY2 and OL2 can possibly be 
ascribed to the presence of proline. Its effects on the aggregation were discussed in Chapter 4, 
where it proved to increase the CAC in homologues compounds (such as OY1/OY2 and 
OL1/OL2). It was therefore confirmed that the modifications of the 3D-structure caused by proline 
played a key role in determining the aggregation behaviour of proline-containing peptides. 
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 5.5 Conclusions 
 
 The hydrophobic content of the synthesised peptide bolaamphiphiles was determined both 
experimentally and theoretically. RP-HPLC is recognised as a versatile technique for such 
determination and it proved to work well. Different conditions, columns and elution programmes 
were used. On the other hand, the theoretical determination was effectively performed by using two 
different approaches, based on the residue addition method and on the fragment addition method. 
The latter (CLOGPFRAGMENTS) was especially useful for the further investigation of the correlation 
with the data obtained from the experimental technique. Such a correlation revealed a good 
consistency, although slightly different correlation coefficients were found. The use of an octadecyl 
column gave similar results with both of the two gradients, thus indicating that it has an inherent 
strong ability to interact with the analyte regardless of the conditions used. Vice versa, the use of a 
dodecyl column showed to be influenced by the experimental conditions (such as the gradient). The 
correlation between CLOGPFRAGMENTS and the tR (C12) for the synthesised bolaamphiphilic peptides 
was shown to vary to some extent with the use of one or the other gradient. Therefore, in the 
present study, the use of a C18 column seemed to give more reliable results in terms of hydrophobic 
content determination. 
 Interestingly, it was also possible to investigate the effect ofhydrophobicityon the self-
assembly behaviour in water. In the previous chapter the relationship between hydrophobic AA and 
enhanced self-organisation properties was already pointed out (Zhang et al., 1993). The 
experimental observations made during steady-state fluorescence measurements about the role of 
hydrophobic residues were confirmed. Compounds showing low CAC were also characterised by a 
significant hydrophobic content (expressed by CLOGPFRAGMENTS).  On the other hand, compounds 
with high CACs proved to have a low hydrophobic content. The only exception was represented for 
proline-containing peptides, where the influence of the 3D structures on the aggregation was much 
more important than the H. 
 The current study presented some limitations. As previously discussed, the use of gradient 
RP-HPLC forhydrophobicitydetermination is limited to some particular cases and isocratic liquid 
chromatography is generally preferred. Capacity factors are related to retention times obtained by 
isocratic elution and therefore were not determined. The lack of a parameter independent from the 
experimental conditions could possibly be translated into poorer R2 values when theoretical and 
experimental data were compared. A similar problem was also found when comparing tR and CAC 
data, resulting in an absence of direct correlation, which was later found using CLOGPFRAGMENTS 
values. 
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Chapter 6 
 
Determination of biological properties of peptides  
and peptide hybrids 
 
 
 
6.1 Introduction 
 
The interest in bolaamphiphilic compounds as possible new antimicrobial drugs is based on 
their detergent-like structure, which resembles surfactants. The study of natural-based 
bolaamphiphiles with biological activity is therefore a very good starting point for the development 
of active leader molecules. During the 1990s novel peptide-based bolaamphiphilic compounds 
were de novo designed around an amino acid pattern resulting from a natural antimicrobial peptide 
(Alvarez-Bravo et al., 1994; Hirakura et al., 1996). The resulting general antimicrobial motif had a 
bolaamphiphilic structure and was made of different combinations of lysine and leucine 
(KLKLnKLK-NH2, where n = 3, 4, 5) (Alvarez-Bravo et al., 1994). Because of its structure, the 
poly-leucine chain – which connects the two charged moieties – was replaced by non-natural amino 
acids to give comparable length (Naidoo, 2004). Still, little was known about the effect on the 
biological activity of the substitution of leucine with hydrophobic non-natural amino acids. In the 
present study ω-amino acids were used to create peptide hybrids and their biological properties 
fully investigated. Further modifications were also used and novel potentially active sequences 
were designed (refer to Chapter 3 for detailed explanations). 
The antimicrobial activity of novel bolaamphiphilic peptides and hybrids was assessed in 
different ways in order to possibly relate it to structure and AA composition. A general screening 
was carried out by using the Bauer-Kirby disk diffusion test (radial diffusion assay) (Bauer et al., 
1966) and then the minimum inhibitory concentration (MIC) was assessed (Wu and Hancock, 
1999; Du Toit and Rautenbach, 2000). Potential toxicity was evaluated using human red blood cells 
(hRBCs) as model mammalian cells. The selectivity towards bacteria was also investigated using 
dye-loaded liposomes presenting neutral or negatively charged membranes (Epand and Epand, 
2003). 
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 6.2 Materials 
 
Peptides and peptide hybrids were synthesised on solid-phase using the Fmoc-polyamide 
protocol and purified by RP-HPLC as previously described (see Chapter 3). 
Acetic acid was supplied by BDH (Poole, UK). Fraction V bovine serum albumin (BSA, 
99%) was supplied by Boehringer Mannheim (Mannheim, Germany). 
Sterile filter paper disks for the Bauer-Kirby diffusion test, Mueller-Hinton agar (MHA, pH 
7.4 ± 0.2), Mueller-Hinton broth (MHB, pH 7.4 ± 0.2) and ATCC bacterial strains were provided 
by Dr AC Whitelaw (Microbiology, National Health Laboratory Service, Groote Schuur Hospital, 
University of Cape Town). 
Saponin by Aldrich (Steinheim, Germany), hRBCs (2% suspension) and culture medium for 
the haemolysis tests were kindly provided by Dr HC Hoppe (Clinical Pharmacology, Groote 
Schuur Hospital, University of Cape Town). 
Triptone soy broth (TSB, soybean-casein digest medium USB, pH 7.3 ± 0.1) and triptone soy 
agar (TSA, soybean-casein digest agar medium USB, pH 7.3 ± 0.1) were from Biolab Diagnostics 
(Midrand, South Africa). Hammersten-casein was from USB Corp. (OH, USA). Polypropylene 
microtitre plates were from Corning Inc. (NY, USA). Gramicidin S (Gram S) was from Aldrich 
(Steinheim, Germany). They were all kindly provided by Dr M Rautenbach (Biochemistry, US). 
Egg 3-SN-Phosphatidylcholine (EPC, > 99%), egg phosphatidylglicerol (EPG, > 99%) and 
cholesterol (CHOL, 99%) were bought from Aldrich (Steinheim, Germany). 5(6)-
carboxyfluorescein (CF, > 99%), Triton® X-100, sodium azide (99%) and Sephadex G50 were 
supplied by Fluka (Buchs, Switzerland). 
Methanol (MeOH, HPLC grade) and isopropyl alcohol (HPLC grade) were from Aldrich 
(Steinheim, Germany). Technical grade DCM was used after distillation (refer to Section 4.3.1). 
Potassium chloride (99%), disodium hydrogenphosphate (99%) and potassium 
dihydrogenphosphate (99%) were from Merck (Darmstadt, Germany). Tris(hydroxyethyl) amino 
methane (Tris, 99.7%), sodium chloride (99%), disodium ethylenediaminotetracetate dihydrate 
(Na2EDTA•2H2O, 99%), ferric chloride hexahydrate (99%) and ammonium thiocyanate (99%) 
were from Saarchem (Wadeville, South Africa).  
Analytical grade water was obtained by filtering glass-distilled water with a Millipore Milli 
Q® (Bedford, MA, USA) 0.22-µm filtering system. 
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6.3 Experimental methods 
 
6.3.1 Antimicrobial activity 
6.3.1.1 Bauer-Kirby disk diffusion test 
Peptides were dissolved at a concentration of 50 µg/µl in 0.01% AcOH / 0.2% BSA. An 
aliquot of 10 µl of the stock solutions (500 µg of peptide) was placed on each disk. The entire set 
of peptides and hybrids thereof were tested against five different strains of bacteria: E. coli (ATCC 
25922), S. aureus (ATCC 25923), P. aeruginosa (ATCC 27853), E. faecalis (ATCC 29212) and S. 
marcescens (clinical isolate). Bacteria were plated in MHA. An aliquot of µl 10 of 0.01% AcOH / 
0.2% BSA was used as negative control. Positive controls were performed as routine analysis by 
the National Health Laboratory Service (UCT Hospital). 
Peptides and controls were incubated aerobically for 18 h at 35 °C before evaluating the 
presence of inhibition areas. 
 
6.3.1.2 MIC determination (I) 
A first method for the MIC determination was a classical broth microdilution assay modified 
for cationic antimicrobial peptides according to the recommendations of REW Hancock Laboratory 
(Wu and Hancock, 1999) ƒ. MIC was determined against E. coli (ATCC 25922), S. aureus (ATCC 
25923) and P. aeruginosa (ATCC 27853). Stock solutions were prepared by dissolving peptides in 
0.01% AcOH / 0.2% BSA at a starting concentration of 640 µg/ml, then diluted with the same 
solution by serial doubling dilutions. Bacterial cultures were diluted in MHB to 5 x 105 CFU/ml 
and plated in ELISA plates. Peptides were added so as to reach a final concentration 10 times lower 
than the stock solutions. Peptides were incubated aerobically for 18 h at 37 °C. MIC was 
represented by the lowest concentration of peptides that clearly inhibited bacterial growth. 
 
6.3.1.3 MIC determination (II) 
 A second method for the determination of MIC was based on a micro-gel well diffusion assay 
(Du Toit and Rautenbach, 2000). 
 A starter culture of E. coli HB101 was grown overnight at 37 °C in TSB to mid-log phase 
(± 0.6 OD unit at 620 nm). A 1% sub-culture was then grown for about three hours (± 0.28 OD unit 
at 620 nm). 
 Plates were sterilised with isopropyl alcohol, dried overnight at 60 °C, then blocked for 60 
minutes with 200 µl/well sterile 0.5% Hammersten casein in PBS, and finally dried overnight 
under UV light to ensure sterility. 
                                                 
ƒ See: www.cmdr.ubc.ca/bobh/methods.php (last accessed on 19/08/05). 
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 Peptides were dissolved in two different solvent systems [(A) Milli-Q® water, (B) 0.01% 
AcOH / 0.2% BSA] to give 0.5 mM stock solutions and then diluted in polypropylene ELISA 
plates by serial doubling dilutions. An aliquot of 20 µl of peptide solution was added to 80 µl of 
bacterial suspension and the plates incubated aerobically at 37 °C for 18 ± 0.5 h. Solvents without 
peptides were used as negative control while Gram S was used as positive control. Sterility and 
bacterial growth were also monitored. Plates were then read by measuring light dispersion at 620 
nm with a Multiscan Plus MKII plate reader (Titertek, AL, USA). The percentage of inhibition was 
calculated according to the following equation: 
 
% inhibition = 100 - [100 x (LDsample – LDbgrd) / (LDgrowth - LDbgrd)] 
 
where LDsample is the light dispersion in the well, LDbgrd is the background light dispersion in a well 
containing bacteria and solvent while LDgrowth is the light dispersion of the untreated bacteria. 
 Experiments were performed in triplicate. 
 
6.3.2 Haemolytic activity 
Haemolytic activity was determined against a fresh 2% suspension of hRBCs (type 0+) from 
healthy donors (Western Province Blood Transfusion Service, South Africa). The cells were 
washed in RPMI 1640 BioWhittaker™ culture medium (supplemented with 50 mM glucose, 
0.65 mM hypoxanthine, 25 mM Hepes, 0.2% Na2HCO3, 0.048 mg/ml gentamicin and 0.5% 
Albumax II) by centrifugation at 1000 rpm for 5 min and the pellet stored at 4 °C for up to three 
weeks. 
Peptides were dissolved in a fresh 0.01% AcOH / 0.2% BSA solution with a final 
concentration of 1 mM. The stock solutions were diluted in ELISA plates with the same solvent by 
serial doubling dilutions. An aliquot of 10 µl of the diluted solutions was added to 90 µl of hRBCs 
suspension placed into ELISA plates. 
 Solvent without peptides was used as negative control and saponin (final concentration 
0.05%) was used as positive control. Plates were incubated at 37 ºC for 24 h and then centrifuged at 
1000 rpm for 2 min. An aliquot of 10 µl of supernatant was transferred into an ELISA plate and 
diluted 10 times with distilled water. Absorbance of released hemoglobin was recorded at 404 nm 
with an H72 plate reader (Anthos Labtec, Austria). All experiments were performed in 
quadruplicate. The percentage of haemolysis was calculated according to the following formula: 
 
% haemolysis = [(Apeptide – Ablank) / (ASaponin – Ablank)] / 100 
 
 
 
(4) 
(5) 
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where Apeptide is the absorbance of the peptide solution at 404 nm, Ablank the absorbance at 404 nm 
without peptide (0% haemolysis) and ASaponin the absorbance in the presence of saponin (100% 
haemolysis). 
6.3.3 Dye-leakage assay from liposomes 
CF-loaded liposomes (80 µl) in buffer (10 mM Tris, 150 mM NaCl, 0.1 mM Na2EDTA·2H20, 
pH 7.4) were placed in black 96-well plates. Peptides were dissolved in the same buffer to give 0.5 
mM stock solutions and then diluted in polypropylene ELISA plates by serial doubling dilutions. 
An aliquot of 20 µl was added to the liposome suspension. Triton® X-100 (final concentration 
0.1%) was used as positive control and the abovementioned buffer as blank. Dye leakage was 
monitored by fluorescence emission (Duzgünes, 2003). Plates were incubated for 2 h at 37 °C 
before measuring the fluorescence emission with a FLX800 Microplate Fluorescence Reader 
(Kontron Bio-Tek, Italy). An excitation wavelength of 460/40 nm and an emission wavelength of 
560/40 nm were used. The percentage of leakage was calculated according to the following 
formula: 
 
% leakage = [(Fpeptide – Fblank) / (FTriton X-100 – Fblank)] / 100 
 
where Fpeptide is the fluorescence emission of the peptide solution, Fblank the fluorescence without 
peptide and FTriton X-100 the fluorescence in the presence of Triton® X-100 (complete lysis of the 
liposomes). Experiments were carried out in triplicate. 
 
6.3.3.1 Preparation of liposomes 
Large unilamellar vesicles by extrusion technique (LUVETs) were prepared according to 
literature (Hope et al., 1985; Mui et al., 2003). Two different kinds of liposomes were prepared: 
negatively charged (EPC:EPG, 10:1 w/w) and neutrally charged (EPC:CHOL, 10:1 w/w). Lipids 
(11 mg) were dissolved in MeOH/DCM and thoroughly dried under high vacuum to form a thin 
layer on the vessel wall. The lipid film was then hydrated with 0.5 ml of a buffer (10 mM Tris, 
150 mM NaCl, 0.1 mM Na2EDTA·2H20, pH 7.4) containing 40 mM 5(6)-carboxyfluorescein and 
vigorously mixed for 1 min to form large multilamellar vesicles (LMVs). Hydration was performed 
at 25 °C, above the transition temperature (Tc) of the lipid mixtures (which is around 0 °C for both 
EPC and EPG). The suspension of LMVs was disrupted by five freeze/thaw cycles. The lipid 
suspension was then extruded through a 100-nm polycarbonate membrane twenty-one times using 
a stainless steel liposome mini-extruder (Avanti Polar Lipids, AL, USA), according to the 
manufacturer’s instructions. Extrusion was performed at 25 °C. Untrapped dye was removed by gel 
filtration through a Sephadex G50 column (1 x 20 cm), eluted with 10 mM Tris, 150 mM NaCl, 
0.1 mM Na2EDTA·2H20, pH 7.4. Elution was monitored by visual observation and the collected 
 (6) 
 - 107 -
fractions were analysed with a Lambda 20 UV-VIS spectrophotometer (Perkin Elmer, UK) 
measuring absorbance at 490 nm (for CF) and light dispersion at 620 nm (for the liposomes). 
 Lipid concentration was determined as described in Section 6.3.3.2.  
 
 6.3.3.2 Determination of lipid concentration  
 Lipid concentration of liposomal suspensions was determined by forming a complex between 
phospholipids and ammonium ferrothiocyanate, according to Stewart (Stewart, 1980). The standard 
ammonium ferrothiocyanate solution (0.1 N) was prepared by dissolving ferric chloride 
hexahydrate (27.03 g) and ammonium thiocyanate (30.40 g) in Milli-Q® water and making up to 
one litre. 
 Duplicate volumes (between 0.1 and 1 ml) of a solution of 10.0 mg of EPC in 100 ml of DCM 
were mixed with 2 ml of ammonium ferrothiocyanate solution. DCM was added to reach a volume 
of 4 ml. The biphasic system was shaken for 1 min. The organic phase was removed and the optical 
density measured at 488 nm with a Lambda 20 UV-VIS spectrophotometer (Perkin Elmer, UK). 
OD values were plotted against EPC concentration to give a calibration curve with R2 = 0.99 ± 
0.01. Lipid concentration was calculated by using the following equation: 
 
concentration (µM) = [1172.43 x OD488 nm] – 1.83 
 
where OD488 nm is the optical density of the samples (at known concentration) at 488 nm. 
 An aliquot of 100 µl of liposome suspension was treated with 2 ml of ammonium 
ferrothiocyanate solution. DCM (2 ml) was added and the system was shaken for 1 min. The 
organic phase was removed and the OD measured at 488 nm. The phospholipid content was 
determined by using formula (7). An average over two determinations was recorded. 
 
 
(7) 
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6.4 Results and discussion 
 
6.4.1 Antimicrobial properties 
The Bauer-Kirby disk diffusion test is a general radial diffusion test for assessing the 
antimicrobial activity of a broad range of molecules (WHO, 1961; NCCLS, 1975). It is based on 
the assumption that the diffusion through the disk/gel is the same for every compound tested. The 
molecules are commonly classified according to the diameter of the inhibition area: active (d > 10 
mm), non-active (no inhibition detected) or partially active  (0 mm < d < 11 mm) (Fig. 6.1).  
In this study some peptides were found to be active against E. coli (KL2), S. aureus (KL2 and 
OY1) and P. aeruginosa (LO1). KL4 was found to be partially active against E. coli and S. aureus. 
The actual diameters of the inhibition zones are listed in Table 6.1. 
 
 
Fig. 6.1: Example of results obtained by Bauer-Kirby test on antimicrobial compounds 
(kindly provided by Dr AC Whitelaw, Microbiology, UCT). 
 
 
Tab. 6.1: Antimicrobial activity of the synthesised compounds according to the Bauer-Kirby disk diffusion 
test performed against [a] E. coli, [b] S. aureus, [c] P. aeruginosa, [d] E. faecalis and [e] S. marcescens 
(diameters of inhibition areas are reported in mm; - = no inhibition) 
 
 
 
 
 
 
 
 
 
 
 
 
PEPTIDE disk content (µg) a b c d e 
KL1 500  - - - - - 
KL2 500 15.0 16.7 - - - 
KL3 500 - - - - - 
KL4 500 0.4 0.5 - - - 
OL1 500 - - - - - 
OL2 500 - - - - - 
OY1 500 - 12 - - - 
OY2 500 - - - - - 
LO1 500 - - 11.2 - - 
LY1 500 - - - - - 
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Nonetheless, most of the compounds did not show any activity with this test, for various 
reasons. Reduction of antimicrobial activity by aggregation of peptides in different culture media 
(such as agar and agarose) was reported long ago (Hider et al., 1983). The parent compounds L3, 
L4 and L5 for example, were also studied in relation with their aggregation in culture medium 
(Alvarez-Bravo et al., 1994; Rautenbach et al., 2006). Aggregation could also explain the loss of 
biological activity for the peptides derived from L3. However, the introduction of non-natural AAs 
and the modification of the secondary structure due to such AAs could also be detrimental to the 
expression of any biological activity. 
Therefore, after the abovementioned general test failed to highlight differences in biological 
activity, further tests were necessary. MIC values against the same bacterial strains were assessed 
with a test specifically modified for cationic antimicrobial peptides. This test was performed in 
solution to highly reduce (if not completely avoid) aggregation due to the medium. Unfortunately, 
MICs were found to be higher than the highest concentration used (64 µg/ml, approximately 70 
µM) for the entire set of peptides tested (Tab. 6.2). Even those peptides which were reported to 
posses impressively low MICs (Naidoo, 2004), such as KL2 and KL4, did not show noteworthy 
MIC values. 
 
Tab. 6.2: MIC values for peptides and peptide hybrids 
 (MIC values in square brackets are taken from Naidoo, 2004) 
 
 
* Values taken from Naidoo, 2004 (L3 and L4) and Alvarez-Bravo et al., 1994 (L5). 
 
 
 
* Values taken from Alvarez-Bravo et al., 1994.  
 
To confirm these results, a second MIC protocol was used, based on a micro-well diffusion 
assay modified from Du Toit and Rautenbach (Du Toit and Rautenbach, 2000). It offered the 
advantage of determining the bacterial growth inhibition by measuring the OD at 620 nm instead of 
visually observing the inhibition. In this way it was possible to establish whether the compound 
tested had any sort of activity (including inhibition lower than 100%), independently from the 
investigator’s optical perception. Moreover, by using this protocol, other studies pointed out the 
possibility to establish the biological activity of molecules that can aggregate in solution, such as 
the bolaamphiphilic peptides and peptide hybrids that this study focuses on. Rautenbach et al. 
(Rautenbach et al., 2006) tested the antimicrobial properties of L3, L4 and L5 peptides with this 
assay. The data indicate that under these conditions only L3 reaches 100% of bacterial growth 
inhibition, while L4 and L5 are active up to only 60% (L4) and 20% (L5). See Figure 6.2. At high 
PEPTIDE  L3* L4* L5* KL1 KL2 KL3 KL4 OL1 OL2 OY1 OY2 LO1 LY1 
MIC (µg/ml) E. coli 8 32 20 > 64 > 64 [16] > 64 
> 64 
[4] > 64 > 64 > 64 > 64 > 64 > 64 
 S. aureus 2 2 2 > 64 > 64 [1] > 64 
> 64 
[0.5] > 64 > 64 > 64 > 64 > 64 > 64 
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concentration, L4 and L5 lose substantial antimicrobial activity and, above 60 µM, the bacterial 
growth inhibition decreases to less than 50% (around 0% for L5). Such a drastic change in the 
activity-concentration plot of L4 and L5 was correlated to aggregation in the culture medium 
(Rautenbach et al., 2006). 
 The synthesised peptides were tested by a similar method and it was possible to confirm a 
trend in which the activity slightly increases with increasing concentrations of peptide. However, 
the activity was found to be modest throughout the range of concentrations used (around 10% of 
growth inhibition at 100 µM) and it was not possible to determine a minimum inhibitory 
concentration. Figures 6.3, 6.4 and 6.5 refer to the activity trend for compounds KL2, OY1 and 
LO1∞ compared to a typical concentration-response curve of Gram S. 
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Fig. 6.2: MIC determination of peptides L3, L4 and L5 with a micro-well diffusion assay (modified 
from Rautenbach et al., 2006). 
 
                                                 
∞ Only compounds classified as active with the Bauer-Kirby disk diffusion test were further tested by this 
method. 
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Fig. 6.3: MIC determination of KL2 (Gram S plot adapted from Rautenbach et al., 2006). 
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Fig. 6.4: MIC determination of OY1 (Gram S plot adapted from Rautenbach et al., 2006). 
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Fig. 6.5: MIC determination of LO1 (Gram S plot adapted from Rautenbach et al., 2006). 
 
The synthesised peptides did not show significant activity in the range of concentrations used 
(commonly employed for the testing of antimicrobial peptides). According to the aggregation 
studies in water (see Chapter 4) peptides and peptide hybrids aggregate at much higher 
concentrations (between 2 and 10 mM, i.e. 20 to 100 times higher than those concentrations used 
here). It is therefore difficult to attribute the loss of antibacterial activity to the aggregation. The 
loss of activity seems more likely to be correlated to the AAs introduced into the primary structure, 
absent in the parent compounds (especially when one considers the ω-AA and the glycyl-prolyl-
glycine linkers which drastically modify the peptides’ three-dimensional structure) (Zhang et al., 
1999). The α-helical structure was therefore assumed to be fundamental for the activity of these 
compounds (Alvarez-Bravo et al., 1994). 
 
6.4.3 Haemolytic activity 
Because of the different lipid compositions of mammalian and bacterial cells, the haemolytic 
activity commonly indicates the toxicity of CAMPs. In this study peptides were incubated for 24 h 
at 37 °C in the presence of hRBCs, although the most commonly used incubation time for 
antimicrobial peptides is around 1 h, and often less (10 to 30 minutes). The use of such a long 
incubation time was intended to enhance any possible interactions with the erythrocytes and then 
evaluate the response of the cells in a highly stressful environment. The released hemoglobin was 
in the range of 2-5% at the highest concentrations of peptides (50-100 µM), and thus confirmed 
that the peptides and hybrids have no, or very poor, haemolytic activity (Fig. 6.6 and Tab. 6.3). 
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Fig 6.6: Haemolytic activity of the synthesised compounds against hRBCs after 24 h at 37 °C. 
Saponin (0.5%) and 0.01% AcOH / 0.2% BSA were used as positive and negative controls respectively. 
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 Tab. 6.3: Haemolytic activity of bolaamphiphilic peptides and peptide hybrids 
 
 
 
 
 
 
 
 
 
 
 
 
§ The HC50 is defined as the concentration of peptide (µM) leading to 50% haemolysis. 
* Reported HC50 for L3, L4 and L5 is 143 µM, > 200 µM and > 200 µM respectively (Naidoo, 2004). 
 
 
 6.4.4 Leakage assay from liposomes 
 The leakage of a fluorescent dye from LUVETs is a very common technique for the 
assessment of membrane lytic activity (Düzgünes, 2003). The use of artificial membranes to mimic 
biological membranes is quite widespread and has found many applications in the study of 
antimicrobial peptides (Epand and Epand, 2003). In the literature there is a well established 
correlation between antimicrobial activity and carboxyfluorescein leakage from liposomes 
(Hirakura et al., 1996). It has some limitations, however, especially if one considers the complexity 
of a natural membrane (lipid composition, proteins, ions, membrane potential). On the other hand, 
it allows one to isolate particular details or characteristics that can be studied independently from 
others. In this study neutral and negatively charged liposomes were prepared, with the idea to 
mimic mammalian and bacterial cells, respectively. In this way it would be possible to determine if 
the compounds tested showed selectivity against a particular kind of cell. 
The action of peptides and peptide hybrids against artificial membranes was assessed by 
monitoring dye leakage from CF-loaded vesicles with an average size of 120 nm, made of 
PC:CHOL (10:1) and PC:PG (10:1). Graphs showing carboxyfluorescein leakage from liposomes 
challenged by different peptides are reported in Figures 6.7 and 6.8. 
 
PEPTIDE L3* L4* L5* KL1 KL1 KL3 KL4 
HC50 (µM)§ >100 >100 >100 >100 >100 >100 >100 
 
PEPTIDE OL1 OL2 OY1 OY2 LO1 LY1 
HC50 (µM)§ >100 >100 >100 >100 >100 >100 
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Fig. 6.7: Carboxyfluorescein leakage from liposomes with different lipid composition challenged by KL1, 
KL2, KL3 and KL4. [A] Negatively charged liposomes (PC:PG, 10:1, lipid concentration 13 µM) and [B] 
neutrally charged liposomes (PC:CHOL, 10:1, lipid concentration 16 µM). 
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Fig. 6.8: Carboxyfluorescein leakage from liposomes with different lipid composition challenged by OL1, 
OL2, OY1, OY2, LO1 and LY1. [A] Negatively charged liposomes (PC:PG, 10:1, lipid concentration 13 
µM) and [B] neutrally charged liposomes (PC:CHOL, 10:1, lipid concentration 16 µM). 
 
 
 The compounds showed inability to interact with artificial membranes as no significant 
leakage of fluorescent dye was detected. Moreover, they did not present selectivity and similar 
trends in the concentration-response curves were observed for both negatively charged and neutral 
liposomes. The novel compounds did not show the same biological properties typical of the parent 
compounds. For example, peptide L5 has been reported to posses a strong ability to selectively 
interact with acidic membranes (Figs. 6.9 [A] and 6.10 [A]) while not provoking leakage from 
neutral vesicles (Figs. 6.9 [B] and 6.10 [B]). The negative charges on the membrane surface favour 
initial electrostatic interactions, which are followed by membrane perturbation and leakage of the 
loaded dye (Hirakura et al., 1996). 
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Fig. 6.9: Time course of carboxyfluorescein leakage from liposomes induced by L5. Lipid composition: [A] 
PE:PG (7:3) and [B] PC:PG (7:3) (after Hirakura et al., 1996). 
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Fig. 6.10: Carboxyfluorescein leakage from liposomes with different lipid composition challenged by L5. [A] 
Negatively charged liposomes and [B] neutrally charged liposomes (after Hirakura et al., 1996). 
 
 
 Once again, the modifications of the primary structure, the simplification of the parent 
peptides’ sequence and the use of non proteinogenic AA (9-Anc and 6-Ahx) were demonstrated to 
be critical factors for the loss of lytic properties and selectivity towards negatively charged 
membranes. 
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 6.5 Conclusions 
 
The determination of the biological properties of the synthesised compounds mainly focused 
on the ability to interact and disorganise lipid membranes. Many antimicrobial peptides show 
inhibition areas of 10-20 mm when tested with the Bauer-Kirby disk diffusion assay α, even if the 
disk content is as low as 10-20 µg. In the present study the disk content was 500 µg, and some 
biological activity was found for compounds KL2, KL4, OY1 and LO1 only. Nonetheless, in these 
cases such activity was possibly related to a concentration effect more than to a real antimicrobial 
action due to interaction with the bacterial membranes by one of the mechanisms mentioned earlier 
(Section 2.1.3). This assumption can be made as other tests (MIC determination I and II) failed to 
establish MIC values even for the compounds that presented some sort of activity. 
As previously discussed, the lack of antimicrobial activity could be ascribed to aggregation in 
the medium but the range of concentrations in which activity and aggregation occur is rather 
different, at least for the compounds tested here. Moreover, all the tests performed showed a good 
consistency: the inability to interact with natural membranes (bacteria, hRBCs) and model 
membranes (liposomes with different lipid compositions) was proved throughout this chapter.  
It therefore appears that the changes applied to sapecin B-derived synthetic peptides did not 
generate biologically active compounds. A possible explanation lies in the modification of the 
three-dimensional structure that such alterations produced. Peptides made of Lys/Leu present a 
typical α-helical structure, which is considered very important for the ability to interact with 
membranes (Alvarez-Bravo et al., 1994). A poly-leucine chain can form hydrogen bonds which are 
not formed by the ω-amino acids’ hydrocarbon chains. CD results showed that, the use of ω-amino 
acids deformed the secondary structure and peptides preferentially took a random structure (see 
Chapter 4 for details). The alteration of structural parameters was stronger in those molecules 
where the ω-amino acid was replaced by a glycyl-prolyl-glycine tripeptide, introducing a β-turn. 
The influence of proline residues on the helicity and antibacterial activity of α-helical peptides is 
well established (Zhang et al., 1999) and the synthesis of proline-containing peptides confirmed the 
important role of structural parameters (i.e. helicity) for the biological activity of parent peptides 
L3, L4 and L5. Within the family of compounds, the structural arrangements were represented by 
α-helices (Ln peptides) → distort α-helices (peptides including C5 and C8 linkers) → β-turn (GPG 
linker). The activity followed a similar path, going from active molecules (L3, L4 and L5 peptides) 
to molecules only active at high concentrations (some peptides including C8 linkers (such as KL2, 
KL4, OL1 and LO1) and finally to non-active molecules (all the others) (Fig. 6.11). 
 
 
                                                 
α Visit: www.cms.hhs.gov/CLIA/downloads/sc04163.pdf (last accessed 05/04/06). 
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Fig. 6.11: Schematic representation of the correlation between secondary structure and biological 
activity for the compounds studied. Images were modified from Hancock, 2001. 
 
 
This study focused on the hydrophobic core of the bolaamphiphilic sapecin B-derived 
peptides. It especially developed around L3 peptide because of its significant antimicrobial activity 
(Hirakura et al., 1996; Nakajima et al., 1997). The obtained results showed that the hydrophobic 
content and the bolaamphiphilic/detergent-like structure was not the only important element for the 
activity. Three-dimensional structure and the ability to form hydrogen bonds are more likely to 
play a primary role in the antimicrobial activity of sapecin-derived compounds.  
Within CAMPs’ broad range of activities, some studies pointed out their ability to stimulate 
the immune system and decrease the possibility of bacterial infections (Brown and Hancock, 2006). 
The parent compound L5, for example, was found to protect organisms from methicillin resistant-S. 
aureus infection (Nakajima et al., 1997), activate the generation of reactive species of oxygen (Cho 
et al., 1990) and induce sustained adaptive immune responses in vivo (Fritz et al., 2004). Research 
on small peptides with no direct antimicrobial activity but with an immunostimulating influence is 
at the very early stages (Bowdish et al., 2005b). Nonetheless, several studies pointed out the 
existence of short peptides which have a strong in vivo immunomodulatory action without having 
any in vitro antibiotic property (Bowdish et al., 2005a). It is not possible to exclude such a role for 
the synthesised peptides and peptide hybrids as well, but the determination of any activity on the 
immune system was far beyond the aim of the current research.  
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Chapter 7 
 
Conclusions and recommendations 
 
 
 
 7.1 Conclusions 
  
 Amphiphilic and bolaamphiphilic peptides with antimicrobial properties represent a 
potentially new field for the development of antimicrobial leader compounds. The combination of 
the surfactant-like structure of bolaamphiphilic molecules and the inherent biological activity of 
short peptides could ultimately turn them into powerful tools mimicking natural materials and 
tissues (Luk and Abbot, 2002; Fairman and Åkerfeldt, 2005). The current research project 
developed around the design and synthesis of a library of compounds with a bolaamphiphilic 
structure, drawn from sapecin-derived synthetic peptides (Alvarez-Bravo et al., 1994). The aims of 
this research comprised (i) the assessment of the self-assembly tendency of basic bolaamphiphilic 
peptides and hybrids, (ii) the study of their supramolecular architectures from a morphological 
point of view, (iii) the characterisation of their hydrophobic profile in relation to the self-assembly 
and (iv) the study of their biological potentialities. 
 
 7.1.1 Understanding of the self-assembly behaviour 
 Amino acid composition and 3D arrangements of the compounds in solution were correlated 
to their aggregation profiles by using fluorescence (Chapter 4). This technique allowed the author 
to study the process while it was occurring. The bolaamphiphile concentration was the driving 
force of the process but other factors were also fundamental. The external environment, and 
specifically the pH, was the trigger for the self-assembly. For the same compound, the CAC in 
0.1% TEA was much lower than that in water.  
 The present study also confirmed the key role of amino acid composition in the self-assembly, 
which was influenced by the type of non-polar AA and the dimensions of the side-chain (Wang et 
al., 2005). Hydrophobic interactions were another important driving force of the self-assembly 
(Zhang et al., 1993; Santoso and Zhang, 2004). Hence, the presence of aromatic AA especially 
promoted the process through the π-stacking of aromatic side-chains (Caplan et al., 2002; Gazit, 
2002). Peptide bolaamphiphiles containing tyrosine showed a significant lower CAC than leucine-
containing analogue molecules. In addition, the role of the 3D structure was also clarified. 
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Proline-containing molecules showed much higher CAC values than analogue peptides containing 
9-aminononanoic acid. 
 
 7.1.2 Morphological study of the supramolecular assemblies 
 The morphology studies performed on the peptide assemblies revealed the complex 
supramolecular architectures formed by these compounds (Chapter 4). The aggregation was 
enforced by a pH modification and it occurred when the net charge of the peptide molecules was 
close to zero (Caplan et al., 2000). After an aging period of up to 15 days, the structures were 
clearly observed by means of different microscopes. CR staining and OM observation gave 
evidence of fibre-like structures characterised by birefringence properties under cross-polarised 
light. SEM micrographs also confirmed the formation of fibres with dimensions in the range of 
several microns (between 500 nm and 2 µm). The coexistence of microtubes/microfibres, vesicles, 
3-way junctions/branches and vesicles budding out of microtubes revealed that the self-assemblage 
of these surfactant-like molecules is a dynamic process (Vauthey et al., 2002). Cryo-SEM also 
revealed the formation of microtubes with consistent dimensions. Two mechanisms of microtube 
formation were detailed as possible pathways for the self-assembly of these molecules.  
   
 7.1.3 Hydrophobic content and its correlation to the self-assembly 
 The hydrophobic content of the synthesised peptide bolaamphiphiles was determined both 
experimentally (RP-HPLC) and theoretically (residue addition method and fragment addition 
method) (Chapter 5). The correlation between experimental and theoretical hydrophobicities 
revealed a good consistency even if slightly different correlation coefficients were found. The use 
of an octadecyl column gave similar results with the two gradients used, thus indicating that this 
type of column has an inherent strong ability to interact with the analyte regardless of the 
conditions used. On the other hand, the use of a dodecyl column was found to be influenced by the 
experimental conditions (such as the gradient). The correlation between CLOGPFRAGMENTS and the 
tR (C12) for the synthesised bolaamphiphilic peptides varied to some extent with the use of one or 
the other gradient. Therefore, in the present study, the use of a C18 column seemed to give more 
reliable results in terms of hydrophobic determination. 
 Interestingly, it was also possible to investigate the effect of the hydrophobic content on the 
self-assembly behaviour in water. In Chapter 4 the relationship between hydrophobic AA and 
enhanced self-organisation properties was already pointed out (Zhang et al., 1993). The 
experimental observations made during steady-state fluorescence measurements about the role of 
hydrophobic residues were confirmed. Compounds showing low CAC were characterised by a 
significant hydrophobic content (expressed by their CLOGPFRAGMENTS) while molecules with high 
CAC values possessed a low H  (Fig. 7.1). The only exception was represented by proline-
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containing peptides, where the influence of the 3D arrangements on the aggregation was much 
more important than the presence of hydrophobic residues. 
     
     
              
Fig. 7.1: Correlation between hydrophobicity (CLOGPFRAGMENTS)  
and CAC for 9-Anc containing molecules. 
 
 
 7.1.4 Influence of non-natural amino acids on the biological activity 
 These novel peptide-based bolaamphiphiles were developed using a synthetic antimicrobial 
pattern as template and comprised previously designed – and supposedly active – molecules (such 
as KL2 and KL4) (Naidoo, 2004). Anyway, the previously reported positive results of Naidoo 
(Naidoo, 2004) regarding the antimicrobial activity of the bolaamphiphilic peptides were not 
confirmed (Chapter 6). Multiple tests in the present investigation gave evidence of a complete lack 
of activity against bacteria and a strong inability to disorganise lipid membranes. The use of an 
amino acid pattern which presents an alternation of hydrophobic and hydrophilic AA was found not 
to be an optimal choice. This motif strongly promoted the self-assembly without having any 
positive effects on the biological activity (Vauthey et al., 2002; von Maltzahn et al., 2003). 
Especially the use of non natural AA (particularly considering the use of 9-Anc and 6-Ahx) greatly 
deformed the 3D arrangements and, as already discussed, could possibly explain the loss of activity 
for those peptide hybrids containing them. Confirmations in this regard were obtained by the use of 
the glycyl-prolyl-glycine tripeptide instead of 9-Anc, as none of the proline-containing peptides 
showed any sort of biological activity. Besides that, the use of more hydrophobic AA (such as 
tyrosine), while strongly increasing the aggregation (Santoso and Zhang, 2004), did not promote 
any lytic activity. Possibly, the aromatic side-chains, whose hydrophobic interactions significantly 
promoted the self-assembly, acted against the lysis of the bacterial membrane as none of the 
compounds containing tyrosine was found to be active. 
 
CAC 
HYDROPHOBICITY 
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 Furthermore, the use of 9-Anc and 6-Ahx affected the hydrophobic content of the sapecin-
derived molecules (expressed as CLOGP). While maintaining the length in terms of C atoms, the 
aliphatic chain gave a lower contribution to the overall H than the poly-leucine chain of L3, L4 and 
L5 peptides. The result was a lower hydrophobic content of the newly synthesised compounds, 
which could possibly be translated into weaker interactions with membranes. 
 
 
 7.2 Limitations 
  
 Even if CAMPs are at the centre of the research for new antibiotics some limitations mark a 
clear boundary between their many possible applications and real uses. In the present study the 
synthesis of hybrid molecules was still based on SPPS techniques (Chapter 3). Furthermore, the 
environmental impact of the synthesis and the high costs of production seriously reduce the 
applications to some restricted areas. Importantly, if the compounds present a low/moderate 
activity then these costs become prohibitive. These constraints could possibly be overcome by 
using enzymatic synthesis and by designing simpler molecules such as amino acid-based 
surfactants (Infante et al., 2004). 
 The alternation of charged and non-polar AAs (the KLK motif from sapecin-derived L3 
peptide) is interesting because of its similarity with some natural antimicrobial patterns. 
Nonetheless, it was shown to lose importance in the creation of hybrid molecules by including non-
proteinogenic AA in the primary structure. Certainly there are tri/pentapeptides that possess 
bioactivity and which are used for the creation of biomaterials through self-assembly, such as RGD 
for cell attachment and growth (Hartgerink et al., 2001), [RADA]n and IKVAV for neurite growth 
(Holmes et al., 2000; Silva et al., 2004). However, it appears that many parameters influenced the 
activity of sapecin-derived peptides and the presence of a KLK (or OLO) motif alone was not 
enough to confer antibiotic properties (Chapter 6). 
 The fluorescence study in water (pH 6) was limited, by technical difficulties, to  
concentrations lower than 45 mM. Consequently only two molecules (OY1 and OY2) were fully 
characterised in water and 0.1% TEA, while the others were only studied in the basic environment 
(pH 10). Nonetheless, even if it was not possible to evaluate the different aggregation profiles in 
water, the study in 0.1% TEA allowed the author to obtain a good general idea of the important 
parameters governing the self-assembly (Chapter 4). 
 CD results poorly followed the aggregation in water. Technical issues mainly affected the 
measurements (too high concentration, absorbing buffer, etc.) and the results were only useful to 
study the 3D structures in solution and confirm the modification of the parent molecules’ α-helix 
(Chapter 4).  
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 The use of gradient RP-HPLC for hydrophobicity determination is usually limited to some 
particular cases and isocratic liquid chromatography (hence k’) is generally preferred. Capacity 
factors were not determined and the lack of a parameter independent from the experimental 
conditions was possibly translated into poor R2 values when theoretical and experimental data were 
compared (R2 values were comprised between 0.86 and 0.96). This problem was also noticed when 
comparing CAC and tR as a direct relationship was absent. However, the use of CLOGPFRAGMENTS 
as H index gave results consistent with the literature, showing a direct correlation between 
hydrophobicity and self-assembly tendency for 9-Anc-containing molecules (Chapter 5). 
 
 
 7.3 Recommendations for future work 
 
 The concept of the bolaamphiphilic molecule could be applied to a new antimicrobial pattern 
from a natural CAMP and used to design new potentially active compounds. The selection of a 
novel highly active sequence from a CAMPs database could be the first step towards the 
development of a new project. The possible activity could then be studied with particular attention 
to the aggregation profile typical of bolaamphiphiles. Interestingly, it could be possible to evaluate 
the activity according to the aggregation status and separately test single molecules or peptide 
assemblies according to diverse experimental conditions (Pérez et al., 1996; Pérez et al., 2002). 
 This bolaamphiphilic model could lead to the creation of nanostructured biomaterials such as 
antimicrobial scaffolds for tissue regeneration, antimicrobial patches for burns and tissue healing, 
antibiotic textile fibers and biodegradable surfactants with biological properties (i.e. soaps). 
 Moreover, also the self-assembly process could be investigated from a different perspective. 
Light dispersion measurements could be used to study peptide aggregation in water without any 
external probe (i.e. pyrene). The use of fluorescent AAs (such as Tyr and Trp) could also offer an 
interesting way to study bolaamphiphiles’ aggregation in water by fluorescence.  
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Appendix A – Examples of natural antimicrobial peptides (adapted from Hancock and Powers, 2001) 
 A-1
PEPTIDE CLASS HOST/SYNTHETIC PDB ID 
CA-MA α-Helix Synthetic 1D9J 
CA-MA analogue (P1) α-Helix Synthetic 1D9L 
CA-MA analogue (P2) α-Helix Synthetic 1D9M 
CA-MA analogue (P3) α-Helix Synthetic 1D9O 
CA-MA analogue (P4) α-Helix Synthetic 1D9P 
Carnobacteriocin B2 α-Helix Carnobacerium piscicola 1CW5 
G-10 Novispirin α-Helix Synthetic 1HU6 
Magainin 2 α-Helix Xenopus laevis 2MAG 
Magainin 2 analogue α-Helix Synthetic 1DUM 
Moricin α-Helix Bombyx mori 1KV4 
Ovispirin-1 α-Helix Synthetic 1HU5 
Sheep myeloid antimicr peptide (Smap-29) α-Helix Ovis aries 1FRY 
T-7 Novispirin α-Helix Synthetic 1HU7 
γ-1-P thionin β-Sheet Triticum turgidum 1GPS 
θ-Defensin 1 β-Sheet Macaca mulatta 1HVZ 
A. hippocastanum antimicr protein 1 (Ah-Amp1) β-Sheet Aesculus hippocastanus 1BK8 
Androctonin β-Sheet Androctonus australis 1CZ6 
Bovine neutrophil β-defensin 12 (BNBD-12) β-Sheet Bos Taurus 1BNB 
Circulin A β-Sheet Chassalia parviflora 1BH4 
Drosomycin β-Sheet Drosophila melanogaster 1MYN 
Gomesin β-Sheet Acanthoscurria gomesiana 1KFP 
Heliomicin β-Sheet Heliothis virescens 1I2U 
Heliomicin analogue β-Sheet Synthetic 1I2V 
Hepcidin-20 β-Sheet Homo sapiens 1M4E 
Hepcidin-25 β-Sheet Homo sapiens 1M4F 
Human β-defensin 1 (Hbd-1) β-Sheet Homo sapiens 1KJ5 & 1E4S & 1IJV 
Human β-defensin 2 (Hbd-2) β-Sheet Homo sapiens 1E4Q 
Human β-defensin 3 (Hbd-3) β-Sheet Homo sapiens 1KJ6 
Human defensin (HNP-3) β-Sheet Homo sapiens 1DFN 
Insect defensin A β-Sheet Protophormia terraenovae 1ICA 
Lactoferricin B β-Sheet Bos Taurus 1LFC 
Leucocin A β-Sheet Leuconostoc gelidum 2LEU & 3LEU 
Mediterranean mussel defensin (MGD-1) β-Sheet Mytillus galloprovincialis 1FJN 
Mouse β-defensin 7 (Mbd-7) β-Sheet Mus musculus 1E4T 
Mouse β-defensin 8 (Mbd-8) β-Sheet Mus musculus 1E4R 
P. sativum defensin 1 (Psd-1) β-Sheet Pisum sativum 1JKZ 
Pafp-S β-Sheet Phytolacca Americana 1DKC 
Protegrin-1 (Pg1) β-Sheet Sus scrofa 1PG1 
Rabbit kidney defensin (RK-1) β-Sheet Oryctolagus cuniculus 1EWS 
Ramoplanin β-Sheet Actinoplanes sp. 1DSR 
Sapecin β-Sheet Sarcophaga peregrina 1LV4 
Tachyplesin I β-Sheet Tachypleus tridentatus 1MA2 & 1MA5 
Tachyplesin I analogue (Tpy4) β-Sheet Synthetic 1MA4 & 1MA6 
Tachystatin β-Sheet Tachypleus tridentatus 1CIX 
Ac-AMP2 Extended Amaranthus caudatus 1MMC 
Indolicidin Extended Bos Taurus 1G89 & 1G8C 
Indolicidin analogue (CP10A) Extended Synthetic 1HR1 
Pw2 Extended Synthetic 1M02 
Tritrpticin Extended Synthetic (potential porcine cathelicidin) 1D6X 
Thanatin Loop Podisus maculiventris 8TFV 
 
Appendix B – Additional mass spectra of peptide bolamaphiphiles 
 B-1
 
 
1. ESI-MS spectrum of crude KL4. Isotope variations are marked by i1, i2 and i3 corresponding to 
m/z-values with 1, 2 or 3 amu higher than the mass calculated from the monoisotope residue mass 
(unknown fragments are indicated by *). 
 
 
 
2. ESI-MS spectrum of crude OL1. Isotope variations are marked by i1, i2 and i3 corresponding to 
m/z-values with 1, 2 or 3 amu higher than the mass calculated from the monoisotope residue mass 
(unknown fragments are indicated by *). 
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Appendix B – Additional mass spectra of peptide bolamaphiphiles 
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3. ESI-MS spectrum of crude OL2. Isotope variations are marked by i1, i2 and i3 corresponding to 
m/z-values with 1, 2 or 3 amu higher than the mass calculated from the monoisotope residue mass 
(unknown fragments are indicated by *). 
 
 
 
4. ESI-MS spectrum of crude OY1. Isotope variations are marked by i1, i2 and i3 corresponding to 
m/z-values with 1, 2 or 3 amu higher than the mass calculated from the monoisotope residue mass 
(unknown fragments are indicated by *). 
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Appendix B – Additional mass spectra of peptide bolamaphiphiles 
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5. ESI-MS spectrum of crude OY2. Isotope variations are marked by i1, i2 and i3 corresponding to 
m/z-values with 1, 2 or 3 amu higher than the mass calculated from the monoisotope residue mass 
(unknown fragments are indicated by *). 
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Appendix C – Bio-Loom determination of the hydrophobic content of synthesised bolaamphiphilic 
peptides and peptide hybrids (Bio-Loom software is available for download from the internet at  
www.biobyte.com/prod/bb/bioloom.html).  
 C-5
 
H-Lys-Leu-Lys-Leu-Leu-Leu-Lys-Leu-Lys-NH2 (L3) 
C:  2.46             
SMILES NOTATION             
NC(CCCCN)C(NC(CC(C)C)C(NC(CCCCN)C(NC(CC(C)C)C(NC(CC(C)C)C(NC(CC(C)C)C(NC(CCCCN)C(
NC(CC(C)C)C(NC(CCCCN)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 2  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 3  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 4  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 5  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 6  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 9  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #10  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #11  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #12  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #13  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #14  | NH2-Amide [A]                          |Measured  | -1.990 
Carbon    |      | 45 aliphatic isolating carbons         |          |  8.775 
ExFragment|Branch| 5 chain and 0 cluster branches         |Chain     |  -.650 
ExFragment|Branch| 9 non-halogen, polar group branches    |Group     | -1.980 
ExFragment|Hydrog| 86 hydrogens on isolating carbons      |          | 19.522 
ExFragment|Bonds | 57 chain and 0 alicyclic (net)         |          | -6.840 
Proximity |YCY   | Fragments 1 & 4: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 1 & 2: -.32 (-2.71+-1.54)    |          |  1.360 
Proximity |YCY   | Fragments 4 & 6: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 6 & 7: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 8: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 8 & 9: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 9 & 11: -.32 (-2.71+-2.71)   |          |  1.734 
Proximity |YCY   | Fragments 11 & 12: -.32 (-2.71+-2.71)  |          |  1.734 
Proximity |YCY   | Fragments 12 & 14: -.32 (-2.71+-1.99)  |          |  1.504 
 
RESULT    |DB=23 | All fragments measured                 |CLOGP=5   |  2.462 
__________________________________________________________ 
 
H-Lys-Leu-Lys-Leu-Leu-Leu-Leu-Lys-Leu-Lys-NH2 (L4) 
C:  3.66   
SMILES NOTATION 
C(=O)(C(NC(C(CC(C)C)NC(=O)C(NC(C(CC(C)C)NC(C(CC(C)C)NC(C(CC(C)C)NC(C(CC(C)C)NC(=O
)C(NC(C(CC(C)C)NC(=O)C(N)CCCCN)=O)CCCCN)=O)=O)=O)=O)CCCCN)=O)CCCCN)N 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 2  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 3  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 4  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 5  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 6  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 9  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #10  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #11  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #12  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #13  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #14  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #15  | NH2-Amide [A]                          |Measured  | -1.990 
Carbon    |      | 50 aliphatic isolating carbons         |          |  9.750 
ExFragment|Branch| 6 chain and 0 cluster branches         |Chain     |  -.780 
ExFragment|Branch| 10 non-halogen, polar group branches   |Group     | -2.200 
ExFragment|Hydrog| 96 hydrogens on isolating carbons      |          | 21.792 
Appendix C – Bio-Loom determination of the hydrophobic content of synthesised bolaamphiphilic 
peptides and peptide hybrids (Bio-Loom software is available for download from the internet at  
www.biobyte.com/prod/bb/bioloom.html).  
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ExFragment|Bonds | 63 chain and 0 alicyclic (net)         |          | -7.560 
Proximity |YCY   | Fragments 1 & 4: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 1 & 2: -.32 (-2.71+-1.54)    |          |  1.360 
Proximity |YCY   | Fragments 4 & 6: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 6 & 7: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 8: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 8 & 9: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 9 & 10: -.32 (-2.71+-2.71)   |          |  1.734 
Proximity |YCY   | Fragments 10 & 12: -.32 (-2.71+-2.71)  |          |  1.734 
Proximity |YCY   | Fragments 12 & 13: -.32 (-2.71+-2.71)  |          |  1.734 
Proximity |YCY   | Fragments 13 & 15: -.32 (-2.71+-1.99)  |          |  1.504 
 
RESULT    |DB=23 | All fragments measured                 |CLOGP=5   |  3.661 
__________________________________________________________ 
 
H-Lys-Leu-Lys-Leu-Leu-Leu-Leu-Leu-Lys-Leu-Lys-NH2 (L5) 
C:  4.86              
SMILES NOTATION              
NC(CCCCN)C(NC(CC(C)C)C(NC(CCCCN)C(NC(CC(C)C)C(NC(CC(C)C)C(NC(CC(C)C)C(NC(CC(C)C)C
(NC(CC(C)C)C(NC(CCCCN)C(NC(CC(C)C)C(NC(CCCCN)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 2  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 3  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 4  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 5  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 6  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 9  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #10  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #11  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #12  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #13  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #14  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #15  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #16  | NH2-Amide [A]                          |Measured  | -1.990 
Carbon    |      | 55 aliphatic isolating carbons         |          | 10.725 
ExFragment|Branch| 7 chain and 0 cluster branches         |Chain     |  -.910 
ExFragment|Branch| 11 non-halogen, polar group branches   |Group     | -2.420 
ExFragment|Hydrog|106 hydrogens on isolating carbons      |          | 24.062 
ExFragment|Bonds | 69 chain and 0 alicyclic (net)         |          | -8.280 
Proximity |YCY   | Fragments 1 & 4: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 1 & 2: -.32 (-2.71+-1.54)    |          |  1.360 
Proximity |YCY   | Fragments 4 & 6: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 6 & 7: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 8: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 8 & 9: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 9 & 10: -.32 (-2.71+-2.71)   |          |  1.734 
Proximity |YCY   | Fragments 10 & 11: -.32 (-2.71+-2.71)  |          |  1.734 
Proximity |YCY   | Fragments 11 & 13: -.32 (-2.71+-2.71)  |          |  1.734 
Proximity |YCY   | Fragments 13 & 14: -.32 (-2.71+-2.71)  |          |  1.734 
Proximity |YCY   | Fragments 14 & 16: -.32 (-2.71+-1.99)  |          |  1.504 
 
RESULT    |DB=23 | All fragments measured                 |CLOGP=5   |  4.861 
_________________________________________________________ 
 
H-Lys-Leu-Lys-6-Ahx-Lys-Leu-Lys-OH (KL1) 
C: -2.59              
SMILES NOTATION 
NC(C(NC(C(NC(C(NCCCCCC(=O)NC(C(NC(C(NC(C(O)=O)CCCCN)=O)CC(C)C)=O)CCCCN)=O)CCCCN)=
O)CC(C)C)=O)CCCCN 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
Appendix C – Bio-Loom determination of the hydrophobic content of synthesised bolaamphiphilic 
peptides and peptide hybrids (Bio-Loom software is available for download from the internet at  
www.biobyte.com/prod/bb/bioloom.html).  
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Fragment  | # 1  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 2  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 3  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 4  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 5  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 6  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 9  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #10  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #11  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #12  | Carboxy (ZW-) [A]                      |Measured  | -1.070 
Carbon    |      | 35 aliphatic isolating carbons         |          |  6.825 
ExFragment|Branch| 2 chain and 0 cluster branches         |Chain     |  -.260 
ExFragment|Branch| 6 non-halogen, polar group branches    |Group     | -1.320 
ExFragment|Hydrog| 66 hydrogens on isolating carbons      |          | 14.982 
ExFragment|Bonds | 45 chain and 0 alicyclic (net)         |          | -5.400 
Proximity |YCY   | Fragments 1 & 4: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 1 & 2: -.32 (-2.71+-1.54)    |          |  1.360 
Proximity |YCY   | Fragments 4 & 6: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 9: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 9 & 10: -.32 (-2.71+-2.71)   |          |  1.734 
Proximity |YCY   | Fragments 10 & 12: -.42 (-2.71+-1.07)  |          |  1.588 
Zwitterion|Pairs | 1 zwitterion pair                      |          | -2.270 
 
RESULT    |DB=23 | All fragments measured                 |CLOGP=5   | -2.588 
_________________________________________________________ 
 
H-Lys-Leu-Lys-9-Anc-Lys-Leu-Lys-OH (KL2) 
C: -1.00 
SMILES NOTATION             
NC(C(NC(C(NC(C(NCCCCCCCCC(=O)NC(C(NC(C(NC(C(O)=O)CCCCN)=O)CC(C)C)=O)CCCCN)=O)CCCC
N)=O)CC(C)C)=O)CCCCN 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 2  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 3  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 4  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 5  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 6  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 9  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #10  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #11  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #12  | Carboxy (ZW-) [A]                      |Measured  | -1.070 
Carbon    |      | 38 aliphatic isolating carbons         |          |  7.410 
ExFragment|Branch| 2 chain and 0 cluster branches         |Chain     |  -.260 
ExFragment|Branch| 6 non-halogen, polar group branches    |Group     | -1.320 
ExFragment|Hydrog| 72 hydrogens on isolating carbons      |          | 16.344 
ExFragment|Bonds | 48 chain and 0 alicyclic (net)         |          | -5.760 
Proximity |YCY   | Fragments 1 & 4: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 1 & 2: -.32 (-2.71+-1.54)    |          |  1.360 
Proximity |YCY   | Fragments 4 & 6: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 9: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 9 & 10: -.32 (-2.71+-2.71)   |          |  1.734 
Proximity |YCY   | Fragments 10 & 12: -.42 (-2.71+-1.07)  |          |  1.588 
Zwitterion|Pairs | 1 zwitterion pair                      |          | -2.270 
 
RESULT    |DB=23 | All fragments measured                 |CLOGP=5   | -1.001 
__________________________________________________________ 
 
 
 
Appendix C – Bio-Loom determination of the hydrophobic content of synthesised bolaamphiphilic 
peptides and peptide hybrids (Bio-Loom software is available for download from the internet at  
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H-Lys-Leu-Lys-6-Ahx-Lys-Leu-Lys-NH2 (KL3) 
C: -1.32 
SMILES NOTATION                         
NC(CCCCN)C(NC(CC(C)C)C(NC(CCCCN)C(NCCCCCC(NC(CCCCN)C(NC(CC(C)C)C(NC(CCCCN)C(N)=O)
=O)=O)=O)=O)=O)=O 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 2  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 3  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 4  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 5  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 6  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 9  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #10  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #11  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #12  | NH2-Amide [A]                          |Measured  | -1.990 
Carbon    |      | 35 aliphatic isolating carbons         |          |  6.825 
ExFragment|Branch| 2 chain and 0 cluster branches         |Chain     |  -.260 
ExFragment|Branch| 6 non-halogen, polar group branches    |Group     | -1.320 
ExFragment|Hydrog| 66 hydrogens on isolating carbons      |          | 14.982 
ExFragment|Bonds | 45 chain and 0 alicyclic (net)         |          | -5.400 
Proximity |YCY   | Fragments 1 & 4: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 1 & 2: -.32 (-2.71+-1.54)    |          |  1.360 
Proximity |YCY   | Fragments 4 & 6: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 9: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 9 & 10: -.32 (-2.71+-2.71)   |          |  1.734 
Proximity |YCY   | Fragments 10 & 12: -.32 (-2.71+-1.99)  |          |  1.504 
 
RESULT    |DB=23 | All fragments measured                 |CLOGP=5   | -1.321 
__________________________________________________________ 
 
H-Lys-Leu-Lys-9-Anc-Lys-Leu-Lys-NH2 (KL4) 
C:  0.27     
SMILES NOTATION         
NC(CCCCN)C(NC(CC(C)C)C(NC(CCCCN)C(NCCCCCCCCC(NC(CCCCN)C(NC(CC(C)C)C(NC(CCCCN)C(N)
=O)=O)=O)=O)=O)=O)=O 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 2  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 3  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 4  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 5  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 6  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 9  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #10  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #11  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #12  | NH2-Amide [A]                          |Measured  | -1.990 
Carbon    |      | 38 aliphatic isolating carbons         |          |  7.410 
ExFragment|Branch| 2 chain and 0 cluster branches         |Chain     |  -.260 
ExFragment|Branch| 6 non-halogen, polar group branches    |Group     | -1.320 
ExFragment|Hydrog| 72 hydrogens on isolating carbons      |          | 16.344 
ExFragment|Bonds | 48 chain and 0 alicyclic (net)         |          | -5.760 
Proximity |YCY   | Fragments 1 & 4: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 1 & 2: -.32 (-2.71+-1.54)    |          |  1.360 
Proximity |YCY   | Fragments 4 & 6: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 9: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 9 & 10: -.32 (-2.71+-2.71)   |          |  1.734 
Proximity |YCY   | Fragments 10 & 12: -.32 (-2.71+-1.99)  |          |  1.504 
RESULT    |DB=23 | All fragments measured                 |CLOGP=5   |   .266 
Appendix C – Bio-Loom determination of the hydrophobic content of synthesised bolaamphiphilic 
peptides and peptide hybrids (Bio-Loom software is available for download from the internet at  
www.biobyte.com/prod/bb/bioloom.html).  
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H-Orn-Leu-Orn-9-Anc-Orn-Leu-Orn-NH2 (OL1) 
C: -1.85              
SMILES NOTATION 
NC(CCCN)C(NC(CC(C)C)C(NC(CCCN)C(NCCCCCCCCC(NC(CCCN)C(NC(CC(C)C)C(NC(CCCN)C(N)=O)=
O)=O)=O)=O)=O)=O 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 2  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 3  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 4  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 5  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 6  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 9  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #10  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #11  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #12  | NH2-Amide [A]                          |Measured  | -1.990 
Carbon    |      | 34 aliphatic isolating carbons         |          |  6.630 
ExFragment|Branch| 2 chain and 0 cluster branches         |Chain     |  -.260 
ExFragment|Branch| 6 non-halogen, polar group branches    |Group     | -1.320 
ExFragment|Hydrog| 64 hydrogens on isolating carbons      |          | 14.528 
ExFragment|Bonds | 44 chain and 0 alicyclic (net)         |          | -5.280 
Proximity |YCY   | Fragments 1 & 4: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 1 & 2: -.32 (-2.71+-1.54)    |          |  1.360 
Proximity |YCY   | Fragments 4 & 6: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 9: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 9 & 10: -.32 (-2.71+-2.71)   |          |  1.734 
Proximity |YCY   | Fragments 10 & 12: -.32 (-2.71+-1.99)  |          |  1.504 
 
RESULT    |DB=23 | All fragments measured                 |CLOGP=5   | -1.850 
_____________________________________________________________________ 
 
H-Orn-Leu-Orn-Gly-Pro-Gly-Orn-Leu-Orn-NH2 (OL2) 
C: -5.33              
SMILES NOTATION 
NC(CCCN)C(NC(CC(C)C)C(NC(CCCN)C(NC([H])C(N1C(C(NC([H])C(NC(CCCN)C(NC(CC(C)C)C(NC(
CCCN)C(N)=O)=O)=O)=O)=O)CCC1)=O)=O)=O)=O 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | [H]* [A]                               |Calculated| -1.316 
Fragment  | # 2  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 3  | Amide [RRA]                            |Derived   | -3.600 
Fragment  | # 4  | [H]* [A]                               |Calculated| -1.316 
Fragment  | # 5  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 6  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 9  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #10  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #11  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #12  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #13  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #14  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #15  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #16  | NH2-Amide [A]                          |Measured  | -1.990 
Carbon    |      | 32 aliphatic isolating carbons         |          |  6.240 
ExFragment|Branch| 2 chain and 0 cluster branches         |Chain     |  -.260 
ExFragment|Branch| 9 non-halogen, polar group branches    |Group     | -1.980 
ExFragment|Hydrog| 57 hydrogens on isolating carbons      |          | 12.939 
ExFragment|Bonds | 41 chain and 5 alicyclic (net)         |Combined  | -5.370 
Proximity |YCY   | Fragments 1 & 2: -.32 (-1.32+-2.71)    |          |  1.288 
Proximity |YCY   | Fragments 1 & 11: -.32 (-1.32+-2.71)   |          |  1.288 
 
Appendix C – Bio-Loom determination of the hydrophobic content of synthesised bolaamphiphilic 
peptides and peptide hybrids (Bio-Loom software is available for download from the internet at  
www.biobyte.com/prod/bb/bioloom.html).  
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Proximity |YCY   | Fragments 2 & 3: -.32 (-2.71+-3.60)    |          |  2.019 
Proximity |YCY   | Fragments 3 & 4: -.32 (-3.60+-1.32)    |          |  1.573 
Proximity |YCY   | Fragments 3 & 5: -.32 (-3.60+-2.71)    |          |  2.019 
Proximity |YCY   | Fragments 5 & 7: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 8: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 8 & 9: -.32 (-2.71+-1.54)    |          |  1.360 
Proximity |YCY   | Fragments 11 & 13: -.32 (-2.71+-2.71)  |          |  1.734 
Proximity |YCY   | Fragments 13 & 14: -.32 (-2.71+-2.71)  |          |  1.734 
Proximity |YCY   | Fragments 14 & 16: -.32 (-2.71+-1.99)  |          |  1.504 
 
RESULT    |DB=23 | Calculated fragment value              |CLOGP=5   | -5.333 
__________________________________________________________ 
 
H-Orn-Tyr-Orn-9-Anc-Orn-Tyr-Orn-NH2 (OY1) 
C: -3.26              
SMILES NOTATION 
NC(CCCN)C(NC(CC1=CC=C(O)C=C1)C(NC(CCCN)C(NCCCCCCCCC(NC(CCCN)C(NC(CC2=CC=C(O)C=C2)
C(NC(CCCN)C(N)=O)=O)=O)=O)=O)=O)=O 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 2  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 3  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 4  | Alcohol or Hydroxy [a]                 |Measured  |  -.440 
Fragment  | # 5  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 6  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 9  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #10  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #11  | Alcohol or Hydroxy [a]                 |Measured  |  -.440 
Fragment  | #12  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #13  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #14  | NH2-Amide [A]                          |Measured  | -1.990 
Carbon    |      | 28 aliphatic isolating carbons         |          |  5.460 
Carbon    |      | 12 aromatic isolating carbons          |          |  1.560 
ExFragment|Branch| 6 non-halogen, polar group branches    |Group     | -1.320 
ExFragment|Hydrog| 58 hydrogens on isolating carbons      |          | 13.166 
ExFragment|Bonds | 40 chain and 0 alicyclic (net)         |          | -4.800 
Benzylbond|Simple| 2 benzyl bonds to simple aromatics     |          |  -.300 
Proximity |YCY   | Fragments 2 & 3: -.32 (-1.54+-2.71)    |          |  1.360 
Proximity |YCY   | Fragments 3 & 5: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 5 & 7: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 8 & 10: -.32 (-2.71+-2.71)   |          |  1.734 
Proximity |YCY   | Fragments 10 & 12: -.32 (-2.71+-2.71)  |          |  1.734 
Proximity |YCY   | Fragments 12 & 14: -.32 (-2.71+-1.99)  |          |  1.504 
 
RESULT    |DB=23 | All fragments measured                 |CLOGP=5   | -3.262 
__________________________________________________________ 
 
H-Orn-Tyr-Orn-Gly-Pro-Gly-Orn-Tyr-Orn-NH2 (OY2) 
C: -6.75 
SMILES NOTATION             
NC(CCCN)C(NC(CC1=CC=C(O)C=C1)C(NC(CCCN)C(NC([H])C(N2C(C(NC([H])C(NC(CCCN)C(NC(CC3
=CC=C(O)C=C3)C(NC(CCCN)C(N)=O)=O)=O)=O)=O)CCC2)=O)=O)=O)=O # Calculated fragment 
value 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | [H]* [A]                               |Calculated| -1.316 
Fragment  | # 2  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 3  | Amide [RRA]                            |Derived   | -3.600 
Fragment  | # 4  | [H]* [A]                               |Calculated| -1.316 
Fragment  | # 5  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 6  | Primary Amine [A]                      |Measured  | -1.540 
Appendix C – Bio-Loom determination of the hydrophobic content of synthesised bolaamphiphilic 
peptides and peptide hybrids (Bio-Loom software is available for download from the internet at  
www.biobyte.com/prod/bb/bioloom.html).  
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Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | Alcohol or Hydroxy [a]                 |Measured  |  -.440 
Fragment  | # 9  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #10  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #11  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #12  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #13  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #14  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #15  | Alcohol or Hydroxy [a]                 |Measured  |  -.440 
Fragment  | #16  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #17  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | #18  | NH2-Amide [A]                          |Measured  | -1.990 
Carbon    |      | 26 aliphatic isolating carbons         |          |  5.070 
Carbon    |      | 12 aromatic isolating carbons          |          |  1.560 
ExFragment|Branch| 9 non-halogen, polar group branches    |Group     | -1.980 
ExFragment|Hydrog| 51 hydrogens on isolating carbons      |          | 11.577 
ExFragment|Bonds | 37 chain and 5 alicyclic (net)         |Combined  | -4.890 
Benzylbond|Simple| 2 benzyl bonds to simple aromatics     |          |  -.300 
Proximity |YCY   | Fragments 1 & 2: -.32 (-1.32+-2.71)    |          |  1.288 
Proximity |YCY   | Fragments 1 & 12: -.32 (-1.32+-2.71)   |          |  1.288 
Proximity |YCY   | Fragments 2 & 3: -.32 (-2.71+-3.60)    |          |  2.019 
Proximity |YCY   | Fragments 3 & 4: -.32 (-3.60+-1.32)    |          |  1.573 
Proximity |YCY   | Fragments 3 & 5: -.32 (-3.60+-2.71)    |          |  2.019 
Proximity |YCY   | Fragments 5 & 7: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 9: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 9 & 10: -.32 (-2.71+-1.54)   |          |  1.360 
Proximity |YCY   | Fragments 12 & 14: -.32 (-2.71+-2.71)  |          |  1.734 
Proximity |YCY   | Fragments 14 & 16: -.32 (-2.71+-2.71)  |          |  1.734 
Proximity |YCY   | Fragments 16 & 18: -.32 (-2.71+-1.99)  |          |  1.504 
 
RESULT    |DB=23 | Calculated fragment value              |CLOGP=5   | -6.745 
_________________________________________________________ 
 
H-Leu-Orn-Leu-9-Anc-Leu-Orn-Leu-NH2 (LO1) 
C:  2.72   
SMILES NOTATION           
NC(CC(C)C)C(NC(CCCN)C(NC(CC(C)C)C(NCCCCCCCCC(NC(CC(C)C)C(NC(CCCN)C(NC(CC(C)C)C(N)
=O)=O)=O)=O)=O)=O)=O 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 2  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 3  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 4  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 5  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 6  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 9  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #10  | NH2-Amide [A]                          |Measured  | -1.990 
Carbon    |      | 36 aliphatic isolating carbons         |          |  7.020 
ExFragment|Branch| 4 chain and 0 cluster branches         |Chain     |  -.520 
ExFragment|Branch| 6 non-halogen, polar group branches    |Group     | -1.320 
ExFragment|Hydrog| 70 hydrogens on isolating carbons      |          | 15.890 
ExFragment|Bonds | 44 chain and 0 alicyclic (net)         |          | -5.280 
Proximity |YCY   | Fragments 1 & 2: -.32 (-1.54+-2.71)    |          |  1.360 
Proximity |YCY   | Fragments 2 & 4: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 4 & 5: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 6 & 7: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 9: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 9 & 10: -.32 (-2.71+-1.99)   |          |  1.504 
 
RESULT    |DB=23 | All fragments measured                 |CLOGP=5   |  2.722 
_________________________________________________________ 
 
Appendix C – Bio-Loom determination of the hydrophobic content of synthesised bolaamphiphilic 
peptides and peptide hybrids (Bio-Loom software is available for download from the internet at  
www.biobyte.com/prod/bb/bioloom.html).  
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H-Leu-Tyr-Leu-9-Anc-Leu-Tyr-Leu-NH2 (LY1) 
C:  5.88        
SMILES NOTATION      
NC(CC(C)C)C(NC(CC1=CC=C(O)C=C1)C(NC(CC(C)C)C(NCCCCCCCCC(NC(CC(C)C)C(NC(CC2=CC=C(O
)C=C2)C(NC(CC(C)C)C(N)=O)=O)=O)=O)=O)=O)=O 
 
  Class   | Type |    Log(P) Contribution Description     | Comment  | Value 
 
Fragment  | # 1  | Primary Amine [A]                      |Measured  | -1.540 
Fragment  | # 2  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 3  | Alcohol or Hydroxy [a]                 |Measured  |  -.440 
Fragment  | # 4  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 5  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 6  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 7  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | # 8  | Alcohol or Hydroxy [a]                 |Measured  |  -.440 
Fragment  | # 9  | NH-Amide [AA]                          |Measured  | -2.710 
Fragment  | #10  | NH2-Amide [A]                          |Measured  | -1.990 
Carbon    |      | 32 aliphatic isolating carbons         |          |  6.240 
Carbon    |      | 12 aromatic isolating carbons          |          |  1.560 
ExFragment|Branch| 4 chain and 0 cluster branches         |Chain     |  -.520 
ExFragment|Branch| 6 non-halogen, polar group branches    |Group     | -1.320 
ExFragment|Hydrog| 70 hydrogens on isolating carbons      |          | 15.890 
ExFragment|Bonds | 40 chain and 0 alicyclic (net)         |          | -4.800 
Benzylbond|Simple| 2 benzyl bonds to simple aromatics     |          |  -.300 
Proximity |YCY   | Fragments 1 & 2: -.32 (-1.54+-2.71)    |          |  1.360 
Proximity |YCY   | Fragments 2 & 4: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 4 & 5: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 6 & 7: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 7 & 9: -.32 (-2.71+-2.71)    |          |  1.734 
Proximity |YCY   | Fragments 9 & 10: -.32 (-2.71+-1.99)   |          |  1.504 
 
RESULT    |DB=23 | All fragments measured                 |CLOGP=5   |  5.882 
_________________________________________________________ 
